WO2009103026A1 - Engineered microorganisms for producing isopropanol - Google Patents
Engineered microorganisms for producing isopropanol Download PDFInfo
- Publication number
- WO2009103026A1 WO2009103026A1 PCT/US2009/034152 US2009034152W WO2009103026A1 WO 2009103026 A1 WO2009103026 A1 WO 2009103026A1 US 2009034152 W US2009034152 W US 2009034152W WO 2009103026 A1 WO2009103026 A1 WO 2009103026A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- bio
- based material
- coa
- material precursor
- isopropanol
- Prior art date
Links
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 title claims description 425
- 244000005700 microbiome Species 0.000 title claims description 101
- 238000000034 method Methods 0.000 claims abstract description 120
- 239000000463 material Substances 0.000 claims abstract description 105
- 239000002243 precursor Substances 0.000 claims abstract description 86
- 238000004519 manufacturing process Methods 0.000 claims abstract description 67
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 235
- 238000006243 chemical reaction Methods 0.000 claims description 196
- 229960004592 isopropanol Drugs 0.000 claims description 194
- 102000004190 Enzymes Human genes 0.000 claims description 138
- 108090000790 Enzymes Proteins 0.000 claims description 138
- ZSLZBFCDCINBPY-ZSJPKINUSA-N acetyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 ZSLZBFCDCINBPY-ZSJPKINUSA-N 0.000 claims description 130
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 claims description 119
- 229910052799 carbon Inorganic materials 0.000 claims description 85
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 75
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 claims description 67
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 claims description 67
- 230000004151 fermentation Effects 0.000 claims description 61
- 238000000855 fermentation Methods 0.000 claims description 60
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 60
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 60
- OJFDKHTZOUZBOS-CITAKDKDSA-N acetoacetyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)CC(=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 OJFDKHTZOUZBOS-CITAKDKDSA-N 0.000 claims description 58
- 229920001184 polypeptide Polymers 0.000 claims description 58
- 239000011942 biocatalyst Substances 0.000 claims description 48
- WDJHALXBUFZDSR-UHFFFAOYSA-M acetoacetate Chemical compound CC(=O)CC([O-])=O WDJHALXBUFZDSR-UHFFFAOYSA-M 0.000 claims description 46
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 45
- 230000000813 microbial effect Effects 0.000 claims description 44
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims description 40
- 108020004414 DNA Proteins 0.000 claims description 39
- 102000053602 DNA Human genes 0.000 claims description 38
- 229910052739 hydrogen Inorganic materials 0.000 claims description 38
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 26
- -1 polypropylene Polymers 0.000 claims description 17
- 229920002472 Starch Polymers 0.000 claims description 14
- 239000008107 starch Substances 0.000 claims description 14
- 235000019698 starch Nutrition 0.000 claims description 14
- 235000000346 sugar Nutrition 0.000 claims description 14
- 239000004743 Polypropylene Substances 0.000 claims description 10
- 229920002678 cellulose Polymers 0.000 claims description 10
- 229920001155 polypropylene Polymers 0.000 claims description 10
- 239000001913 cellulose Substances 0.000 claims description 9
- 229920001277 pectin Polymers 0.000 claims description 8
- 239000001814 pectin Substances 0.000 claims description 8
- 235000010987 pectin Nutrition 0.000 claims description 8
- 229920002488 Hemicellulose Polymers 0.000 claims description 7
- 239000003377 acid catalyst Substances 0.000 claims description 4
- 239000000203 mixture Substances 0.000 abstract description 6
- 210000004027 cell Anatomy 0.000 description 118
- 108090000623 proteins and genes Proteins 0.000 description 115
- 239000000047 product Substances 0.000 description 64
- BAWFJGJZGIEFAR-NNYOXOHSSA-O NAD(+) Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-O 0.000 description 62
- 230000014509 gene expression Effects 0.000 description 52
- 230000037361 pathway Effects 0.000 description 51
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 50
- 241000588724 Escherichia coli Species 0.000 description 39
- 239000000758 substrate Substances 0.000 description 35
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 34
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 32
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 32
- 239000000126 substance Substances 0.000 description 32
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 31
- 239000013612 plasmid Substances 0.000 description 31
- 229910002092 carbon dioxide Inorganic materials 0.000 description 28
- 239000008103 glucose Substances 0.000 description 28
- 239000002609 medium Substances 0.000 description 28
- 230000008569 process Effects 0.000 description 27
- 102000007698 Alcohol dehydrogenase Human genes 0.000 description 26
- 108010021809 Alcohol dehydrogenase Proteins 0.000 description 26
- 150000001413 amino acids Chemical class 0.000 description 25
- 102000004169 proteins and genes Human genes 0.000 description 25
- 150000007523 nucleic acids Chemical class 0.000 description 24
- 235000018102 proteins Nutrition 0.000 description 24
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 23
- 241000193454 Clostridium beijerinckii Species 0.000 description 22
- 229940100228 acetyl coenzyme a Drugs 0.000 description 22
- 102000039446 nucleic acids Human genes 0.000 description 21
- 108020004707 nucleic acids Proteins 0.000 description 21
- 241000193403 Clostridium Species 0.000 description 20
- 108060008225 Thiolase Proteins 0.000 description 20
- 108091022873 acetoacetate decarboxylase Proteins 0.000 description 20
- 229940044613 1-propanol Drugs 0.000 description 19
- 102000002932 Thiolase Human genes 0.000 description 18
- 229960005335 propanol Drugs 0.000 description 17
- 108010084715 isopropanol dehydrogenase (NADP) Proteins 0.000 description 16
- 102000040430 polynucleotide Human genes 0.000 description 16
- 108091033319 polynucleotide Proteins 0.000 description 16
- 239000002157 polynucleotide Substances 0.000 description 16
- 229960000723 ampicillin Drugs 0.000 description 15
- 230000001965 increasing effect Effects 0.000 description 15
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 14
- 239000002028 Biomass Substances 0.000 description 13
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Natural products CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 13
- 241000193401 Clostridium acetobutylicum Species 0.000 description 13
- 230000004913 activation Effects 0.000 description 13
- 238000001994 activation Methods 0.000 description 13
- 150000001875 compounds Chemical class 0.000 description 13
- 239000000543 intermediate Substances 0.000 description 13
- 230000037353 metabolic pathway Effects 0.000 description 13
- 101100313703 Clostridium acetobutylicum (strain ATCC 824 / DSM 792 / JCM 1419 / LMG 5710 / VKM B-1787) thlA gene Proteins 0.000 description 12
- 101100313720 Clostridium pasteurianum thl gene Proteins 0.000 description 12
- 101100217614 Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd) atoB gene Proteins 0.000 description 12
- 108010022074 acetoacetyl-CoA hydrolase Proteins 0.000 description 12
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 12
- FERIUCNNQQJTOY-UHFFFAOYSA-M Butyrate Chemical compound CCCC([O-])=O FERIUCNNQQJTOY-UHFFFAOYSA-M 0.000 description 11
- 101150006589 adc gene Proteins 0.000 description 11
- 239000003795 chemical substances by application Substances 0.000 description 11
- 238000006297 dehydration reaction Methods 0.000 description 11
- 239000003112 inhibitor Substances 0.000 description 11
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 11
- 241000193830 Bacillus <bacterium> Species 0.000 description 10
- 101100385572 Clostridium acetobutylicum (strain ATCC 824 / DSM 792 / JCM 1419 / LMG 5710 / VKM B-1787) ctfA gene Proteins 0.000 description 10
- 241000235648 Pichia Species 0.000 description 10
- 102000004357 Transferases Human genes 0.000 description 10
- 108090000992 Transferases Proteins 0.000 description 10
- 240000008042 Zea mays Species 0.000 description 10
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 10
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 10
- 235000005822 corn Nutrition 0.000 description 10
- 230000002503 metabolic effect Effects 0.000 description 10
- 230000004048 modification Effects 0.000 description 10
- 238000012986 modification Methods 0.000 description 10
- 241000894006 Bacteria Species 0.000 description 9
- 101150056596 azin2 gene Proteins 0.000 description 9
- 239000003054 catalyst Substances 0.000 description 9
- 230000018044 dehydration Effects 0.000 description 9
- 238000012217 deletion Methods 0.000 description 9
- 230000037430 deletion Effects 0.000 description 9
- 238000004817 gas chromatography Methods 0.000 description 9
- 230000002779 inactivation Effects 0.000 description 9
- 108010092060 Acetate kinase Proteins 0.000 description 8
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 7
- 239000006227 byproduct Substances 0.000 description 7
- 150000001720 carbohydrates Chemical class 0.000 description 7
- 235000014633 carbohydrates Nutrition 0.000 description 7
- 230000001419 dependent effect Effects 0.000 description 7
- 239000000446 fuel Substances 0.000 description 7
- 239000007789 gas Substances 0.000 description 7
- 230000002068 genetic effect Effects 0.000 description 7
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 7
- 239000002773 nucleotide Substances 0.000 description 7
- 125000003729 nucleotide group Chemical group 0.000 description 7
- 102100026105 3-ketoacyl-CoA thiolase, mitochondrial Human genes 0.000 description 6
- 108010006229 Acetyl-CoA C-acetyltransferase Proteins 0.000 description 6
- 241000186216 Corynebacterium Species 0.000 description 6
- 241000196324 Embryophyta Species 0.000 description 6
- 241000233866 Fungi Species 0.000 description 6
- 241000187654 Nocardia Species 0.000 description 6
- 241000589516 Pseudomonas Species 0.000 description 6
- 241000607142 Salmonella Species 0.000 description 6
- 241000187747 Streptomyces Species 0.000 description 6
- 238000007792 addition Methods 0.000 description 6
- 150000001298 alcohols Chemical class 0.000 description 6
- 235000010633 broth Nutrition 0.000 description 6
- RGJOEKWQDUBAIZ-UHFFFAOYSA-N coenzime A Natural products OC1C(OP(O)(O)=O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-UHFFFAOYSA-N 0.000 description 6
- 239000005516 coenzyme A Substances 0.000 description 6
- 229940093530 coenzyme a Drugs 0.000 description 6
- KDTSHFARGAKYJN-UHFFFAOYSA-N dephosphocoenzyme A Natural products OC1C(O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 KDTSHFARGAKYJN-UHFFFAOYSA-N 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 description 6
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 239000003345 natural gas Substances 0.000 description 6
- 239000002904 solvent Substances 0.000 description 6
- 241000186063 Arthrobacter Species 0.000 description 5
- 241000228212 Aspergillus Species 0.000 description 5
- 241000722885 Brettanomyces Species 0.000 description 5
- 241000186146 Brevibacterium Species 0.000 description 5
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 5
- 101100385573 Clostridium acetobutylicum (strain ATCC 824 / DSM 792 / JCM 1419 / LMG 5710 / VKM B-1787) ctfB gene Proteins 0.000 description 5
- 108020004705 Codon Proteins 0.000 description 5
- 241000235035 Debaryomyces Species 0.000 description 5
- 241001123633 Galactomyces Species 0.000 description 5
- 241000589236 Gluconobacter Species 0.000 description 5
- 241001149669 Hanseniaspora Species 0.000 description 5
- 241000235649 Kluyveromyces Species 0.000 description 5
- 241001123674 Metschnikowia Species 0.000 description 5
- 229910019142 PO4 Inorganic materials 0.000 description 5
- 241000235652 Pachysolen Species 0.000 description 5
- 241000316848 Rhodococcus <scale insect> Species 0.000 description 5
- 241000223252 Rhodotorula Species 0.000 description 5
- 102000019259 Succinate Dehydrogenase Human genes 0.000 description 5
- 108010012901 Succinate Dehydrogenase Proteins 0.000 description 5
- 241001147775 Thermoanaerobacter brockii Species 0.000 description 5
- 241000235152 Williopsis Species 0.000 description 5
- 241000589634 Xanthomonas Species 0.000 description 5
- 241000235017 Zygosaccharomyces Species 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 230000002378 acidificating effect Effects 0.000 description 5
- 150000001336 alkenes Chemical class 0.000 description 5
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 5
- 239000001569 carbon dioxide Substances 0.000 description 5
- 229960005091 chloramphenicol Drugs 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 230000004907 flux Effects 0.000 description 5
- 239000012634 fragment Substances 0.000 description 5
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 5
- 238000004811 liquid chromatography Methods 0.000 description 5
- 239000003921 oil Substances 0.000 description 5
- 235000019198 oils Nutrition 0.000 description 5
- 238000007254 oxidation reaction Methods 0.000 description 5
- 239000010452 phosphate Substances 0.000 description 5
- 229920000642 polymer Polymers 0.000 description 5
- 239000002994 raw material Substances 0.000 description 5
- 230000009467 reduction Effects 0.000 description 5
- 102000006589 Alpha-ketoglutarate dehydrogenase Human genes 0.000 description 4
- 108020004306 Alpha-ketoglutarate dehydrogenase Proteins 0.000 description 4
- 241001508395 Burkholderia sp. Species 0.000 description 4
- 241001464430 Cyanobacterium Species 0.000 description 4
- 241000620209 Escherichia coli DH5[alpha] Species 0.000 description 4
- 241001302584 Escherichia coli str. K-12 substr. W3110 Species 0.000 description 4
- 101100462488 Phlebiopsis gigantea p2ox gene Proteins 0.000 description 4
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 4
- 241000235346 Schizosaccharomyces Species 0.000 description 4
- 241000235006 Torulaspora Species 0.000 description 4
- 241000235013 Yarrowia Species 0.000 description 4
- XJLXINKUBYWONI-DQQFMEOOSA-N [[(2r,3r,4r,5r)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2s,3r,4s,5s)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate Chemical compound NC(=O)C1=CC=C[N+]([C@@H]2[C@H]([C@@H](O)[C@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-DQQFMEOOSA-N 0.000 description 4
- LIPOUNRJVLNBCD-UHFFFAOYSA-N acetyl dihydrogen phosphate Chemical compound CC(=O)OP(O)(O)=O LIPOUNRJVLNBCD-UHFFFAOYSA-N 0.000 description 4
- 150000007513 acids Chemical class 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 4
- 239000003245 coal Substances 0.000 description 4
- 239000008121 dextrose Substances 0.000 description 4
- 230000007613 environmental effect Effects 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- 239000001963 growth medium Substances 0.000 description 4
- 230000005764 inhibitory process Effects 0.000 description 4
- 238000011081 inoculation Methods 0.000 description 4
- 239000002054 inoculum Substances 0.000 description 4
- 238000012269 metabolic engineering Methods 0.000 description 4
- 230000004060 metabolic process Effects 0.000 description 4
- 238000001823 molecular biology technique Methods 0.000 description 4
- 239000000178 monomer Substances 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 4
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 description 4
- 230000003647 oxidation Effects 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 4
- 101150060030 poxB gene Proteins 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- QPRQEDXDYOZYLA-UHFFFAOYSA-N sec-pentyl alcohol Natural products CCC(C)CO QPRQEDXDYOZYLA-UHFFFAOYSA-N 0.000 description 4
- 241000894007 species Species 0.000 description 4
- 230000004102 tricarboxylic acid cycle Effects 0.000 description 4
- 239000013598 vector Substances 0.000 description 4
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 3
- 241000588722 Escherichia Species 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 229930091371 Fructose Natural products 0.000 description 3
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 3
- 239000005715 Fructose Substances 0.000 description 3
- 235000010469 Glycine max Nutrition 0.000 description 3
- 102000013460 Malate Dehydrogenase Human genes 0.000 description 3
- 108010026217 Malate Dehydrogenase Proteins 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 108091028043 Nucleic acid sequence Proteins 0.000 description 3
- 108700023175 Phosphate acetyltransferases Proteins 0.000 description 3
- 241000235070 Saccharomyces Species 0.000 description 3
- 101100398785 Streptococcus agalactiae serotype V (strain ATCC BAA-611 / 2603 V/R) ldhD gene Proteins 0.000 description 3
- 101100386830 Zymomonas mobilis subsp. mobilis (strain ATCC 31821 / ZM4 / CP4) ddh gene Proteins 0.000 description 3
- 230000033228 biological regulation Effects 0.000 description 3
- ZTQSAGDEMFDKMZ-UHFFFAOYSA-N butyric aldehyde Natural products CCCC=O ZTQSAGDEMFDKMZ-UHFFFAOYSA-N 0.000 description 3
- 230000010261 cell growth Effects 0.000 description 3
- 210000000349 chromosome Anatomy 0.000 description 3
- 210000000172 cytosol Anatomy 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 230000002255 enzymatic effect Effects 0.000 description 3
- 238000005755 formation reaction Methods 0.000 description 3
- 239000001760 fusel oil Substances 0.000 description 3
- 238000010353 genetic engineering Methods 0.000 description 3
- 150000004676 glycans Chemical class 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 230000001939 inductive effect Effects 0.000 description 3
- 101150026107 ldh1 gene Proteins 0.000 description 3
- 101150041530 ldha gene Proteins 0.000 description 3
- 239000003550 marker Substances 0.000 description 3
- 239000002207 metabolite Substances 0.000 description 3
- 150000002772 monosaccharides Chemical class 0.000 description 3
- 229920001542 oligosaccharide Polymers 0.000 description 3
- 150000002482 oligosaccharides Chemical class 0.000 description 3
- 238000005457 optimization Methods 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 230000003362 replicative effect Effects 0.000 description 3
- 229920002477 rna polymer Polymers 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid group Chemical class S(O)(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 3
- 230000009466 transformation Effects 0.000 description 3
- 239000002699 waste material Substances 0.000 description 3
- ASJSAQIRZKANQN-CRCLSJGQSA-N 2-deoxy-D-ribose Chemical compound OC[C@@H](O)[C@@H](O)CC=O ASJSAQIRZKANQN-CRCLSJGQSA-N 0.000 description 2
- IWTBVKIGCDZRPL-LURJTMIESA-N 3-Methylbutanol Natural products CC[C@H](C)CCO IWTBVKIGCDZRPL-LURJTMIESA-N 0.000 description 2
- 108010023941 Acetyl-CoA Hydrolase Proteins 0.000 description 2
- HGINCPLSRVDWNT-UHFFFAOYSA-N Acrolein Chemical compound C=CC=O HGINCPLSRVDWNT-UHFFFAOYSA-N 0.000 description 2
- 241000203069 Archaea Species 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical class N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241001453380 Burkholderia Species 0.000 description 2
- 241001112696 Clostridia Species 0.000 description 2
- 241000186522 Clostridium aurantibutyricum Species 0.000 description 2
- 108091026890 Coding region Proteins 0.000 description 2
- 108700010070 Codon Usage Proteins 0.000 description 2
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical class O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- 229920001353 Dextrin Polymers 0.000 description 2
- 239000004375 Dextrin Substances 0.000 description 2
- 241000192125 Firmicutes Species 0.000 description 2
- 108010068370 Glutens Proteins 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- NYHBQMYGNKIUIF-UUOKFMHZSA-N Guanosine Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O NYHBQMYGNKIUIF-UUOKFMHZSA-N 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 2
- NBBJYMSMWIIQGU-UHFFFAOYSA-N Propionic aldehyde Chemical compound CCC=O NBBJYMSMWIIQGU-UHFFFAOYSA-N 0.000 description 2
- 108010009736 Protein Hydrolysates Proteins 0.000 description 2
- 102000001253 Protein Kinase Human genes 0.000 description 2
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 2
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- 101150067366 adh gene Proteins 0.000 description 2
- 101150014383 adhE gene Proteins 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 230000001476 alcoholic effect Effects 0.000 description 2
- 229940072056 alginate Drugs 0.000 description 2
- 229920000615 alginic acid Polymers 0.000 description 2
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 2
- 238000002306 biochemical method Methods 0.000 description 2
- 238000005842 biochemical reaction Methods 0.000 description 2
- 230000031018 biological processes and functions Effects 0.000 description 2
- WTEOIRVLGSZEPR-UHFFFAOYSA-N boron trifluoride Chemical compound FB(F)F WTEOIRVLGSZEPR-UHFFFAOYSA-N 0.000 description 2
- 238000011088 calibration curve Methods 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 230000002860 competitive effect Effects 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 238000009833 condensation Methods 0.000 description 2
- 230000005494 condensation Effects 0.000 description 2
- 238000006482 condensation reaction Methods 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 238000005336 cracking Methods 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- RWGFKTVRMDUZSP-UHFFFAOYSA-N cumene Chemical compound CC(C)C1=CC=CC=C1 RWGFKTVRMDUZSP-UHFFFAOYSA-N 0.000 description 2
- 239000000645 desinfectant Substances 0.000 description 2
- 235000019425 dextrin Nutrition 0.000 description 2
- 238000011143 downstream manufacturing Methods 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 238000012239 gene modification Methods 0.000 description 2
- 230000005017 genetic modification Effects 0.000 description 2
- 235000013617 genetically modified food Nutrition 0.000 description 2
- 235000021312 gluten Nutrition 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 150000002430 hydrocarbons Chemical class 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 230000000415 inactivating effect Effects 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- PHTQWCKDNZKARW-UHFFFAOYSA-N isoamylol Chemical compound CC(C)CCO PHTQWCKDNZKARW-UHFFFAOYSA-N 0.000 description 2
- 150000002576 ketones Chemical class 0.000 description 2
- 229920005610 lignin Chemical class 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 235000013379 molasses Nutrition 0.000 description 2
- 238000002703 mutagenesis Methods 0.000 description 2
- 231100000350 mutagenesis Toxicity 0.000 description 2
- 230000035772 mutation Effects 0.000 description 2
- 239000002777 nucleoside Substances 0.000 description 2
- 229920000620 organic polymer Polymers 0.000 description 2
- 239000005022 packaging material Substances 0.000 description 2
- 230000029553 photosynthesis Effects 0.000 description 2
- 238000010672 photosynthesis Methods 0.000 description 2
- 230000027086 plasmid maintenance Effects 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 239000004626 polylactic acid Substances 0.000 description 2
- 239000001294 propane Substances 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000004064 recycling Methods 0.000 description 2
- 230000010076 replication Effects 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 238000012552 review Methods 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 239000011593 sulfur Substances 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- 238000013518 transcription Methods 0.000 description 2
- 230000035897 transcription Effects 0.000 description 2
- XDIYNQZUNSSENW-UUBOPVPUSA-N (2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanal Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O XDIYNQZUNSSENW-UUBOPVPUSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- PKAUICCNAWQPAU-UHFFFAOYSA-N 2-(4-chloro-2-methylphenoxy)acetic acid;n-methylmethanamine Chemical compound CNC.CC1=CC(Cl)=CC=C1OCC(O)=O PKAUICCNAWQPAU-UHFFFAOYSA-N 0.000 description 1
- 101150078509 ADH2 gene Proteins 0.000 description 1
- 101150026777 ADH5 gene Proteins 0.000 description 1
- QTXZASLUYMRUAN-QLQASOTGSA-N Acetyl coenzyme A (Acetyl-CoA) Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1.O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 QTXZASLUYMRUAN-QLQASOTGSA-N 0.000 description 1
- 240000000073 Achillea millefolium Species 0.000 description 1
- 235000007754 Achillea millefolium Nutrition 0.000 description 1
- NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 description 1
- 241000186046 Actinomyces Species 0.000 description 1
- 241000589158 Agrobacterium Species 0.000 description 1
- 241000589151 Azotobacter Species 0.000 description 1
- 229910015900 BF3 Inorganic materials 0.000 description 1
- 241000194110 Bacillus sp. (in: Bacteria) Species 0.000 description 1
- 241000606125 Bacteroides Species 0.000 description 1
- 241000588807 Bordetella Species 0.000 description 1
- 241000589562 Brucella Species 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- 241000253373 Caldanaerobacter subterraneus subsp. tengcongensis Species 0.000 description 1
- 241000222178 Candida tropicalis Species 0.000 description 1
- 101100189168 Capsicum frutescens PAMT gene Proteins 0.000 description 1
- UGFAIRIUMAVXCW-UHFFFAOYSA-N Carbon monoxide Chemical compound [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 description 1
- 241000620141 Carboxydothermus Species 0.000 description 1
- 241000606161 Chlamydia Species 0.000 description 1
- 241001112695 Clostridiales Species 0.000 description 1
- 241000193163 Clostridioides difficile Species 0.000 description 1
- 241000423302 Clostridium acetobutylicum ATCC 824 Species 0.000 description 1
- 241000193469 Clostridium pasteurianum Species 0.000 description 1
- 241000193468 Clostridium perfringens Species 0.000 description 1
- RGJOEKWQDUBAIZ-IBOSZNHHSA-N CoASH Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCS)O[C@H]1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-IBOSZNHHSA-N 0.000 description 1
- 229920001634 Copolyester Polymers 0.000 description 1
- MIKUYHXYGGJMLM-GIMIYPNGSA-N Crotonoside Natural products C1=NC2=C(N)NC(=O)N=C2N1[C@H]1O[C@@H](CO)[C@H](O)[C@@H]1O MIKUYHXYGGJMLM-GIMIYPNGSA-N 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 102000002004 Cytochrome P-450 Enzyme System Human genes 0.000 description 1
- 108010015742 Cytochrome P-450 Enzyme System Proteins 0.000 description 1
- NYHBQMYGNKIUIF-UHFFFAOYSA-N D-guanosine Natural products C1=2NC(N)=NC(=O)C=2N=CN1C1OC(CO)C(O)C1O NYHBQMYGNKIUIF-UHFFFAOYSA-N 0.000 description 1
- 241000610754 Desulfotomaculum reducens Species 0.000 description 1
- 101100269269 Drosophila mayaguana Adh gene Proteins 0.000 description 1
- 101100060880 Drosophila melanogaster colt gene Proteins 0.000 description 1
- 241000186811 Erysipelothrix Species 0.000 description 1
- 241001522878 Escherichia coli B Species 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 241000206602 Eukaryota Species 0.000 description 1
- 241000589601 Francisella Species 0.000 description 1
- 241000605909 Fusobacterium Species 0.000 description 1
- 210000000712 G cell Anatomy 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 241000606790 Haemophilus Species 0.000 description 1
- 108010020056 Hydrogenase Proteins 0.000 description 1
- 241000588748 Klebsiella Species 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 239000002841 Lewis acid Substances 0.000 description 1
- 241000186781 Listeria Species 0.000 description 1
- 239000006137 Luria-Bertani broth Substances 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 241000604448 Megasphaera elsdenii Species 0.000 description 1
- 101100054943 Mus musculus Adh4 gene Proteins 0.000 description 1
- 241000186359 Mycobacterium Species 0.000 description 1
- 241000863420 Myxococcus Species 0.000 description 1
- 241000588653 Neisseria Species 0.000 description 1
- 238000000636 Northern blotting Methods 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 108700026244 Open Reading Frames Proteins 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical class [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 1
- 108010026552 Proteome Proteins 0.000 description 1
- 241000588769 Proteus <enterobacteria> Species 0.000 description 1
- 241000589540 Pseudomonas fluorescens Species 0.000 description 1
- 241000589781 Pseudomonas oleovorans Species 0.000 description 1
- 241000589776 Pseudomonas putida Species 0.000 description 1
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical group CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 1
- 241000589180 Rhizobium Species 0.000 description 1
- 241000606701 Rickettsia Species 0.000 description 1
- 240000000111 Saccharum officinarum Species 0.000 description 1
- 235000007201 Saccharum officinarum Nutrition 0.000 description 1
- 241000607720 Serratia Species 0.000 description 1
- 241000607768 Shigella Species 0.000 description 1
- 108020004459 Small interfering RNA Proteins 0.000 description 1
- 238000002105 Southern blotting Methods 0.000 description 1
- 101100340279 Sphingobium yanoikuyae icd gene Proteins 0.000 description 1
- 241000605008 Spirillum Species 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 244000057717 Streptococcus lactis Species 0.000 description 1
- 235000014897 Streptococcus lactis Nutrition 0.000 description 1
- 241000589886 Treponema Species 0.000 description 1
- 241000607598 Vibrio Species 0.000 description 1
- 239000005862 Whey Substances 0.000 description 1
- 102000007544 Whey Proteins Human genes 0.000 description 1
- 108010046377 Whey Proteins Proteins 0.000 description 1
- 241000607734 Yersinia <bacteria> Species 0.000 description 1
- HCCBNDDJPKNSLM-WOQKIVQTSA-N [[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(3R)-4-[[3-(2-hexadecylsulfanylethylamino)-3-oxopropyl]amino]-3-hydroxy-2,2-dimethyl-4-oxobutyl] hydrogen phosphate Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSCCCCCCCCCCCCCCCC)O[C@H]1N1C2=NC=NC(N)=C2N=C1 HCCBNDDJPKNSLM-WOQKIVQTSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- IKHGUXGNUITLKF-XPULMUKRSA-N acetaldehyde Chemical compound [14CH]([14CH3])=O IKHGUXGNUITLKF-XPULMUKRSA-N 0.000 description 1
- 150000001241 acetals Chemical class 0.000 description 1
- 125000002339 acetoacetyl group Chemical group O=C([*])C([H])([H])C(=O)C([H])([H])[H] 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 108020002494 acetyltransferase Proteins 0.000 description 1
- 102000005421 acetyltransferase Human genes 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- 239000002154 agricultural waste Substances 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 230000000692 anti-sense effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Chemical class OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- 101150006429 atoB gene Proteins 0.000 description 1
- 238000010533 azeotropic distillation Methods 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Chemical class OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- 229920013724 bio-based polymer Polymers 0.000 description 1
- 230000003851 biochemical process Effects 0.000 description 1
- 229920000229 biodegradable polyester Polymers 0.000 description 1
- 239000004622 biodegradable polyester Substances 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000001851 biosynthetic effect Effects 0.000 description 1
- 230000036983 biotransformation Effects 0.000 description 1
- BSDUHMFABVUZLQ-UHFFFAOYSA-N butan-1-ol;ethanol;propan-2-ol Chemical compound CCO.CC(C)O.CCCCO BSDUHMFABVUZLQ-UHFFFAOYSA-N 0.000 description 1
- KFVUXNKQQOUCAH-UHFFFAOYSA-N butan-1-ol;propan-2-ol Chemical compound CC(C)O.CCCCO KFVUXNKQQOUCAH-UHFFFAOYSA-N 0.000 description 1
- DNZWLJIKNWYXJP-UHFFFAOYSA-N butan-1-ol;propan-2-one Chemical compound CC(C)=O.CCCCO DNZWLJIKNWYXJP-UHFFFAOYSA-N 0.000 description 1
- 150000001721 carbon Chemical group 0.000 description 1
- 150000001722 carbon compounds Chemical class 0.000 description 1
- 229910002091 carbon monoxide Inorganic materials 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 230000007073 chemical hydrolysis Effects 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 101150085107 clfA gene Proteins 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 239000003034 coal gas Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000003184 complementary RNA Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000021615 conjugation Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000010924 continuous production Methods 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 230000001086 cytosolic effect Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 239000012024 dehydrating agents Substances 0.000 description 1
- 230000000779 depleting effect Effects 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000004520 electroporation Methods 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 230000005183 environmental health Effects 0.000 description 1
- 230000007071 enzymatic hydrolysis Effects 0.000 description 1
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 1
- 210000003527 eukaryotic cell Anatomy 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000013604 expression vector Substances 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 101150004992 fadA gene Proteins 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 108020001507 fusion proteins Proteins 0.000 description 1
- 102000037865 fusion proteins Human genes 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 238000002309 gasification Methods 0.000 description 1
- 239000003502 gasoline Substances 0.000 description 1
- 239000003254 gasoline additive Substances 0.000 description 1
- 230000006692 glycolytic flux Effects 0.000 description 1
- 229940029575 guanosine Drugs 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 150000002391 heterocyclic compounds Chemical class 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 101150034989 idhA gene Proteins 0.000 description 1
- 238000012309 immunohistochemistry technique Methods 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 238000009655 industrial fermentation Methods 0.000 description 1
- 239000012770 industrial material Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000004922 lacquer Substances 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 150000007517 lewis acids Chemical class 0.000 description 1
- 238000000622 liquid--liquid extraction Methods 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 210000004962 mammalian cell Anatomy 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 239000006151 minimal media Substances 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 230000002438 mitochondrial effect Effects 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- YKYONYBAUNKHLG-UHFFFAOYSA-N n-Propyl acetate Natural products CCCOC(C)=O YKYONYBAUNKHLG-UHFFFAOYSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 238000007899 nucleic acid hybridization Methods 0.000 description 1
- 150000003833 nucleoside derivatives Chemical class 0.000 description 1
- 125000003835 nucleoside group Chemical group 0.000 description 1
- 235000021048 nutrient requirements Nutrition 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000011368 organic material Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000002018 overexpression Effects 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 230000004108 pentose phosphate pathway Effects 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 238000005373 pervaporation Methods 0.000 description 1
- 239000003348 petrochemical agent Substances 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 239000003209 petroleum derivative Substances 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
- 239000011574 phosphorus Chemical class 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 230000000243 photosynthetic effect Effects 0.000 description 1
- 239000013600 plasmid vector Substances 0.000 description 1
- 238000005498 polishing Methods 0.000 description 1
- 229920000747 poly(lactic acid) Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 125000000075 primary alcohol group Chemical group 0.000 description 1
- 150000003138 primary alcohols Chemical class 0.000 description 1
- 230000006861 primary carbon metabolism Effects 0.000 description 1
- 238000007639 printing Methods 0.000 description 1
- 238000011027 product recovery Methods 0.000 description 1
- 229940090181 propyl acetate Drugs 0.000 description 1
- 210000001938 protoplast Anatomy 0.000 description 1
- IGFXRKMLLMBKSA-UHFFFAOYSA-N purine Chemical compound N1=C[N]C2=NC=NC2=C1 IGFXRKMLLMBKSA-UHFFFAOYSA-N 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000000754 repressing effect Effects 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 239000007320 rich medium Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- 235000003441 saturated fatty acids Nutrition 0.000 description 1
- 150000003333 secondary alcohols Chemical class 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 239000011877 solvent mixture Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 239000004753 textile Substances 0.000 description 1
- 101150050362 thl gene Proteins 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 230000001228 trophic effect Effects 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 1
- HGBOYTHUEUWSSQ-UHFFFAOYSA-N valeric aldehyde Natural products CCCCC=O HGBOYTHUEUWSSQ-UHFFFAOYSA-N 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 235000019871 vegetable fat Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 239000003039 volatile agent Substances 0.000 description 1
- 238000001238 wet grinding Methods 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 210000005253 yeast cell Anatomy 0.000 description 1
- 239000010457 zeolite Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/02—Preparation of oxygen-containing organic compounds containing a hydroxy group
- C12P7/04—Preparation of oxygen-containing organic compounds containing a hydroxy group acyclic
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P5/00—Preparation of hydrocarbons or halogenated hydrocarbons
- C12P5/02—Preparation of hydrocarbons or halogenated hydrocarbons acyclic
- C12P5/026—Unsaturated compounds, i.e. alkenes, alkynes or allenes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/24—Preparation of oxygen-containing organic compounds containing a carbonyl group
- C12P7/26—Ketones
- C12P7/28—Acetone-containing products
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02E—REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
- Y02E50/00—Technologies for the production of fuel of non-fossil origin
- Y02E50/10—Biofuels, e.g. bio-diesel
Definitions
- the present invention relates to a process for the conversion of carbohydrates to propanol using microorganisms and the chemical conversion of fermentation-produced propanol to propylene or polypropylene.
- Bio-based materials are starting to replace traditional petrochemically derived materials in a growing number of areas. For example, ink derived from soybean oil has replaced more than 90% of the petro-based ink used by the US newspaper industry (Wool, RP., Xiuzhi, SS. Bio-Based Polymers and Composites. (2005) Elsevier Academic Press).
- Bio- based alcohols such as isopropanol, ethanol, butanol and isobutanol offer another environmentally friendly raw material that can be used to develop greener materials, fuels and chemicals.
- Bio-based material precursors which include 1-propanol and 2-propanol, can be used to generate bio-based materials, such as propylene and polypropylene.
- IPA isopropanol
- the other most significant use of IPA is as a chemical intermediate. It is a component of cleaners, disinfectants, room sprays, lacquers and thinners, adhesives, pharmaceuticals, cosmetics and toiletries. It is also used as an extractant and as a dehydrating agent.
- Xanthan gum for example, is extracted with IPA.
- isopropanol is also used as a gasoline additive, to dissolve water and ice in fuel lines and tanks thereby preventing the water from accumulating in the fuel lines and freezing at low temperatures.
- IPA is also sold as rubbing alcohol and used as a disinfectant.
- IPA is currently produced by one of two processes that use petrochemically derived precursors: (1) a two-step (indirect) process during which propylene is hydrogenated and then hydrolysed using acid and water or (2) a one-step (direct) process during which propylene is hydrogenated using an acid catalyst.
- 1- ⁇ ropanol or n-propanol is commonly used in the chemical industry as a solvent and for resins and for production of esters such as propyl acetate and cellulose ester.
- 1 -propanol is a colorless, highly flammable liquid that is volatile at room temperature and normal atmospheric pressure. It is miscible with water and organic solvents.
- Propanol is a component of fusel oil, which is a byproduct formed during fermentation of yeast to produce ethanol.
- the annual world production capacity of petrochemically-derived 1 -propanol in 1979 exceeded 130,000 tons. By 1993 the world production capacity had increased to 180,000 tons (Unruh, J.D. and Pearson, D. 2000.
- n-Propyl Alcohol Kirk-Othmer Encyclopedia of Chemical Technology. It is produced in nature by the decomposition of organic materials by a variety of microorganisms and occurs in plants and fusel oil. 1 -propanol is produced from petrochemically-derived ethene by reaction with carbon monoxide and hydrogen to give propionaldehyde, which is then hydrogenated. It is also a byproduct of methanol manufacture and may be produced from propane directly or from acrolein. The major use of 1 -propanol is as a multi-purpose solvent in industry and in the home. It is used in flexographic printing ink and textile applications, products for personal use, such as cosmetics and lotions, and in window cleaning, polishing, and antiseptic formulations.
- Microorganisms of the genus Clostridium have been reported to produce isopropanol, together with other solvents and acids, by fermentation.
- George et al reported five species of Clostridia that produce isopropanol in addition to butanol or butanol and acetone (George HA, Johnson JL, Moore WE, Holdeman LV, Chen JS. Acetone, Isopropanol, and Butanol Production by Clostridium beijerinckii (syn. Clostridium butylicum) and Clostridium aurantibutyricum. Appl. Environ. Microbiol. 1983. 45(3): 1160-1163).
- C heijerinckii VPI2968 produced 9.8 niM isopropanol and 44.8 mM butanol.
- C. beijerinckii VPI2982 produced 1.6 niM isopropanol and 41 ,3 mM butano ⁇ .
- "C. butylicum" NRRL B593 produced 8.0 mM isopropanol and 61.7 mM butanol.
- C. aurantibuiyricum ATCC 17777 produced 4.5 mM isopropanol, 45.4 rnM butanol, and 20.5 mM acetone.
- aurantibutyricum NCIB 10659 produced 10.0 mM isopropanol, 42.4 mM butanol, and 14.5 mM acetone.
- Another report described strain 172CY that produces isopropanol and butanol in a continuous process using a CA-alginate immobilized fermenter (Araki K, Minami T, Sueki M, Kimura T. Continuous Fermentation by Butanol-Isopropanol Producing Microorganisms Immobilized by Ca- Alginate. J Soc Fermentation and Bioengineering. 1993. 71(1):9-14.),
- Bermejo et al disclose the heterologous expression in E. coll of an "acetone operon" composed of four Clostridium acetobutylicum genes (Bermejo et al, Appl Environ Microbiol. 1998 Mar;64(3): 1079-85). Expression of this acetone pathway allowed the production of acetone from glucose in E. coli.
- the four clostridial genes of the acetone pathway described by Bermejo encode three enzymes that can convert acetyl-coenzyme A (acetyl-CoA) and acetate into acetone.
- the enzyme thiolase which is encoded by the thl gene, generates acetoacetyl-CoA from two acetyl-CoA molecules by a condensation reaction.
- acetoacetyl- CoA:acetate/butyrate:CoA transferase (CoAT), which is encoded by the ctfA and the ctfB genes, converts acetoacetyl-CoA and acetate into acetoacetate and acetyl-CoA.
- acetoacetate decarboxylase (AADC), which is encoded by the adc gene, converts the acetoacetate into acetone and carbon dioxide.
- acetobutylicum does not possess a secondary alcohol dehydrogenase, it is unable to produce the secondary alcohol isopropanol from the ketone substrate acetone.
- other species have been identified that contain either a primary- secondary alcohol dehydrogenase or a secondary alcohol dehydrogenase that are capable of converting acetone to isopropanol.
- a primary-secondary alcohol dehydrogenase was characterized from two strains (NRRL B593 and NESTE 255) of Clostridium beijerinckii (Ismaiel, A, A., Zhu, C- X., Colby, G.D. and Chen, J.-S.
- Fusel alcohols are a component of alcoholic fermentation broths.
- the total fusel alcohol content of wine is about 0.8-1.2 g/L.
- the major constituents of the fusel alcohol fraction of wine and other products of alcoholic fermentations are frequently referred to as fusel oil or fusel alcohol.
- fusel oil or fusel alcohol These constituents are alcohols with more than two carbon atoms and commonly include 1-propanol, isopropanol, isobutanol, 2- and 3-methylbutanol among others, which are produced naturally as mixtures and in small amounts by yeast.
- Acetic acid, acetaldehyde, ethyl acetate, propanol, isobutanol, 2- and 3-methylbutanol account for more than half of these volatiles, the other half being distributed among 600-800 minor volatile compounds present in very low amounts (acetals, organic acids, alcohols, phenolic and heterocyclic compounds, esters, lactones, terpenes and sulfur-containing compounds) (Oliveira E. S. et al. 2005 World Journal of Microbiology and Biotechnology 21 :1569-1576; Regodon Mateos JA, et al, Enzyme and Microbial Technology 40 (2006) 151-157).
- Embodiments of the invention include recombinant microorganisms that contain a pathway to produce isopropanol and these microorganisms are used to produce isopropanol where at least one enzyme of the pathway is heterologous to the microorganism.
- Use of a heterologous host allows genomic manipulations to be performed quickly since a host can be chosen that has better understood molecular biology, and having far better developed molecular biology techniques, than that of the Clostridia species previously available. Additionally, heterologous expression also avoids complications by native or endogenous regulation.
- an engineered microorganism is provided that produces isopropanol at high yield by biochemically converting a carbon source to isopropanol.
- the engineered microorganisms express a metabolic pathway for the production of isopropanol.
- a recombinant microbial host cell comprising each of the DNA molecules encoding a polypeptide or group of polypeptides that catalyze the conversion:
- the at least one DNA molecule is heterologous to said microbial host cell and wherein said microbial host cell produces isopropanol.
- a recombinant microbial host cell comprising each of the DNA molecules encoding a polypeptide that catalyzes the conversion:
- the at least one DNA molecule is heterologous to said microbial host cell and wherein said microbial host cell produces isopropanol.
- the at least one DNA molecule is heterologous to said microbial host cell
- an isopropanol containing fermentation medium produced by a method comprising:
- the at least one DNA molecule is heterologous to said microbial host cell
- an isopropanol containing fermentation medium produced by a method comprising:
- the at least one DNA molecule is heterologous to said microbial host cell
- isopropanol produced by a method comprising:
- a method of making a bio-based material precursor comprising: a) providing a feedstock comprising a suitable carbon source obtained from starch, cellulose, hemicellu ⁇ ose, or pectin; and b) contacting the feedstock of a) with a biocatalyst operable to produce the bio-based material precursor, wherein the bio-based material precursor is produced at a yield of at least about 50 per cent of theoretical yield; and c) recovering the bio-based material precursor.
- a method of making a bio-based material precursor comprising: a) providing a feedstock comprising a suitable carbon source obtained from starch, cellulose > hemicellulose, or pectin; and b) contacting the feedstock of a) with a biocatalyst operable to produce the bio-based material precursor, wherein the bio-based material precursor is produced at a volumetric productivity of at least about 0.4 g/L/h.; and c) recovering the bio-based material precursor.
- a method of making a bio-based material precursor comprising: a) providing a feedstock comprising a suitable carbon source obtained from starch, cellulose, hemicellulose, or pectin; and b) contacting the feedstock of a) with a biocatalyst operable to produce the bio-based material precursor, wherein the bio-based material precursor is produced at a titer of at least about 14 g/L.; and c) recovering the bio-based material precursor.
- a method of making a bio-based material precursor comprising: a) providing a feedstock comprising a suitable carbon source obtained from starch, cellulose, hemicellulose, or pectin; and b) contacting the feedstock of a) with a biocatalyst operable to produce the bio-based material precursor, wherein the bio-based material precursor is produced at: i) a yield of at least about 50 per cent of theoretical; ii) a volumetric productivity of at least about 0.4 g/L/h; and iii) a titer of at least about 14 g/L; and c) recovering the bio-based material precursor.
- a method of producing propylene comprising: a) contacting a biocatalyst with a fermentable carbon source under conditions whereby propanol is produced; b) recovering the propanol; and c) dehydrating the recovered propanol in the presence of an acid catalyst, thereby producing propylene and water.
- the method optionally includes (d) separating the propylene from the water obtained in step (c); and (e) recovering the propylene.
- FIGURE 1 illustrates the metabolic pathways involved in the conversion of glucose to acids and solvents in Clostridium acetobutylicum (A).
- Other strains of the genus Clostridium produce isopropanol by reduction of acetone via an alcohol dehydrogenase (B).
- FIGURES 2A and 2B illustrate a pathway in E. coli from glucose to isopropanol according to embodiments of the present disclosure.
- the pathway is shown under aerobic conditions (FIGURE 2A) and anaerobic conditions (FIGURE 2B).
- FIGURE 3 depicts plasmid pACT, also referred to herein as pGV 1031, containing the thl, ctfA, ctfB, and adc genes from Clostridium acetobutylicum which are expressed from the native thiolase promoter.
- FIGURE 4 depicts plasmid pGV 1093 containing the C. beijerinckii adhl open reading frame inserted between the EcoRl and Bam ⁇ l sites in the pUC19 plasmid vector.
- FIGURE 5 depicts plasmid pGVl 259 containing the C. beijerinckii adhl gene which is expressed from the Puaco-i promoter. - J l -
- FIGURE 6 depicts plasmid pGV 1699 containing the C. acetobutylicum thl, ctfA, ct ⁇ , and adc genes expressed from the native thl promoter as well as the C beijerinckii adhl gene expressed form the PuacO-i promoter.
- microorganism includes prokaryotic and eukaryotic microbial species from the domains Archaea, Bacteria and Eukaryote, the latter including yeast and filamentous fungi, protozoa, algae, or higher Protista.
- cell microbial cells
- microbes are used interchangeably with the term microorganism.
- Gram-negative bacteria include cocci, nonenteric rods and enteric rods.
- the genera of Gram-negative bacteria include, for example, Neisseria, Spirillum, Pasleurella, Brucella, Yersinia, Francisella, Haemophilus, Bordetella, Escherichia, Salmonella, Shigella, Klebsiella, Proteus, Pseudomonas, Bacteroides, Acelobacter, Aerobacter, Agrobacterium, Azotobacter, Myxococcus, Spirilla, Serratia, Vibrio, Rhizobium, Chlamydia, Rickettsia, Treponema and Fusobacterium.
- Gram positive bacteria include cocci, nonsporulating rods and sporulating rods.
- the genera of gram positive bacteria include, for example, Actinomyces, Bacillus, Clostridium, Corynebacterium, Erysipelothrix, Lactobacillus, Listeria, Mycobacterium, Nocardia, Staphylococcus, Streptococcus and Streptomyces.
- the terra "carbon source” generally refers to a substrate or compound suitable to be used as a source of carbon for prokaryotic or simple eukaryotic cell growth.
- Carbon sources may be in various forms, including, but not limited to polymers, carbohydrates, acids, alcohols, aldehydes, ketones, amino acids, peptides, etc. These include, for example, various monosaccharides such as glucose, oligosaccharides, polysaccharides, celMosic material, saturated or unsaturated fatty acids, succinate, lactate, acetate, ethanol, etc., or mixtures thereof.
- the carbon source may additionally be a product of photosynthesis, including, but not limited to glucose.
- Carbon sources which serve as suitable starting materials for the production of isopropanol include, but are not limited to, biomass hydrolysates, glucose, starch, cellulose, hemicellulose, xylose, lignin, lignin compounds, dextrose, fructose, galactose, com, liquefied corn meal, corn steep liquor (a byproduct of corn wet milling process that contains nutrients leached out of corn during soaking), molasses, lignocellulose, and maltose.
- Photosynthetic organisms can additionally produce a carbon source as a product of photosynthesis.
- carbon sources may be selected from biomass hydrolysates and glucose.
- Glucose, dextrose and starch can be from an endogenous or exogenous source.
- other carbon sources which may be more accessible, inexpensive, or both, can be substituted for glucose with relatively minor modifications to the host microorganisms.
- use of other renewable and economically feasible substrates may be preferred. These may include agricultural waste, starch- based packaging materials, corn fiber hydrolysate, soy molasses, fruit processing industry waste, and whey permeate, etc.
- the term “y ⁇ dd” refers to the amount of product per amount of carbon source in g/g.
- the yield may be exemplified for glucose as the carbon source. It is understood unless otherwise noted that yield is expressed as a percentage of the theoretical yield.
- theoretical yield is defined as the maximum amount of product that can be generated per total amount of substrate as dictated by the stoichiometry of the metabolic pathway used to make the product. For example, the theoretical yield for one typical conversion of glucose to isopropanol is 0.33 g/g. As such, a yield of isopropanol from glucose of 29.7 g/g would be expressed as 90% of theoretical or 90% theoretical yield. It is understood that while in the present disclosure the yield is exemplified for glucose as a carbon source, the invention can be applied to other carbon sources and the yield may vary depending on the carbon source used. One skilled in the art can calculate yields on various carbon sources.
- microorganisms herein disclosed are, in some cases, engineered using genetic engineering techniques, to provide microorganisms which utilize heterologously expressed enzymes to produce isopropanol at high yield.
- enzyme refers to any substance that catalyzes or promotes one or more chemical or biochemical reactions, which usually includes enzymes totally or partially composed of a polypeptide, but can include enzymes composed of a different molecule including polynucleotides.
- polynucleotide is used herein interchangeably with the term “nucleic acid” and refers to an organic polymer composed of two or more monomers including nucleotides, or nucleosides, including but not limited to single stranded or double stranded, sense or antisense deoxyribonucleic acid (DNA) of any length and, where appropriate, single stranded or double stranded, sense or antisense ribonucleic acid (RNA) of any length, including siRNA.
- DNA single stranded or double stranded
- RNA ribonucleic acid
- nucleotide refers to any of several compounds that consist of a ribose or deoxyribose sugar joined to a purine or a pyrimidine base and to a phosphate group, and that are the basic structural units of nucleic acids.
- nucleoside refers to a compound (as guanosine or adenosine) that consists of a purine or pyrimidine base combined with deoxyribose or ribose and is found especially in nucleic acids.
- polynucleotide includes nucleic acids of any length, DNA, RNA, analogs and fragments thereof, A polynucleotide of three or more nucleotides is also called “nucleotidic oligomer” or “oligonucleotide”.
- protein or “polypeptide” as used herein indicates an organic polymer composed of two or more amino acidic monomers and/or analogs thereof.
- amino acid or “amino acidic monomer” refers to any natural and/or synthetic amino acids including glycine and both D or L optical isomers.
- polypeptide includes amino acidic polymer of any length including Ml length proteins, and peptides as well as analogs and fragments thereof.
- pathway refers to a biological process including one or more enzymatically controlled chemical reactions by which a substrate is converted into a product. Accordingly, a pathway for the conversion of a carbon source to isopropanol is a biological process including one or more enzymatically controlled reactions by which the carbon source is converted into isopropanol.
- a “heterologous pathway” refers to a pathway wherein at least one of the one or more chemical reactions is catalyzed by at least one heterologous enzyme.
- a “native pathway” refers to a pathway wherein the one or more chemical reactions are catalyzed by a native enzyme.
- heterologous or “exogenous” as used herein with reference to enzymes and polynucleotides indicates enzymes or polynecleotides that are expressed in an organism other than the organism from which they originated or are found in nature, independently on the level of expression that can be lower, equal to, or higher than the level of expression of the molecule in the native microorganism.
- the term “native” or “endogenous” as used herein with reference to enzymes and polynucleotides indicates enzymes and polynucleotides that are expressed in the organism in which they originated or are found in nature, independently of the level of expression that can be lower equal or higher than the level of expression of the molecule in the native microorganism.
- host or "host cells” are used interchangeably herein and refer to microorganisms, native or wild-type, eukaryotic or prokaryotic that can be engineered for the conversion of a carbon source to isopropanol.
- host and “host cells” refers not only to the particular subject cell but to the progeny or potential progeny of such a cell. Because certain modifications may occur in succeeding generations due to either mutation or environmental influences, such progeny may not, in fact, be identical to the parent cell, but are still included within the scope of the term as used herein.
- a "parental microorganism" or a "parent cell” functions as a reference cell for successive genetic modification events.
- Each modification event may be accomplished by introducing a nucleic acid molecule in to the reference cell.
- the introduction facilitates the expression or over-expression of a target enzyme.
- the term “facilitates” encompasses the activation of endogenous polynucleotides encoding a target enzyme through genetic modification of e.g., a promoter sequence in a parental microorganism. It is further understood that the term “facilitates” encompasses the introduction of heterologous polynucleotides encoding a target enzyme in to a parental microorganism.
- activate indicates any modification in the genome and/or proteome of a microorganism that increases the biological activity of the biologically active molecule in the microorganism.
- exemplary activations include but are not limited to modifications that result in the conversion of the molecule from a biologically inactive form to a biologically active form and from a biologically active form to a biologically more active form, and modifications that result in the expression of the biologically active molecule in a microorganism wherein the biologically active molecule was previously not expressed or expressed at lower concentrations.
- activation of a biologically active molecule can be performed by expressing a native or heterologous polynucleotide encoding for the biologically active molecule in the microorganism, by expressing a native or heterologous polynucleotide encoding for an enzyme involved in the pathway for the synthesis of the biological active molecule in the microorganism, or by expressing a native or heterologous molecule that enhances the expression of the biologically active molecule in the microorganism.
- the term "metabolically engineered” or “metabolic engineering” involves rational pathway design and assembly of biosynthetic genes, genes associated with operons, and control elements of such polynucleotides, for the production of a desired metabolite.
- Methodically engineered can further include optimization of metabolic flux by regulation and optimization of transcription, translation, protein stability and protein functionality using genetic engineering and appropriate culture condition including the reduction of, disruption, or knocking out of, a competing metabolic pathway that competes with an intermediate leading to a desired pathway.
- the recombinant microorganisms herein disclosed are engineered to activate, and, in particular, express heterologous enzymes that can be used in the production of isopropanol.
- the recombinant microorganisms are engineered to activate heterologous enzymes that catalyze the conversion of acetyl-CoA to isopropanol.
- recombinant microorganism and “recombinant host cell” are used interchangeably herein and refer to microorganisms that have been genetically modified to express or over-express endogenous polynucleotides, or to express heterologous polynucleotides, such as those included in a vector, or which have a reduction in expression of an endogenous gene.
- the polynucleotide generally encodes a target enzyme involved in a metabolic pathway for producing a desired metabolite. It is understood that the terms “recombinant microorganism” and “recombinant host cell” refer not only to the particular recombinant microorganism but to the progeny or potential progeny of such a microorganism. Because certain modifications may occur in succeeding generations due to either mutation or environmental influences, such progeny may not, in fact, be identical to the parent cell, but are still included within the scope of the term as used herein.
- deleting genes means that a gene is deleted or otherwise mutated to inactivate the gene.
- Deletions can be of coding sequences or regulatory sequences provided they do not tend to revert and provided they inactivate the gene product (or gene products as the case may be).
- Operons can be inactivated as well.
- sequence identity refers to the occurrence of exactly the same nucleotide or amino acid in the same position in aligned sequences.
- sequence similarity takes approximate matches into account, and is meaningful only when such substitutions are scored according to some measure of “difference” or “sameness” with conservative or highly probable substitutions assigned more favorable scores than non-conservative or unlikely ones.
- any enzyme that catalyzes a conversion described in herein may be used.
- any homologous enzymes that are at least about 70%, 80%,
- any genes encoding for enzymes with the same activity as any of the enzymes of the isopropanol pathway may be used in place of the enzymes.
- These enzymes may be wild-type enzymes from a different organism, or may be artificial, recombinant or engineered enzymes.
- nucleic acid sequences which encode substantially the same or a functionally equivalent amino acid sequence can also be used express the polynucleotide encoding such enzymes.
- it can be advantageous to modify a coding sequence to enhance its expression in a particular host.
- the codons that are utilized most often in a species are called
- Codons can be substituted to reflect the preferred codon usage of the host, a process sometimes called "codon optimization” or "controlling for species codon bias.”
- Codon optimization or "controlling for species codon bias.”
- the heterologous or native genes can be under the control of an inducible promoter or a constitutive promoter.
- the heterologous genes may either be integrated into a chromosome of the host microorganism, or exist as an extra-chromosomal genetic elements that can be stably passed on ("inherited") to daughter cells.
- extra-chromosomal genetic elements such as plasmids, BAC, YAC, etc.
- integrational mutagenesis is a genetic engineering technique that can be used to selectively inactivate undesired genes from a host chromosome. Pursuant to this technique, a fragment of a target gene is cloned into a non-replicative vector with a selection marker to produce a non- replicative integrational plasmid.
- the partial gene in the non-replicative plasmid can be recombined with the internal homologous region of the original target gene in the parental chromosome, which results in insertional inactivation of the target gene.
- Any method can be used to introduce an exogenous nucleic acid molecule into microorganisms and many such methods are well known to those skilled in the art. For example, transformation, electroporation, conjugation, and fusion of protoplasts are common methods for introducing nucleic acid into microorganisms.
- exogenous nucleic acid molecule contained within a microorganism described herein can be maintained within that cell in any form.
- exogenous nucleic acid molecules can be integrated into the genome of the cell or maintained in an episomai state that can stably be passed on ("inherited") to daughter cells.
- extra-chromosomal genetic elements such as plasmids, etc.
- the microorganisms can be stably or transiently transformed.
- the microorganisms described herein can contain a single copy, or multiple copies of a particular exogenous nucleic acid molecule as described above.
- Methods for expressing polypeptide from an exogenous nucleic acid molecule are well known to those skilled in the art. Such methods include, without limitation, constructing a nucleic acid such that a regulatory element promotes the expression of a nucleic acid sequence that encodes the desired polypeptide.
- regulatory elements are DNA sequences that regulate the expression of other DNA sequences at the level of transcription.
- regulatory elements include, without limitation, promoters, enhancers, and the like.
- the exogenous genes can be under the control of an inducible promoter or a constitutive promoter.
- methods for expressing a polypeptide from an exogenous nucleic acid molecule in microorganisms are well known to those skilled in the art.
- heterologous control elements can be used to activate or repress expression of endogenous genes.
- the gene for the relevant enzyme, protein or RNA can be eliminated by known deletion techniques.
- microorganisms within the scope of the disclosure can be identified by techniques specific to the particular enzyme being expressed, over-expressed or repressed. Methods of identifying the strains with the desired phenolype are well known to those skilled in the art. Such methods include, without limitation, PCR and nucleic acid hybridization techniques such as northern and Southern blot analysis, altered growth capabilities on a particular substrate or in the presence of a particular substrate, a chemical compound, a selection agent and the like.
- immunohistochemistry and biochemical techniques can be used to determine if a cell contains a particular nucleic acid by detecting the expression of the encoded polypeptide.
- an antibody having specificity for an encoded enzyme can be used to determine whether or not a particular cell contains that encoded enzyme.
- biochemical techniques can be used to determine if a cell contains a particular nucleic acid molecule encoding an enzymatic polypeptide by detecting a product produced as a result of the expression of the enzymatic polypeptide.
- transforming a cell with a vector encoding an alcohol dehydrogenase (ADH) and detecting isopropanol in the cytosol cell extracts or culture medium supernatant resulting from the ADH catalyzed conversion of acetone to isopropanol indicates that the vector is both present and the gene product is active.
- ADH alcohol dehydrogenase
- Metabolization of a carbon source is said to be "balanced" when the NAD(P)H produced during the oxidation reactions of the carbon source equals the NAD(P)H utilized to convert the carbon source to metabolization end products. Under these conditions, all the NAD(P)H is recycled. Without recycling, the NAD(P)H/NAD(P) + ratio becomes imbalanced and will cause the organism to ultimately die unless alternate metabolic pathways are available to maintain a balanced NAD(P)H/NAD(P) + ratio.
- Biocatalyst means a living system or cell of any type that speeds up chemical reactions by lowering the activation energy of the reaction and is neither consumed nor altered in the process.
- Biocatalysts may include, but are not limited to, microorganisms such as yeasts, fungi, bacteria, and archaea, including recombinant microorganisms and metabolically engineered microorganisms.
- feedstock is defined as a raw material or mixture of raw materials supplied to a biocatalyst or fermentation process from which other products can be made.
- a carbon source such as biomass or the carbon compounds derived from biomass are a feedstock for a biocatalyst that produces a bio-based material precursor in a fermentation process.
- a feedstock may contain nutrients other than a carbon source.
- the term feedstock is used interchangeably with the term "renewable feedstock", as the feedstocks used in the present invention are generated from biomass or traditional carbohydrates, which are renewable substances.
- bio-based material precursor refers to a compound in which some or all carbon contained within the compound is derived from petroleum, natural gas or coal.
- bio-based material precursor or “renewable material precursor” refers to a compound in which all carbon contained within the compound is derived from biomass that is biochemically converted, at least in part, in to a bio-based material precursor by a biocatalyst.
- a bio -based material precursor is further defined as an alcohol that contains three carbon atoms and which contains less than 0.5 oxygen atoms per carbon atom.
- a bio-based material precursor may be configured for conversion, either chemically or biochemically, into a bio-based material.
- bio-based material or “renewable material” refers to a substance in which all carbon contained within the substance is derived from bio-based material precursors, which are connected to each other by chemical or biochemical reactions.
- a bio-based material is comprised of at least two bio-based material precursors.
- volume productivity is defined as the amount of product per volume of media in a fermenter per unit of time.
- rate is the amount of product per unit of time, e.g., g/hr, inasmuch as the volume of the fermenter may be fixed at a chosen volume.
- productivity is herein further defined as the specific productivity in g product per g of cell dry weight (cdw) per hour (g product g cdw '! h "1 ).
- titer is defined as the strength of a solution or the concentration of a substance in solution. For example, the titer of a bio-based material precursor in a fermentation broth is described as g of bio-based material precursor in solution per liter of fermentation broth.
- the term "titer” is used interchangeably throughout with the term “titre”.
- the term "tolerance” is defined as the ability of the biocatalyst to maintain its specific productivity at a given concentration of an inhibitor.
- the term "tolerant” describes a biocatalyst that maintains its specific productivity at a given concentration of an inhibitor. For example if in the presence of 2% of an inhibitor a biocatalyst maintains the specific productivity that it had at 0 to 2%, the biocatalyst is tolerant to 2% of the inhibitor or has a tolerance to 2% of the inhibitor.
- rate of inhibition is defined as the rate of decrease of the specific productivity of a biocatalyst relative to the increased concentration of an inhibitor, at inhibitor levels above the inhibitory concentration.
- the term “resistance” is defined as the property of a biocatalyst to have a low rate of inhibition in the presence of increasing concentrations of an inhibitor in the fermentation broth.
- the term “more resistant” describes a biocatalyst that has a lower rate of inhibition towards an inhibitor than another biocatalyst with a higher rate of inhibition towards the same inhibitor.
- the two biocatalysts A and B both with a tolerance of 2% to an inhibitor bio-based material precursor and a specific productivity of 1 g product g CDVT 1 h "1 , exhibit at 3% bio-based material precursor a specific productivity of 0.5 g product g CDW 1 h "1 and 0.75 g product g CDW "1 If'for A and B, respectively.
- the biocatalyst B is more resistant than A.
- the term "byproduct" means an undesired product related to the production of bio-based material precursor. Byproducts are generally disposed as waste, adding cost to a process.
- DDG distaldistillers dried grains
- thermo-chemical and enzymatic hydrolysis processes provide a variety of substrates for fermentation. Since raw materials account for the majority of the production cost for biologically produced commodity chemicals and bio-based material precursors, for example by fermentation, it is important to utilize most, if not all carbon- containing compounds from renewable substrates. Further, the carbon source must be converted with high yield into the desired product, as undesired byproducts increase the overall cost of the process.
- the substrate cost can represent up to 70% of the value of the product (Danner, H. 1999 Chemical Society Reviews 28:395-405).
- Corn for example, is typically processed into starch and further processed to dextrose.
- impurities Some of the impurities are corn gluten, gluten meal and germ.
- Others are a variety of starch, dextrin, and soluble dextrins or other and/or all oligomers and dextrose.
- dextrose (glucose) is currently the only feedstock for further fermentation.
- a biocatalyst produces a high level, or titer, of the desired product.
- a high product titer reduces the cost of downstream processing and product separation and can reduce the operating costs associated with purification of the product.
- the higher the bio-based material precursor concentration the less cost of recovering that bio-based material precursor from the fermentation broth during product recovery.
- High product titers also reduce the waste streams coming out of the fermentation and out of the downstream processing, which reduces the overall process cost.
- the biocatalyst In order for a biocatalyst to produce high levels of bio-based material precursor during fermentation, the biocatalyst must be tolerant and resistant to high levels of the bio-based material precursor.
- the biocatalyst of this invention produces high levels of bio-based material precursor during a fermentation process and is resistant to high levels of the bio-based material precursor.
- the biocatalyst of this invention functions normally or with minimal impairment in the presence of high levels of bio-based material precursor.
- the performance characteristics of the biocatalyst described herein include a high productivity of the conversion of a feedstock to a bio-based material precursor.
- Productivity has an impact on capital costs for a bio-based material precursor plant and depends on the amount of biocatalyst used during the fermentation and the specific activity of the biocatalyst.
- High volumetric productivity of the biocatalyst shortens the process time and, therefore, for a given plant size, increases the output of the plant over the plant lifetime.
- High volumetric productivity increases the return on the capital investment and decreases the cost of the bio-based material precursor.
- High cell density fermentation increases the volumetric productivity and reduces investment costs.
- ethanol production plants operate at volumetric productivities ranging from 1-3 g ethanol I "1 h '1 with the specific ethanol productivity, e.g., for Saccharomyces cerevisiae being 2 g ethanol g cell dry weight (CDW) "1 h '! (Appl. Microbiol. Biotcchnol.
- Isopropanol tiler in fed batch fermentation reached 13.6 g/L at a productivity of 0.38 g/L/h and at a yield of 51% of the theoretical yield (Jojima, T. et al. 2008 Applied Microbiology and Biotechnology. 77: 1219-1224).
- 1-propanol was recently produced in recombinant E. coll Atsumi et al. expressed enzymes from Lactococcus lactis (Kivd) and from Saccharomyces cerevisiae (Adh2) to produce 1-propanol from glucose.
- the titer reached was 0.03 g/L at a productivity of 0.0008 g/L/h.
- the yield was not reported (Atsumi et al. 2008 Nature 451 :86-89).
- Shen and Liao Shen CR and JC Liao. Metabolic Engineering. 2008 10:312-320 have recently described the production of 1- propanol in recombinant E. coli cells.
- a method is provided herein which uses a biocatalyst that can economically, and biochemically convert, such as through a fermentation, a feedstock, including carbohydrates and sugars derived from renewable biomass, into a bio-based material precursor, such as 1-propanol or 2-propanol (isopropanol).
- the bio-based material precursor can then be used in further chemical or biochemical processing to generate a bio-based material, such as propylene or polypropylene.
- the polymerization of propylene to polypropylene is known in the art.
- the bio- based material precursor such as 1-propanol and/or 2-propanol generated by the biocatalyst in a fermentation process must be free of unwanted by products so as to be useful to generate a bio- based material, such as propylene or polypropylene, with properties as required by the American Society for Testing and Materials (ASTM).
- ASTM American Society for Testing and Materials
- Propylene is an important petrochemical feedstock for producing materials such as polypropylene and chemicals such as cumene, butanols, isopropanol, acrylonitrile, and propylene oxide.
- Propylene is a petroleum product derived from processing oil, natural gas, and coal. Traditionally, propylene was obtained directly by distillation of oil or condensation of liquids from natural gas. As world-wide demand has exceeded these sources, additional propylene is produced by cracking larger hydrocarbons and converting natural gas and coal gas using chemical catalysts. Because of its relatively high value and high demand, most propylene intentionally produced at refineries is sold into the chemical market.
- propylene generated at refinery may be oligomerized with other small olefins produced in a cracking unit to produce hydrocarbons that are blended with fuels such as gasoline.
- Propylene is produced in three major grades as described in Standard Guide ASTM D5273, the industry guideline for specifying grades of propylene concentrates. The three grades are Polymer Grade - the highest purity at >99% propylene, Chemical Grade - 92-99% propylene suitable for producing petrochemicals, and Refinery Grade - 60-90% propylene suitable for producing polygas and other fuel-related materials.
- Propylene can also be produced by the chemical dehydration of propanol, for example 1- or 2-propanol, using one of many different types of acid catalysts including, but not limited to, acidic alumina and zeolites, acidic organic-sulfonic acid resins, mineral acids such as phosphoric and sulfuric acids, and Lewis acids such as boron trifluoride and aluminum compounds(March, Jerry. Advanced Organic Chemistry. New York: John Wiley and Sons, 1992).
- Propatiols used to produce propylene by dehydration can be generated chemically by condensing syngas produced by the gasification of coal, natural gas, or biomass.
- An additional route to producing renewable propanols from biomass includes fermentation technologies such as the Isopropanol-Butanol-Ethanol (IBE) process described previously (George HA et al. Appl Environ Microbiol. 1983 Mar;45(3):l 160-1163. Chen JS and SF Hiu. BiotechnoL Lett. 1986 8(5):371-376. Durre P. Appl. Microbiol. BiotechnoL 1998 49:639-648) and the homofermentation of carbohydrates to 1- or 2-propanol described herein and in the literature (Hanai T, et al. Appl. Environ. Microbiol. 2007 73(24):7814-7818. Jojima .
- IBE Isopropanol-Butanol-Ethanol
- renewable propylene of any grade has chemical properties virtually indistinguishable from propylene produced from non-renewable sources such as oil, natural gas, and coal (however, renewable propylene can be distinguished from non-renewable propylene using ASTM 6866-05). All materials and chemicals produced from non-renewable propylene can be made with renewable propylene using processes and techniques described in the art. The homofermentation of feedstock to 1- or 2-propanol described herein, however, is required to enable the production of renewable versions of these materials and chemicals at costs that are competitive with the non-renewable routes.
- the process for producing propylene from 1 - or 2-pro ⁇ anol is stable to water and includes a mechanism for removing this water as it is generated. With little or no modification, a typical propanol dehydration process can accommodate propanols containing additional water.
- Propanols produced by the fermentation of carbohydrates are removed from the aqueous environment of the fermenter using various techniques, generating propanols that contain varying amounts (e.g. 0-70% w/w) of water.
- These "wet" propanols e.g., propanols comprising about 1% to about 30% water
- dry propanols e.g., propanols comprising less than about 1% water
- the quality of the propylene produced from wet propanol is unchanged relative to propylene produced from dry propanol.
- the recombinant microorganism is capable of converting a carbon source to isopropanol.
- the recombinant microorganism of the present disclosure is capable of converting a carbon source to acetyl-Co A and of converting acetyl-CoA to isopropanol.
- Host organisms can be engineered to express a metabolic pathway for the conversion of acetyl-CoA to isopropanol wherein at least one of the pathway enzymes is heterologous to the host (FIGURES 2A and 2B).
- the recombinant microorganism of the present disclosure is capable of catalyzing the following chemical conversions (Pathway 1): Acetyl-CoA ⁇ Acetate + CoA (conversion 1)
- the recombinant microorganism of the present disclosure expresses genes encoding the following enzymes that catalyze conversions 1, 2, 3.1 , 4 and 5 of
- Pathway 1 phosphate acetyltrasferase and acetate kinase (catalyzes conversion 1) acetyl-CoA-acetyltransferase (thiolase) (catalyzes conversion 2) acetoacetyl-Co A:acetate/butyrate coenzyme- A transferase (catalyzes conversion 3.1) acetoacetate decarboxylase (catalyzes conversion 4) secondary alcohol dehydrogenase (catalyzes conversion 5)
- the recombinant microorganism of the present disclosure is capable of catalysing the following chemical conversions (Pathway 2):
- the recombinant microorganism of the present disclosure expresses genes encoding the following enzymes that catalyze above reactions 2, 3.2, 4, and 5 of
- Pathway 2 acetyl-CoA-acetyltransferase (thiolase) (catalyzes conversion 2) acetoacetyl-CoA hydrolase (catalyzes conversion 3.2) acetoacetate decarboxylase (catalyzes conversion 4) secondary alcohol dehydrogenase (catalyzes conversion 5)
- At least one of the genes expressed within the recombinant microorganism is heterologous to the microorganism.
- Such heterologous genes may be identified within and obtained from a heterologous microorganism (such as Clostridium acetobulylicum or Clostridium beijerinckii), and can be introduced into an appropriate host using conventional molecular biology techniques.
- the at least one of heterologous genes enable the recombinant microorganism to produce isopropanol or a metabolic intermediate thereof, at least in an amount greater than that produced by the wild-type counterpart microorganism.
- Useful microorganisms that can be used as recombinant hosts may be either eukaryotic or prokaryotic microorganisms. While Escherichia is one of the hosts that may be used according to the present disclosure, other hosts may be used, including yeast strains such as Saccharomyces strains.
- other suitable recombinant hosts include, but are not limited to, Pichia, Hansenula, Yarrow ia, Aspergillus, Kluyveromyces, Pachysolen, Rhodotorula, Zygosaccharomyces, Galactomyces, Schizosaccharomyces, Torulaspora, Debaryomyces, Williopsis, Dekkera, Kloeckera, Metschnikowia and Candida.
- the recombinant hosts include, but are not limited to, Arthrobacter, Bacillus, Brevibacterium, Clostridium, Corynebacterium, Gluconobacter, Nocardia, Pseudomonas, Rhodococcus, Salmonella, Streptomyces, and Xanthomonas .
- such hosts include E, coli W3110, E. coli B 5 Pseudomonas oleovorans, Pseudomonas fluorescens, Pseudomonas putida, and Saccharomyces cerevisiae.
- the engineered microorganism is an E.
- the engineered microorganism is yeast, for example Saccharomyces cerevisiae.
- yeasts have pathways in both the cytosol and the mitochondria that generate acetyl-CoA. Because the conversion in yeast of acetyl-CoA to isopropanol takes place in the cytosol, it is desirable for recombinant yeast of the present invention to have increased cytosolic concentrations of acetyl-CoA relative to wild-type levels. Additionally, mitochondrial concentrations of acetyl-Co A can be reduced.
- conversion 1 is catalyzed by enzymes classified as E.C.2,3.1.8 and E.C.2.7.2.1 that convert acetyl-CoA to acetate via the intermediate acetylphosphate, e.g., the enzymes phosphate acetyltrasferase (pta) and acetate kinase (ackAB) from either E. coli or Clostridium species.
- Conversion 2 is catalyzed by an enzyme classified as E.C. 2.3.1,19, i.e., an cetyl-CoA acetyltransferase (thiolase).
- Conversion 3.1 is catalyzed by an enzyme classified as E.C.
- Conversion 3.2 is catalyzed by an enzyme classified as EC 3.1.2.11, i.e., an acetoacetyl-CoA hydrolase.
- Conversion 4 is catalyzed by an enzyme classified as E.C. 4.1.1.4, i.e., an acetoacetate decarboxylase.
- Conversion 5 is catalyzed by an alcohol dehydrogenase, such as an alcohol dehydrogenase from the C. beijerinckii, the Burkholderia sp., or Thermoanaerobacter brockii,
- a recombinant microorganism includes activation of enzymes that convert acetyl-CoA to acetate via the intermediate acetylphosphate.
- activation results from the expression of the endogenous enzymes.
- activation results from the expression of heterologous enzymes.
- Suitable enzymes include, but are not limited to, phosphate acetyltrasferase, which catalyzes the conversion of acetyl-CoA to acetylphosphate, and acetate kinase, which catalyzes the conversion of acetylphosphate to acetate.
- these enzymes are encoded by pta and ackAB from E, coli or a Clostridium species.
- a recombinant microorganism provided herein is engineered to activate an acetyl-CoA acetyltransferase (thiolase) as compared to a parental microorganism.
- Thiolase E.C. 2.3.1.19 catalyzes the condensation of an acetyl group onto an acetyl-CoA molecule. This enzyme has been overexpressed, amongst other enzymes, in E. coli under its native promoter for the production of acetone (Bermejo et at,, Appl Environ. Mirobiol 64: 1079-1085, 1998).
- the increased thioiase expression results from the activation of an endogenous thiolase.
- the increased thiolase expression results from the expression of a heterologous thiolase gene.
- the heterologous thiolase gene is from a Clostridium species.
- the thiolase is the C. acetobutylicum enzyme encoded by the gene thl (GenBank accession U08465, protein ID AAA82724.1), and whose amino acid sequence is given in SEQ ID NO; 4.
- Other homologous thiolases include, but are not limited to, those from:, C.
- pasteurianum e.g., protein ID ABAl 8857.1
- C. beijerinckii sp. e.g., protein ID EAP59904.1 or EAP59331.1
- Clostridium perfringens sp. e.g., protein ID ABG86544.1, ABG83108.1
- Clostridium difficile sp. e.g., protein ID CAJ67900.1 or ZPJJ1231975.1
- Thermoanaerobaclerium thermosaccharolyticum e.g.
- E. coli thiolase could also be active in a hetorologously expressed isopropanol pathway.
- E. coli synthesizes two distinct 3-ketoacyI-CoA thiolases. One is a product of the fadA gene, the second is the product of the atoB gene.
- a recombinant microorganism provided herein is engineered to activate an acetoacetyl-CoA:acetate/butyrate coenzyme-A transferase (CoAT) as compared to a parental microorganism.
- CoAT (E.C. 2.8.3.9) transfers the coenzyme A from acetoacetyl-CoA to acetate resulting in the products acetoacetate and acetyl- CoA.
- the increased CoAT expression results from the activation of an endogenous CoAT.
- the increased CoAT expression results from the expression of a heterologous CoAT gene.
- the heterologous CoAT gene is from a Clostridium species.
- the CoAT is the C. acetobutylicum enzyme encoded by the two genes ctfA (GenBank accession NC_001988, protein ID NPJ49326.1) and ct ⁇ (GenBank accession NC_001988, protein ID NPJ 49327.1), and whose amino acid sequences are given in SEQ ID N0:5 and SEQ ID NO:6, respectively.
- a recombinant microorganism provided herein is engineered to activate an acetoacetyl-CoA hydrolase as compared to a parental microorganism.
- Acetoacetyl- CoA hydrolase (EC 3.1.2.11) catalyzes the hydrolysis of acetoacetyl-CoA to form acetoacetate and CoA.
- the increased acetoacetyl-CoA hydrolase expression results from activation of an endogenous acetoacetyl-CoA hydrolase. In another embodiment, the increased acetoacetyl-CoA hydrolase expression results from the expression of a heterologous acetoacetyl- CoA hydrolase gene.
- acetoacetyl-CoA hydrolases have been identified in mammalian cells (see e.g., Drummond, 1960; Baird, 1970; Baird, 1969; Zammit, 1979; Rous, 1976; Aragon, 1983; Patel, 1978; Patel, 1978).
- the substrate specificity of an acetyl-CoA hydrolase (E.C. 3.1.2,1) can be altered by protein engineering techniques such as 'directed evolution' so lhat it can convert acetoacetyl-CoA as a substrate.
- the acetyl-CoA hydrolase Achlp from Saccharomyces cerevisae (Genbank accession NPJ)09538.1) can be used for this purpose.
- a recombinant microorganism provided herein is engineered to activate an acetoacetate decarboxylase as compared to a parental microorganism.
- Acetoacetate decarboxylase (E.C. 4.1.1.4) converts acetoacetate into acetone and carbon dioxide.
- the increased acetoacetate decarboxylase expression results from activation of an endogenous acetoacetate decarboxylase.
- the increased acetoacetate decarboxylase expression results from the expression of a heterologous acetoacetate decarboxylase gene.
- the heterologous acetoacetate decarboxylase gene is from a Clostridium species.
- the acetoacetate decarboxylase is the C. acetobutylicum enzyme encoded by the adc gene (GenBank accession NC_001988, protein ID NP_149328.1), and whose amino acid sequence is given in SEQ ID NO: 7.
- a recombinant microorganism provided herein is engineered to activate an alcohol dehydrogenase (ADH) as compared to a parental microorganism. ADH reduces acetone to isopropanol with the oxidation OfNAD(P)H to NAD(P) + .
- ADH alcohol dehydrogenase
- the increased ADH expression results from activation of an endogenous ADH.
- the increased ADH expression results from the expression of a heterologous ADH gene.
- the heterologous ADH gene is from a Clostridium species.
- the ADH is the NADPH-dependant C. beijerinckii enzyme encoded by the adhl gene (GenBank accession AFl 57307, protein ID AAA23199.2), and whose amino acid sequence is given in SEQ ID NO: 8.
- suitable alcohol dehydrogenases include, but are not limited to, the Burkholderia sp.
- AIU 652 enzyme which is NADH-dependent or the Thermoanaerobacter brockii alcohol dehydrogenase (Genbank protein ID CAA46053.1) encoded by tbad gene (Genbank accession number X64841).
- any enzyme that catalyzes the above described conversions may be used.
- any homologous enzymes that are at least about 70%, 80%, 90%, 95%, 99% identical with respect to their amino acid sequence, or sharing at least about 60%, 70%, 80%, 90%, 95% sequence homology with respect to their amino acid sequence to any of the polypeptides described herein, can be used in place of these wild-type polypeptides.
- One skilled in the art can easily identify corresponding, homologous genes in other microorganisms by convention molecular biology techniques (such as sequence homology search, cloning based on homologous sequences, etc.).
- Nucleic acid sequences that encode enzymes useful for generating metabolic intermediates of the isopropanol pathway disclosed herein e.g., thiolase, phosphate acetyl trasferase, acetate kinase, acetoacetyl ⁇ CoA:acetate/butyrate coenzyrne-A transferase, acetoacetate decarboxylase, acetoacetyl-CoA hydrolase, alcohol dehydrogenase
- enzymes useful for generating metabolic intermediates of the isopropanol pathway disclosed herein e.g., thiolase, phosphate acetyl trasferase, acetate kinase, acetoacetyl ⁇ CoA:acetate/butyrate coenzyrne-A transferase, acetoacetate decarboxylase, acetoacetyl-CoA hydrolase, alcohol dehydrogenase
- appropriate host cells such as bacterial or
- all five genes encoding for enzymes that catalyze conversions of Pathway 1, namely conversions 1, 2, 3.1, 4, and 5 are expressed from a single piasmid.
- several combinations are possible, including, but not limited to; all genes expressed on a high-copy, medium-copy, or low-copy piasmid; all genes expressed from a single promoter; all genes expressed each with their own promoter; and synthetic operons of one, two, three, and/or four genes expressed from several promoters.
- Methods for optimizing the expression level ratios of the genes to achieve high productivity are known to those skilled in the art and can be applied to the expression system for expression of these genes.
- all five genes adhl, (hi, ct/A, ct/B, and adc, are expressed from a single piasmid.
- several combinations are possible, including, but not limited to; all genes expressed on a high-copy, medium-copy, or low-copy piasmid; all genes expressed from a single promoter; all genes expressed each with their own promoter; and synthetic operons of one, two, three, and/or four genes expressed from several promoters.
- all four genes encoding for enzymes that catalyze conversions of Pathway 2, namely conversions 2, 3.2, 4, and 5 are expressed from a single piasmid.
- genes expressed on a high-copy, medium-copy, or low-copy piasmid including but not limited to; all genes expressed on a high-copy, medium-copy, or low-copy piasmid; all genes expressed from a single promoter; all genes expressed each with their own promoter; and synthetic operons of one, two, three, and/or four genes expressed from several promoters.
- Methods for optimizing the expression level ratios of the genes to achieve high productivity are known to those skilled in the art and can be applied to the expression system for expression of these genes.
- Clones expressing improved enzymes are identified in a high-throughput screen, or in some cases, by selection, and the gene(s) encoding those improved enzymes are isolated and the process is applied iteratively until an enzyme with the desired activity is obtained.
- engineered E. coli strains which contain the most effective variant of a desired isopropanol-producing pathway
- directed evolution of the enzyme can be performed to obtain improved enzymes resulting in an improved isopropanol production pathway.
- Similar processes can also be used to identify and isolate strains with a higher isopropanol yield per glucose metabolized.
- NADH that is not oxidized during the conversion of acetyl- CoA to isopropanol is otherwise oxidized so that metabolism is balanced with respect to NAD + reduction and NADH oxidation.
- excess NADH is oxidized by native enzymes or metabolic pathways.
- excess NADH is oxidized by heterologously expressed enzymes or metabolic pathways.
- excess NAD(P)H produced during the conversion of a carbon source to isopropanol can be removed by coupling the oxidation OfNAD(P)H to the reduction of a metabolic intermediate.
- such a metabolic intermediate is pyruvate or acetyl-CoA.
- TCA cycle can be disrupted at the succinate dehydrogenase/fumarate reductase step or at the alpha-keto glutarate dehydrogenase step to prevent consumption of acetyl-CoA through this pathway and the consequent loss of carbon as CO 2 .
- disruption of the TCA cycle must occur in such a way that all required anapleurotic pathways are maintained.
- Another solution that allows the engineered isopropanol pathway to operate anaerobically is to couple the isopropanol pathway with expression of another biocatalyst, such as a cytochrome P450 or a reductase, thereby consuming the remaining reducing equivalents to generate a redox-balanced pathway.
- another biocatalyst such as a cytochrome P450 or a reductase
- One non-limiting example of this embodiment is to use an engineered P450 to convert propane to propanol while consuming reducing equivalents.
- excess NAD(P)H produced during the conversion of a carbon source to isopropanol can be removed by a heterologously overexpressed hydrogenase, which couples the oxidation of NADH to the formation of hydrogen.
- NADPH-dependent, endogenous processes that produce NADPH are upregulated.
- processes include, but are not limited to, upregulating the pentose phosphate pathway and the activity of transhydrogenase enzymes.
- NADPH-dependent, protein engineering techniques may be used to convert said NADPH-dependent alcohol dehydrogenase (s) to an N ADH-dependent alcohol dehydrogenase(s).
- the second biochemical process comprises of culturing a recombinant microorganism of the invention in a suitable culture medium under suitable culture conditions.
- Suitable culture conditions depend on the temperature optimum, pli optimum, and nutrient requirements of the host microorganism and are known by those skilled in the art. These culture conditions may be controlled by methods known by those skilled in the art.
- E. coli cells are typically grown at temperatures of about 25°C to about
- Growth media used to produce isopropanol according to the present invention include common media such as Luria Bertani (LB) broth, EZ-Rich medium, and commercially relevant minimal media that utilize cheap sources of nitrogen, sulfur, phosphorus, mineral salts, trace elements and a carbon source as defined.
- LB Luria Bertani
- EZ-Rich medium commercially relevant minimal media that utilize cheap sources of nitrogen, sulfur, phosphorus, mineral salts, trace elements and a carbon source as defined.
- the fermentation is performed using a batch reactor.
- the fermentation can be done by fed-batch or continuous reactors. Fermentations may be performed under aerobic or anaerobic conditions, where anaerobic or microaerobic conditions are preferred during the isopropanol production phase.
- the amount of isopropanol produced in the fermentation medium can be determined using a number of methods known in the art, for example, high performance liquid chromatography or gas chromatography
- a method of producing isopropanol comprises culturing any of the recombinant microorganisms of the present disclosure for a time under aerobic conditions or micro-aerobic conditions, to produce a cell mass, in particular in the range of from about 1 to about 100 g dry cells liter, or preferably in the range of from about 1 to about 1O g dry cells liter "1 , then altering the culture conditions for a time and under conditions to produce isopropanol, in particular for a time and under conditions wherein isopropanol is detectable in the culture, and recovering isopropanol.
- the culture conditions are altered from aerobic or micro-aerobic conditions to anaerobic conditions.
- the culture conditions are altered from aerobic conditions to micro-aerobic conditions.
- isopropanol may be isolated from the culture medium by methods, such as pervaporation, liquid-liquid extraction, or gas stripping.
- novel technologies such as use of azeotropic distillation or separation, as disclosed in US12342992 and PCTUS0888187, may be used to recover propanols from fermentation broth.
- the engineered microorganism produces isopropanol at a yield of greater than 40% of theoretical, a volumetric productivity of greater than 0.2 g/l/h and a final titer of greater than 5 g/1 isopropanol.
- the engineered microorganism produces isopropanol at a yield of greater than 50% of theoretical, a volumetric productivity of greater than 0.4 g/l/h and a final titer of greater than 14 g/1 isopropanol.
- a recombinant microorganism herein described that expresses a pathway for the production of isopropanol is further engineered to inactivate any competing pathways that consume metabolic intermediates of the isopropanol producing pathway.
- the recombinant microorganism is further engineered to direct the carbon flux from the carbon source to isopropanol.
- direction of carbon-flux to isopropanol can be performed by inactivating metabolic pathways that compete with the isopropanol production pathway.
- inactivation of a competing pathway is performed by inactivating an enzyme involved in the conversion of a substrate to a product within the competing pathway.
- the enzyme that is inactivated may preferably catalyze the conversion of a metabolic intermediate for the production of isopropanol or may catalyze the conversion of a metabolic intermediate of the competing pathway.
- the inactivation is performed by deleting from the microorganism's genome a gene coding for an enzyme involved in pathway that competes wlth the isopropanol production to make available the carbon to the one or more enzymes of the isopropanol producing pathway.
- deletion of the genes encoding for these enzymes improves the isopropanol yield because more carbon is made available to one or more enzymes of the isopropanol producing pathway.
- pGV1031 E. coli cells transformed with plasmid pACT, also referred to herein as plasmid pGV1031 were used to convert glucose to acetone.
- the plasmid contains the thl, ctfA, ct/B, and adc genes under the control of the native thiolase promoter.
- Plasmid pACT has been described previously (Bermejo LL, Welker NE, Papoutsakis ET, Expression of Clostridium acetobutylicum ATCC 824 genes in Escherichia coli for acetone production and acetate detoxification, Appl Environ Microbiol, 64(3): 1079-85 (1998 Mar), thl encodes the thiolase enzyme that catalyzes the condensation reaction of two acetyl CoA molecules to generate acetoacetyl-CoA.
- ctfA and ctfB encode subunits of acetoacetyl-CoA:acetate/butyrate CoA tranferase (CoAT) that converts the acetoacetyl-CoA and acetic/butyric acid into acetoacetate and the corresponding acyl-CoA.
- adc encodes the acetoacetate decarboxylase that catalyzes the conversion of acetoacetate to acetone and carbon dioxide.
- Plasmid pGV1031 is shown in FIGURE 3 and its sequence is given in SEQ ID NO:1.
- pGV1093 E. coli cells transformed with plasmid pGV 1093 were used to convert acetone to isopropanoi. This plasmid contains the gene for the primary/secondary alcohol dehydrogenase (adhl) from the Clostridium beijerinckii strain NRRL B593. Plasmid pGV1093 was derived from the previously described pGL89 plasmid (Peretz M, Bogin O, TeI-Or S, Cohen A, Li G, Chen JS, Burstein Y.
- pGV1093 was constructed by subcloning an approximately 1.6 kb EcoRI/BamHI fragment containing adhl from pGL89 into pUC19 digested with EcoRI/BamHI. pGV1093 is shown in FIGURE 4 and its sequence is given in SEQ ID NO:2.
- pGV1259 To convert glucose to isopropanol directly, five genes are co-expressed from two separate plasmids. These are: a primary/secondary alcohol dehydrogenase from Clostridium beijerinckii, herein referred to as adhl; thl, a gene encoding thiolase from Clostridium acetobutylicum; ctfA and ct ⁇ , the genes encoding acetoacetyl-CoA:acetate/butyrate coenzyme-A transferase subunits from C. acetobutylicum; and adc, the gene encoding acetoacetate decarboxylase from C. acetobutylicum.
- adhl a primary/secondary alcohol dehydrogenase from Clostridium beijerinckii, herein referred to as adhl
- thl a gene encoding thiolase from Clostridium acetobutylicum
- the plasmid expressing adhl is not preferred for co-transformation into E. coli with pACT for two reasons: 1) both plasmids have a CoIEl origin of replication, and 2) both plasmids contain an ampicillin resistance marker for plasmid maintenance.
- adhl is subcloned from pGV 1093 into a more suitable expression vector, pZA32 (Lutz and Bujard, Nucleic Acids Res., 25(6): 1203-1210, 1997).
- pZA32 has a pl5A origin of replication, a chloramphenicol resistance marker for plasmid maintenance, and Pu ao o-i promoter for adhl expression.
- the adhl gene is PCR amplified from pGV1093 using primers 487 (5'- AATTGGCGCCGAATTCATGAAAGGTTTTGC-S') and 488 (5' ⁇
- pGV1259 expresses adhl from the Puaco-t promoter.
- the plasmid map of pGV1259 is depicted in FIGURE 5, the sequence is given in SEQ ID NO:3.
- pGV1699 As an alternative to pGV1259 plasmid pGV1699 is designed which expresses all five genes of pathway 1 on a single plasmid.
- the nucleotide sequence encoding for P L ⁇ ac0- ⁇ and adhl is PCR amplified from ⁇ GV1259 using primers 1246 (5'- AATTGTCGACCGAGAAATGTGAGCGGAT AAC-3') and 1247 (5'- AATTGCATGCGTCTTTCGACTGAGCCTTTCG-3') containing Sail and Sphl, respectively.
- the amplified PCR product and pGV1031 are restriction digested using enzymes Sail and Sphl, gel purified, and then ligated together using the Rapid Ligation Kit (Roche, Indianapolis, IN). The resulting plasmid expresses the C.
- E. coli W3110 GenBank: AP009048
- E. coli B GenBank: AAWW00000000
- E. coli ER2275 Bomejo et al, AppL Environ, Microbiol., 64(3): 1079-1085, 1998) cells were freshly transformed with pGV1031 and plated onto LB-ampicillin 100 ⁇ g/mL plates for 12 hrs at 37 0 C. Single colonies from the LB- ampicillin plates were used to inoculate 5 rnL cultures of SD-7 medium (LuIi and Strohl, Appl Environ.
- Microbiol, 56(4), 1004-1011, 1990 containing 100 ⁇ g/mL ampicillin and allowed to grow for 12 hrs at 37 0 C at 250rpm.
- the above precultures were used to inoculate 125 mL of SD- 8 medium (LuIi and Strohl, _4p/?/. Environ, Microbiol, 64(3), 1004-1011, 1990) containing 100 ⁇ g/mL ampicillin in 2 L Erlenmeyer flasks at 1% (vol/vol) of inoculum. Cultures were grown at 37 0 C and 250 rpm.
- the temperature program for separating the products was 225 0 C injector, 225°C detector, 50 0 C oven for 3 minutes, then 8°C/minute gradient to 80 0 C, 13°C/minute gradient to 17O 0 C, 50°C/minute gradient to 22O 0 C then 22O 0 C for 3 minutes.
- the samples were also analyzed by LC to monitor acetate production. A 900 ⁇ L volume of the filtered samples was transferred to 1.5ml vial. The samples were run on an Aminex HPX-87H column using a 0.008N sulfuric acid mobile phase at a flow rate of 0.05 mL/min. The total run time was 30 min.
- E. coli DH5 ⁇ Zl electrocompetent cells were freshly transformed with pGV1093.
- E. coli DH5 ⁇ Zl electrocompetent cells were freshly transformed with pUC19, which does not contain an alcohol dehydrogenase.
- the transformed cells were plated onto LB-Ampicillin 100 ⁇ g/mL plates and incubated for 12 hrs at 37°C. To grow the strains, 4 niL precultures of both E. coli DH5 ⁇ Zl pGV1093 and E.
- coli DH5 ⁇ Zl pUC19 in LB-Ampicillin 100 ⁇ g/ml were inoculated with single colonies of freshly transformed cells from the LB-Ampicillin plates, These cultures were grown overnight (approximately 18h) at 37 0 C with shaking at 250 rpm. Precultures were used to inoculate 15 mL LB-Ampicillin 100 ⁇ g/mL cultures in 250 mL Erlenmeyer flasks at a rate of 1% (vol/vol) of the preculture used as inoculum. Cultures were grown at 37°C with shaking at 250 rpm for 5 hrs, then induced with 1 mM IPTG (isopropyl- ⁇ -D-thiogalactopyranoside).
- a 900 ⁇ L volume of the sample was transferred to a 1.5 mL gas chromatography vial and 90 ⁇ L of 10 mM 1-butanol was added as an internal standard.
- Samples were run on a Series II Plus gas chromatograph with a flame ionization detector (FID), fitted with a HP-7673 autosampler system using purchased standards and 5 -point calibration curves with internal standards. All samples were injected at a volume of 1.0 ⁇ L.
- Direct analysis of the acetone substrate and the isopropanol product was performed on a Supelco SPB-I capillary column (60 m length, 0,53 mm ID 5 5 ⁇ m film thickness) connected to the FID detector.
- the temperature program for separating the alcohol products was 225°C injector, 225°C detector, 5O 0 C oven for 3 minutes, then 15°C/minute gradient to 1 15°C, 25°C/minute gradient to 225 0 C, then 250 0 C for 3 minutes.
- E. coli W3110 Zl (Lutz and Bujard, Nucleic Acids Res,, 25(6): 1203-1210, 1997) electrocompetent cells are freshly co-transformed with pGV 1259 and pGV 1031.
- the transformed cells are plated onto LB-ampicillin 100 ⁇ g/mL, -chloramphenicol 25 ⁇ g/mL plates and incubated for 12 hrs at 37°C.
- Single colonies from the transformed plates are used to inoculate 5 mL of SD-7 medium (LuIi and Strohl, Appl Environ. Microbiol, 56(4), 1004-101 1, 1990) containing ampicillin 100 ⁇ g/mL and chloramphenicol 25 ⁇ g/mL. These cultures are incubated for 12 hrs at 37 0 C at 250 rpm. The above precultures are used to inoculate 125 mL of SD-8 medium (LuIi and Strohl, Appl.
- the engineered microorganism is expected to produce isopropanol at a yield of greater than 40% of theoretical, a volumetric productivity of greater than 0.2 g/I/h and a final titer of greater than 5 g/1 isopropanol.
- the thl, clfA/B and adc genes are expressed constitutively from the native thiolase promoter whereas the adhl gene is expressed from the inducible PuacO-t promoter, to allow for initial acetone accumulation followed by production of isopropanol.
- This system allows the time of induction of the adhl gene to vary and then the corresponding isopropanol production to be monitored.
- E. coli W3110 Zl (Lutz and Bujard, Nucleic Acids Res., 25(6): 1203-1210, 1997) electrocompetent cells are freshly co-transformed with pGV1699, carrying genes thl, ctfA/B, adc expressed from the native C. acetobutylicum thl promoter and C. beijerinckii adhl, from a Py ⁇ o-i promoter .
- the transformed cells are plated onto LB-ampicillin 100 ⁇ g/mL plates and incubated for l2 hrs at 37°C.
- Single colonies from the transformed plates are used to inoculate 5 mL of SD-7 medium (LuIi and Strohl, Appl Environ. Microbiol, 56(4), 1004-101 1 5 1990) containing ampicillin 100 ⁇ g/mL. These cultures are incubated for 12 hrs at 37 0 C at 250 rpm. The above precultures are used to inoculate 125 mL of SD-8 medium (LuIi and Strohl, Appl Environ. Microbiol, 56(4), 1004-1011, 1990) containing ampicillin 100 ⁇ g/mL and chloramphenicol 25 ⁇ g/mL in 2 L Erlenmeyer flasks at 1% (vol/vol) of inoculum.
- Cultures are grown at 37 0 C and growth is monitored by OD 600 nm every hour. The culture is induced with 1 mM isopropyl ⁇ -D-thiogalactoside (IPTG) during the late-exponential phase. To monitor isopropanol production, culture samples (3 mL) are taken from the cultures every 3 hrs for 30 hrs with the first sample taken at the time of inoculation. Samples are processed and analyzed by GC and LC for acetone and isopropanol production as described in Example 2 and Example 3.
- IPTG isopropyl ⁇ -D-thiogalactoside
- the engineered microorganism is expected to produce isopropanol at a yield of greater than 50% of theoretical, a volumetric productivity of greater than 0.4 g/l/h and a final titer of greater than 14 g/1 isopropanol.
- the present application provides a recombinant microbial host cell comprising each of the DNA molecules encoding a polypeptide or group of polypeptides that catalyze the conversion: (i) Acetyl-CoA to Acetate and CoA (conversion 1); (ii) Acetyl-CoA to Acetoacetyl-CoA and CoA (conversion 2); (iii) Acetoacetyl-CoA and Acetate to Acetoacetate and Acetyl-CoA (conversion 3.1); (iv) Aceloacetate to Acetone and CO2 (conversion 4); (v) Acetone and NAD(P)H and H+ to Isopropanol and NAD(P)+ (conversion 5), wherein the at least one DNA molecule is heterologous to said microbial host cell and wherein said microbial host cell produces isopropanol at a yield of greater than 25%, 40%, 50%, or 75% of theoretical.
- the group of polypeptides that catalyzes conversion 1 may include phosphate acetyltransferase and acetate kinase.
- the phosphate acetyltransferase may be encoded by the E. coli gene pta and the acetate kinase may be encoded by the E. coli gene ackAB.
- the polypeptide that catalyzes conversion 2 may be acetyl-CoA-acety ransferase having an amino acid sequence of SEQ ID NO:4.
- the polypeptide that catalyzes conversion 3.1 may be acetoacetyl-CoA:acetate/butyrate coenzyme-A transferase.
- the acetoacetyl- CoA:acetate/butyrate coenzyme-A transferase may be encoded by the C. acetobutyrlicum genes ctfA and ctfB having a corresponding amino acid sequence of SEQ ID NO: 5 and 6.
- the polypeptide that catalyzes conversion 4 may be acetoacetate decarboxylase having an amino acid sequence of SEQ ID NO:7.
- the polypeptide that catalyzes conversion 5 may be a secondary alcohol dehydrogenase that may or may not be heterologous to said microorganism.
- the secondary alcohol dehydrogenase may be from Clostridium beijerinckii, from Burkholderia spp., or from Thermo anaerobacter brockii.
- the Clostridium beijerinckii may be strain NRRL B593 or strain NESTE 225.
- the alcohol dehydrogenase includes the amino acid sequence of SEQ ID NO:8.
- the microorganism may include a deletion or inactivation of competing acetyl-CoA consuming genes.
- the microorganism may be an E.
- the microorganism may be an E. coli strain that includes a deletion or inactivation of a gene or genes selected from the group consisting of poxB, adhE, ldhA, frdABCD, succinate dehydrogenase, malate dehydrogenase, alpha-ketoglutarate dehydrogenase and combinations thereof.
- the microorganism may be an E. coli strain that includes a deletion or inactivation of a gene or genes selected from the group consisting of poxB, ldhA, frdABCD and combinations thereof.
- the cell may be selected from the group consisting of: a bacterium, a cyanobacterium, a filamentous fungus and a yeast.
- the microorganism may be an E.
- the microorganism may be a member of a genus selected from the group consisting of Pichia, Hansenula, Yarrowia, Aspergillus, Kluyveromyces, Pachysolen, Rhodotorula, Zygosaccharomyces, Galactomyces, Schizosaccharomyces, Torulaspora, Debaryomyces, Williopsis, Dekkera, Kloeckera, Metschnikowia or Candida.
- the microorganism may be a member of a genus selected from the group consisting of Arthrobacter, Bacillus, Brevibacterium, Clostridium, Corynebacterium, Gluconobacter, Nocardia, Pseudomonas, Rhodococcus, Streptomyces, or Xanthomonas. In some embodiments, all of the polypeptides are heterologous to said microorganism.
- a recombinant microbial host cell is provide that each of the DNA molecules encoding a polypeptide that catalyzes the conversion: (i) Acetyl-CoA to Acetoacetyl-CoA and CoA (conversion 2); (U) Acetoacetyl-CoA + H2O ⁇ Acetoacetate + CoA (conversion 3.2); (iii) Acetoacetate to Acetone and CO2 (conversion 4); (iv) Acetone and NAD(P)H and H+ to Isopropanol and NAD(P)+ (conversion 5); wherein the at least one DNA molecule is heterologous to said microbial host cell and wherein said microbial host cell produces isopropanol.
- the host cell may produce isopropanol at a yield of greater than 25%, 40%, 50%, or 75% of theoretical.
- the polypeptide that catalyzes conversion 2 may be acetyl- CoA-acetyltransferase having an amino acid sequence of SEQ ID NO:4.
- the polypeptide that catalyzes conversion 3,2 may be acetoacetyl-CoA hydrolase.
- the polypeptide that catalyzes conversion 4 may be acetoacetate decarboxylase having an amino acid sequence of SEQ ID NO:7,
- the polypeptide that catalyzes conversion 5 may be a secondary alcohol dehydrogenase heterologous or not heterologous to said microorganism.
- the secondary alcohol dehydrogenase may be derived from Clostridium beijerinckii, from Burkholderia spp., or from Thermoanaerobacter brockii.
- the Clostridium beijerinckii may be strain NRRL B593 or strain NESTE 225.
- the secondary alcohol dehydrogenase may include an amino acid sequence of SEQ ID NO:8.
- the host cell may include a deletion or inactivation of competing acetyl-CoA consuming genes.
- the host cell may be an E.
- the host cell may be an E, coli strain which comprises deletion or inactivation of a gene or genes selected from the group consisting of poxB, adhE, ldhA, frdABCD j succinate dehydrogenase, malate dehydrogenase, alpha-ketoglutarate dehydrogenase and combinations thereof.
- the host cell may be an E, coli strain which comprises deletion or inactivation of a gene or genes selected from the group consisting of poxB, idhA, frdABCD and combinations thereof.
- the host cell may be selected from the group consisting of: a bacterium, a cyanobacterium, a filamentous fungus and a yeast.
- the host cell may be E.
- the host cell may be a member of a genus selected from the group consisting of Pichia, Hansenula, Yarrowia > Aspergillus, Kluyveromyces, Pachysolen, Rhodotorula, Zygosaccharomyces, Galactomyces, S chizo saccharomyces, Torulaspora, Debaryomyces, Williopsis, Dekkera, Kloeckera, Metschnikowia or Candida.
- the host cell may be a member of a genus selected from the group consisting of Arthrobacter, Bacillus, Brevibacterium, Clostridium, Corynebacterium, Gluconobacter, Nocardia, Pseudomonas, Rhodococcus, Streptomyces, or Xanthomonas.
- all of said enzymes may be heterologous to said microbial host cell.
- a method for the production of isopropanol includes (a) providing a recombinant microbial host cell comprising each of the DNA molecules encoding a polypeptide or group of polypeptides that catalyze the conversion: (i) Acetyl-CoA to Acetate and CoA (conversion 1); (ii) Acetyl-CoA to Acetoacetyl-CoA and CoA (conversion 2); (iii) Acetoacetyl-CoA and Acetate to Acetoacetate and Acetyl-CoA (conversion 3.1); (iv) Acetoacetate to Acetone and CO2 (conversion 4); (v) Acetone and NAD(P)H and H+ to Isopropanol and NAD(P)+ (conversion 5), wherein the at least one DNA molecule is heterologous to said microbial host cell; (b) contacting the host cell of (i) with a fermentable carbon substrate in
- the fermentable carbon substrate may be selected from the group consisting of monosaccharides, oligosaccharides, and polysaccharides.
- the carbon substrate may be selected from the group consisting of glucose, sucrose, and fructose.
- the conditions may be anaerobic, microaerobic or aerobic.
- the host cell may be contacted with the carbon substrate in a minimal medium.
- the group of polypeptides that catalyzes conversion 1 may be phosphate acetyltrasferase and acetate kinase.
- the phosphate acetyltransferase may be encoded by the E. coli gene pta and the acetate kinase may be encoded by the E. coli gene ackAB.
- the polypeptide that catalyzes conversion 2 may be acetyl-CoA- acetyltransferase having an amino acid sequence of SEQ ID NO:4.
- the polypeptide that catalyzes conversion 3.1 may be acetoacetyl-CoA:acetate/butyrate coenzyme- A transferase.
- the acetoacetyl-CoA:acetate/butyrate coenzyme- A transferase may be encoded by the C. acetobutyrlicum genes ctfA and ctfB which have corresponding amino acid sequence of SEQ ID NO:5 and 6.
- the polypeptide that catalyzes conversion 4 may be acetoacetate decarboxylase having an amino acid sequence of SEQ ID NO:7
- the polypeptide that catalyzes conversion 5 may be a secondary alcohol dehydrogenase having an amino acid sequence of SEQ ID NO:8.
- the host cell may be selected from the group consisting of: a bacterium, a cyanobacterium, a filamentous fungus and a yeast.
- the host cell may be E. coli., Saccharomyces cerevisiae, a member of the genus Salmonella, a member of the genus Bacillus, or a member of the genus Clostridium.
- the host cell may be a member of a genus selected from the group consisting of Pichia, Hansenula, Yarrowia, Aspergillus, Kluyveromyces, Pachysolen, Rhodotorula, Zygosaccharomyces, Galactomyces, Schizosaccharomyces, Tom ⁇ aspora, Debaryomyces, Williopsis, Dekkera, Kloeckera, Metschnikowia or Candida.
- a genus selected from the group consisting of Pichia, Hansenula, Yarrowia, Aspergillus, Kluyveromyces, Pachysolen, Rhodotorula, Zygosaccharomyces, Galactomyces, Schizosaccharomyces, Tom ⁇ aspora, Debaryomyces, Williopsis, Dekkera, Kloeckera, Metschnikowia or Candida.
- the host cell may be a member of a genus selected from the group consisting of Arthrobacter, Bacillus, Brevibacterium, Clostridium, Corynebacterium, Gluconobacter, Nocardia, Pseudomonas, Rhodococcus, Streptomyces, or Xanthomonas.
- an isopropanol containing fermentation medium is provided.
- the medium is produced by a method comprising: (a) providing recombinant microbial host cell comprising each of the DNA molecules encoding a polypeptide or group of polypeptides that catalyze the conversion: (i) Acetyl-CoA to Acetate and CoA (conversion 1 ); (ii) Acetyl-CoA to Acetoacetyl-CoA and CoA (conversion 2); (iii) Acetoacetyl-CoA and Acetate to Acetoacetate and Acetyl-CoA (conversion 3.1); (iv) Acetoacetate to Acetone and CO2 (conversion 4); (v) Acetone and NAD(P)H and H+ to Isopropanol and NAD(P)+ (conversion 5), wherein the at least one DNA molecule is heterologous to said microbial host cell; (b) contacting the host cell of (i) with a
- Additional embodiments include isopropanol produced by a method comprising: (a) providing recombinant microbial host cell comprising each of the DNA molecules encoding a polypeptide or group of polypeptides that catalyze the conversion: (i) Acetyl-CoA to Acetate and CoA (conversion 1); ( ⁇ ) Acetyl-CoA to Acetoacetyl-CoA and CoA (conversion 2); (iii) Acetoacetyl-CoA and Acetate to Acetoacetate and Acetyl-CoA (conversion 3.1); (iv) Acetoacetate to Acetone and CO2 (conversion 4); (v) Acetone and NAD(P)H and H+ to Isopropanol and NAD(P)+ (conversion 5), wherein the at least one DNA molecule is heterologous to said microbial host cell; (b) contacting the host cell of (i) with a fermentable carbon substrate in a fermentation medium under conditions whereby is
- Other embodiments include a method for the production of isopropanol comprising: (a) providing a recombinant microbial host cell comprising each of the DNA molecules encoding a polypeptide that catalyzes the conversion: (i) Acetyl-CoA to Acetoacetyl- CoA and CoA (conversion 2); (ii) Acetoacetyl-CoA + H2O ⁇ Acetoacetate + CoA (conversion 3.2); (iii) Acetoacetate to Acetone and CO2 (conversion 4); (iv) Acetone and NAD(P)H and H+ to Isopropanol and NAD(P)+ (conversion 5), wherein the at least one DNA molecule is heterologous to said microbial host cell; (b) contacting the host cell of (i) with a fermentable carbon substrate in a fermentation medium under conditions whereby isopropanol is produced; and (c) recovering said isopropanol.
- the fermentable carbon substrate may be selected from the group consisting of monosaccharides, oligosaccharides, and polysaccharides.
- the carbon substrate may be selected from the group consisting of glucose, sucrose, and fructose.
- the conditions may be anaerobic, microaerobic, or aerobic.
- the host cell may be contacted with the carbon substrate in a minimal medium.
- the polypeptide that catalyzes conversion 2 may be acetyl-CoA-acetyltransferase having an amino acid sequence of SEQ ID NO:4.
- the polypeptide that catalyzes conversion 3.2 may be acetoacetyl-CoA hydrolase.
- the polypeptide that catalyzes conversion 4 may be acetoacetate decarboxylase having an amino acid sequence of SEQ ID NO:7.
- the polypeptide that catalyzes conversion 5 may be a secondary alcohol dehydrogenase having an amino acid sequence of SEQ ID NO:8.
- the host cell is selected from the group cons ⁇ sting of: a bacterium, a cyanobacterium, a filamentous fungus and a yeast.
- the host cell may be E. coli, Saccharomyces cerevisiae, a member of the genus Salmonella, a member of the genus Bacillus, or a member of the genus Clostridium.
- the host cell may be a member of a genus selected from the group consisting of Pichia, Hansenula, Yarrowia, Aspergillus, Kluyveromyces, Pachysolen, Rhodotorula, Zygosaccharomyces, Galactomyces, Schizosaccharomyces, Torulaspora, Debaryomyces, Williopsis, Dekkera, Kloeckera, Metschnikowia or Candida.
- a genus selected from the group consisting of Pichia, Hansenula, Yarrowia, Aspergillus, Kluyveromyces, Pachysolen, Rhodotorula, Zygosaccharomyces, Galactomyces, Schizosaccharomyces, Torulaspora, Debaryomyces, Williopsis, Dekkera, Kloeckera, Metschnikowia or Candida.
- the host cell may be a member of a genus selected from the group consisting of Arthrobacter, Bacillus, Brevibacterium, Clostridium, Corynebacterium, Gluconobacter, Nocardia, Pseudomonas, Rhodococcus, Streptomyces, or Xanthomonas.
- an isopropanol containing fermentation medium is provided.
- the medium is produced by a method comprising: (a) providing a recombinant microbial host cell comprising each of the DNA molecules encoding a polypeptide that catalyzes the conversion: (i) Acetyl-CoA to Acetoacetyl-CoA and CoA (conversion 2); (ii) Acetoacetyl- CoA + H2O ⁇ Acetoacetate + CoA (conversion 3.2); (iii) Acetoacetate to Acetone and CO2 (conversion 4); (iv) Acetone and NAD(P)H and H+ to Isopropanol and NAD(P)+ (conversion 5), wherein the at least one DNA molecule is heterologous to said microbial host cell; (b) contacting the host cell of (i) with a fermentable carbon substrate in a fermentation medium under conditions whereby isopropanol is produced; and (c) recovering said isopropanol.
- isopropanol produced by a method comprising: (a) providing a recombinant microbial host cell comprising each of the DNA molecules encoding a polypeptide that catalyzes the conversion: (i) Acetyl-CoA to Acetoacetyl- CoA and CoA (conversion 2); (ii) Acetoacetyl-CoA + H2O ⁇ Acetoacetate + CoA (conversion 3.2); (iii) Acetoacetate to Acetone and CO2 (conversion 4); (iv) Acetone and NAD(P)H and H+ to Isopropanol and NAD(P)+ (conversion 5), wherein the at least one DNA molecule is heterologous to said microbial host cell; (b) contacting the host cell of (i) with a fermentable carbon substrate in a fermentation medium under conditions whereby isopropanol is produced; and (c) recovering said isopropanol.
- ACTATGCC A AAATATAATA T TTTAAA C ATATTAT GAAGTTATATTATAACTATCTGCCTGTTCATCGCTATTTCGCT T G A G ATAT AATATAA GC TTTTAT GAATAATAATATTATTCATATTGAACCAGAAATGCTGTTGAAAAAAACAAC A TTTACAT TT CC AATAA C T G T CGTATTTTCCGCCAGTGTTGTATTTTCATACATGTTTTAAATTATTGATTGTTAAA A AATATC CATAAAAT C AT C T G A C TTTATATTATATTTTTTTATCTTTATATATAGTGTACTTCTGTTTATTCCTAA T GG A TCCT CTA G A G T CG A CC T GC A GGCATGCAAGCTTGGCGTAATCATGGTCATAGCTGTTTCCTGTGTGAAATTGT TATCCGC T CACAATT CC A C A C A C AA C ATA CGAGCCGGAAGCATAAAGTGTAAAGCCTGGGGTGCCTAATGAGTGAGCTA
- AACATTATCCC AA GCAGTATCTATGGTTAAACCAGGAGGAATAATTTCTAATATAAATTATCATGGAAGTGGAGATG
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Wood Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Methods and compositions for the production of bio-based material precursors are provided.
Description
ENGINEERED MICROORGANISMS FOR PRODUCING PROPANOL
[0001] The present application is related to and claims the benefit of the earliest available effective filing dates under 35 USC §119(e) from the following listed provisional applications: U.S. Provisional Application Serial No. 61/029,183, filed February 15, 2008; U.S. Provisional Application Serial No. 61/029,200, filed February 15, 2008; U.S. Provisional Application Serial No. 61/033,659, filed March 4, 2008; and U.S. Provisional Application Serial No. 61/055,886, filed May 23, 2008. In addition, for purposes of the USPTO extra-statutory requirements, the present application constitutes a continuation-in-part of U.S. Patent Application Serial No. 12/106,173 (U.S. Publication No. US 2008/0293125), filed April 18, 2008, which is currently co-pending. Applicant is designating the present application as a continuation-in-part of its parent application as set forth above, but expressly points out that such designations are not to be construed in any way as any type of commentary and/or admission as to whether or not the present application contains any new matter in addition to the matter of its parent application. AU subject matter of the above-referenced applications is incorporated herein by reference to the extent such subject matter is not inconsistent herewith.
FIELD OF THE INVENTION
[0002] The present invention relates to a process for the conversion of carbohydrates to propanol using microorganisms and the chemical conversion of fermentation-produced propanol to propylene or polypropylene.
BACKGROUND
[0003] In the early 1940s, Henry Ford first investigated the use of soy based plastics in vehicles. This initiated the first wave of interest in bio-based and agri-based industrial materials. These, traditionally defined as 'engineering material made from living matter such as starch or bio-derived monomers that is often biodegradable', have the potential to improve sustainability of natural resources, environmental quality and national security while competing economically with petrochemically derived materials. Growing concern over depleting fossil energy resources and the geo-political instability of oil-rich nations has re-focused both government and public
efforts in the area of bio-based materials, fuels and chemicals. In addition, environmental concerns relating to the possibility of carbon dioxide related climate change is an important social and ethical driving force which is starting to result in government regulations and policies such as the 2002 US Farm bill (http://www.rurdev.usda.gov/rbs/farmbill/) the goal of which is to increase the government's purchase and use of bio-based products. [0004] Bio-based materials are starting to replace traditional petrochemically derived materials in a growing number of areas. For example, ink derived from soybean oil has replaced more than 90% of the petro-based ink used by the US newspaper industry (Wool, RP., Xiuzhi, SS. Bio-Based Polymers and Composites. (2005) Elsevier Academic Press). 'Soy ink' is available in brighter colors, is more environmentally friendly and allows for more efficient paper recycling. Paints, detergents and plastics based on vegetable oils and fats function as viable green alternatives to traditional petro-based ones. Poly lactic acid (PLA), made using lactate derived from corn or sugarcane, is a biodegradable polyester. The uses of bio-based PLA range from biomedical applications such as sutures and stents to packaging material and disposable tableware. Bio-propanediol, made from corn, can be used as a starting material for a number of industrial products including composites, adhesives, laminates, copolyesters and solvents. Bio- based alcohols such as isopropanol, ethanol, butanol and isobutanol offer another environmentally friendly raw material that can be used to develop greener materials, fuels and chemicals. Bio-based material precursors, which include 1-propanol and 2-propanol, can be used to generate bio-based materials, such as propylene and polypropylene. [0005] The first and biggest use of isopropanol (IPA) is as a solvent. The other most significant use of IPA is as a chemical intermediate. It is a component of cleaners, disinfectants, room sprays, lacquers and thinners, adhesives, pharmaceuticals, cosmetics and toiletries. It is also used as an extractant and as a dehydrating agent. Xanthan gum, for example, is extracted with IPA. In addition, isopropanol is also used as a gasoline additive, to dissolve water and ice in fuel lines and tanks thereby preventing the water from accumulating in the fuel lines and freezing at low temperatures. IPA is also sold as rubbing alcohol and used as a disinfectant. [0006] IPA is currently produced by one of two processes that use petrochemically derived precursors: (1) a two-step (indirect) process during which propylene is hydrogenated and then hydrolysed using acid and water or (2) a one-step (direct) process during which propylene is hydrogenated using an acid catalyst. In 2003, the global petrochemical based IPA production reached 2152 thousand metric tons with most of the production focused in the US, Western
Europe and Japan. The global demand for isopropanol and propylene continues to increase at a rate of about 3% per year. An environmentally friendly and bio-based alternative to the petro- based production process is the production of IPA by fermentation from renewable biomass. However, to be viable and outperform in the current petrochemical IPA market, a fermentative process for the production of IPA must be cost-effective.
[0007] 1-ρropanol or n-propanol is commonly used in the chemical industry as a solvent and for resins and for production of esters such as propyl acetate and cellulose ester. 1 -propanol is a colorless, highly flammable liquid that is volatile at room temperature and normal atmospheric pressure. It is miscible with water and organic solvents. Propanol is a component of fusel oil, which is a byproduct formed during fermentation of yeast to produce ethanol. [0008] The annual world production capacity of petrochemically-derived 1 -propanol in 1979 exceeded 130,000 tons. By 1993 the world production capacity had increased to 180,000 tons (Unruh, J.D. and Pearson, D. 2000. "n-Propyl Alcohol", Kirk-Othmer Encyclopedia of Chemical Technology). It is produced in nature by the decomposition of organic materials by a variety of microorganisms and occurs in plants and fusel oil. 1 -propanol is produced from petrochemically-derived ethene by reaction with carbon monoxide and hydrogen to give propionaldehyde, which is then hydrogenated. It is also a byproduct of methanol manufacture and may be produced from propane directly or from acrolein. The major use of 1 -propanol is as a multi-purpose solvent in industry and in the home. It is used in flexographic printing ink and textile applications, products for personal use, such as cosmetics and lotions, and in window cleaning, polishing, and antiseptic formulations. Second in importance is its use as an intermediate in the manufacture of a variety of chemical compounds (ENVIRONMENTAL HEALTH CRITERIA 102, World Health Organization, Geneva, Switzerland 1990, ISBN 92 4 157102 0). An environmentally friendly and bio-based alternative to the petro-based production process is the production of 1 -propanol by fermentation from renewable biomass. However, to be viable and outperform in the current petrochemical 1 -propanol market, a fermentative process for the production of 1 -propanol must be cost-effective.
[0009] Microorganisms of the genus Clostridium have been reported to produce isopropanol, together with other solvents and acids, by fermentation. George et al reported five species of Clostridia that produce isopropanol in addition to butanol or butanol and acetone (George HA, Johnson JL, Moore WE, Holdeman LV, Chen JS. Acetone, Isopropanol, and Butanol Production by Clostridium beijerinckii (syn. Clostridium butylicum) and Clostridium aurantibutyricum.
Appl. Environ. Microbiol. 1983. 45(3): 1160-1163). C heijerinckii VPI2968 produced 9.8 niM isopropanol and 44.8 mM butanol. C. beijerinckii VPI2982 produced 1.6 niM isopropanol and 41 ,3 mM butanoϊ. "C. butylicum" NRRL B593 produced 8.0 mM isopropanol and 61.7 mM butanol. C. aurantibuiyricum ATCC 17777 produced 4.5 mM isopropanol, 45.4 rnM butanol, and 20.5 mM acetone. C. aurantibutyricum NCIB 10659 produced 10.0 mM isopropanol, 42.4 mM butanol, and 14.5 mM acetone. Another report described strain 172CY that produces isopropanol and butanol in a continuous process using a CA-alginate immobilized fermenter (Araki K, Minami T, Sueki M, Kimura T. Continuous Fermentation by Butanol-Isopropanol Producing Microorganisms Immobilized by Ca- Alginate. J Soc Fermentation and Bioengineering. 1993. 71(1):9-14.),
[0010] Bermejo et al disclose the heterologous expression in E. coll of an "acetone operon" composed of four Clostridium acetobutylicum genes (Bermejo et al, Appl Environ Microbiol. 1998 Mar;64(3): 1079-85). Expression of this acetone pathway allowed the production of acetone from glucose in E. coli.
[0011] The four clostridial genes of the acetone pathway described by Bermejo encode three enzymes that can convert acetyl-coenzyme A (acetyl-CoA) and acetate into acetone. In the first step, the enzyme thiolase, which is encoded by the thl gene, generates acetoacetyl-CoA from two acetyl-CoA molecules by a condensation reaction. The enzyme acetoacetyl- CoA:acetate/butyrate:CoA transferase (CoAT), which is encoded by the ctfA and the ctfB genes, converts acetoacetyl-CoA and acetate into acetoacetate and acetyl-CoA. In the final step, acetoacetate decarboxylase (AADC), which is encoded by the adc gene, converts the acetoacetate into acetone and carbon dioxide.
[0012] Because C, acetobutylicum does not possess a secondary alcohol dehydrogenase, it is unable to produce the secondary alcohol isopropanol from the ketone substrate acetone. However, other species have been identified that contain either a primary- secondary alcohol dehydrogenase or a secondary alcohol dehydrogenase that are capable of converting acetone to isopropanol. For example, a primary-secondary alcohol dehydrogenase was characterized from two strains (NRRL B593 and NESTE 255) of Clostridium beijerinckii (Ismaiel, A, A., Zhu, C- X., Colby, G.D. and Chen, J.-S. Purification and Characterization of a primary-secondary alcohol dehydrogenase from two strains of Clostridium beijerinckii. J. Bacteriol. 1993 175:5097- 5105). This enzyme was shown to depend on NADPH and could convert both acetone and butyraldehyde to the corresponding alcohols isopropanol and n-butanol, respectively. Similarly,
a secondary alcohol dehydrogenase from a strain (AIU 652) of Burkholderia sp. has been characterized (Isobe, K., and Wakao, N. Thermostable NAD+-dependent (R)-specific secondary alcohol dehydrogenase from cholesterol-utilizing Burkholderia sp. AIU 652, J. Biosci. Bioengr. 2003 96(4):387-393). This enzyme was shown to be NADH dependent. [0013] Fusel alcohols are a component of alcoholic fermentation broths. The total fusel alcohol content of wine is about 0.8-1.2 g/L. The major constituents of the fusel alcohol fraction of wine and other products of alcoholic fermentations are frequently referred to as fusel oil or fusel alcohol. These constituents are alcohols with more than two carbon atoms and commonly include 1-propanol, isopropanol, isobutanol, 2- and 3-methylbutanol among others, which are produced naturally as mixtures and in small amounts by yeast. Acetic acid, acetaldehyde, ethyl acetate, propanol, isobutanol, 2- and 3-methylbutanol account for more than half of these volatiles, the other half being distributed among 600-800 minor volatile compounds present in very low amounts (acetals, organic acids, alcohols, phenolic and heterocyclic compounds, esters, lactones, terpenes and sulfur-containing compounds) (Oliveira E. S. et al. 2005 World Journal of Microbiology and Biotechnology 21 :1569-1576; Regodon Mateos JA, et al, Enzyme and Microbial Technology 40 (2006) 151-157).
SUMMARY
[0014] Embodiments of the invention include recombinant microorganisms that contain a pathway to produce isopropanol and these microorganisms are used to produce isopropanol where at least one enzyme of the pathway is heterologous to the microorganism. Use of a heterologous host allows genomic manipulations to be performed quickly since a host can be chosen that has better understood molecular biology, and having far better developed molecular biology techniques, than that of the Clostridia species previously available. Additionally, heterologous expression also avoids complications by native or endogenous regulation. [0015] In an embodiment, an engineered microorganism is provided that produces isopropanol at high yield by biochemically converting a carbon source to isopropanol. The engineered microorganisms express a metabolic pathway for the production of isopropanol. [0016] In an embodiment, there is provided a recombinant microbial host cell comprising each of the DNA molecules encoding a polypeptide or group of polypeptides that catalyze the conversion:
(i) Acetyl-CoA to Acetate and CoA (conversion 1)
(ii) Acetyl-CoA to Acetoacetyl-CoA and CoA (conversion 2)
(iii) Acetoacetyl-CoA and Acetate to Acetoacetate and Acetyl-CoA (conversion
3.1)
(iv) Acetoacetate to Acetone and CO2 (conversion 4)
(v) Acetone and NAD(P)H and H+ to Isopropanol and NAD(P)+ (conversion 5)
wherein the at least one DNA molecule is heterologous to said microbial host cell and wherein said microbial host cell produces isopropanol.
[0017] In another embodiment, there is provided a recombinant microbial host cell comprising each of the DNA molecules encoding a polypeptide that catalyzes the conversion:
(i) Acetyl-CoA to Acetoacetyl-CoA and CoA (conversion 2)
(ii) Acetoacetyl-CoA + H2O → Acetoacetate + CoA (conversion 3.2)
(iii) Acetoacetate to Acetone and CO2 (conversion 4)
(iv) Acetone and NAD(P)H and H+ to Isopropanol and NAD(P)+ (conversion 5)
wherein the at least one DNA molecule is heterologous to said microbial host cell and wherein said microbial host cell produces isopropanol.
[0018] In yet another embodiment, there is provided a method for the production of isopropanol comprising:
(a) providing a recombinant microbial host cell comprising each of the DNA molecules encoding a polypeptide or group of polypeptides that catalyze the conversion: (i) Acetyl-CoA to Acetate and CoA (conversion 1)
(ii) Acetyl-CoA to Acetoacetyl-CoA and CoA (conversion 2) (iii) Acetoacetyl-CoA and Acetate to Acetoacetate and Acetyl-CoA (conversion
3.1)
(iv) Acetoacetate to Acetone and CO2 (conversion 4)
(v) Acetone and NAD(P)H and H+ to Isopropanol and NAD(P)+ (conversion 5)
wherein the at least one DNA molecule is heterologous to said microbial host cell;
(b) contacting the host cell of (i) with a fermentable carbon substrate in a fermentation medium under conditions whereby isopropanol is produced; and
(c) recovering said isopropanol.
[0019] In still another embodiment, there is provided an isopropanol containing fermentation medium produced by a method comprising:
(a) providing a recombinant microbial host cell comprising each of the DNA molecules encoding a polypeptide or group of polypeptides that catalyze the conversion:
(i) Acetyl-CoA to Acetate and CoA (conversion 1)
(ii) Acetyl-CoA to Acetoacetyl-CoA and CoA (conversion 2) (iii) Acetoacetyl-CoA and Acetate to Acetoacetate and Acetyl-CoA (conversion 3.1)
(iv) Acetoacetate to Acetone and CO2 (conversion 4)
(v) Acetone and NAD(P)H and H+ to Isopropanol and NAD(P)+ (conversion 5)
wherein the at least one DNA molecule is heterologous to said microbial host cell and
(b) contacting the host cell of (i) with a fermentable carbon substrate in a fermentation medium under conditions whereby isopropanol is produced; and
(c) recovering said isopropanol.
[0020] In another embodiment, there is provided a method for the production of isopropanol comprising:
(a) providing a recombinant microbial host cell comprising each of the DNA molecules encoding a polypeptide that catalyzes the conversion:
(i) Acetyl-CoA to Acetoacetyl-CoA and CoA (conversion 2)
(ii) Acetoacetyl-CoA + H2O → Acetoacetate + CoA (conversion 3.2)
(iii) Acetoacetate to Acetone and CO2 (conversion 4)
(iv) Acetone and NAD(P)H and H+ to Isopropanol and NAD(P)+ (conversion 5)
wherein the at least one DNA molecule is heterologous to said microbial host cell and
(b) contacting the host cell of (i) with a fermentable carbon substrate in a fermentation medium under conditions whereby isopropanol is produced.
[0021] In yet another embodiment, there is provided a method for the production of isopropanol comprising:
(a) providing a recombinant microbial host cell comprising each of the DNA molecules encoding a polypeptide that catalyzes the conversion:
(i) Acetyl-CoA to Acetoacetyl-CoA and CoA (conversion 2)
(ii) Acetoacetyl-CoA + H2O → Acetoacetate + CoA (conversion 3.2)
(iii) Acetoacetate to Acetone and CO2 (conversion 4)
(iv) Acetone and NAD(P)H and H+ to Isopropanol and NAD(P)+ (conversion 5)
wherein the at least one DNA molecule is heterologous to said microbial host cell;
(b) contacting the host cell of (i) with a fermentable carbon substrate in a fermentation medium under conditions whereby isopropanol is produced; and
(c) recovering said isopropanol.
[0022] In still another embodiment, there is provided an isopropanol containing fermentation medium produced by a method comprising:
(a) providing a recombinant microbial host cell comprising each of the DNA molecules encoding a polypeptide that catalyzes the conversion:
(i) Acetyl-CoA to Acetoacetyl-CoA and CoA (conversion 2)
(ii) Acetoacetyl-CoA + H2O ~→ Acetoacetate + CoA (conversion 3.2)
(iii) Acetoacetate to Acetone and CO2 (conversion 4)
(iv) Acetone and NAD(P)H and H+ to Isopropanol and NAD(P)+ (conversion 5)
wherein the at least one DNA molecule is heterologous to said microbial host cell;
(b) contacting the host cell of (i) with a fermentable carbon substrate in a fermentation medium under conditions whereby isopropanol is produced; and
(c) recovering said isopropanol.
[0023] In another embodiment, there is provided a method for producing isopropanol comprising:
(a) providing recombinant microbial host cell comprising each of the DNA molecules encoding a polypeptide or group of polypeptides that catalyze the conversion: (i) Acetyl-CoA to Acetate and CoA (conversion 1)
(ii) Acetyl-CoA to Acetoacetyl-CoA and CoA (conversion 2) (iii) Acetoacetyl-CoA and Acetate to Acetoacetate and Acetyl-CoA (conversion
3-1)
(iv) Acetoacetate to Acetone and CO2 (conversion 4)
(v) Acetone and NAD(P)H and H+ to Isopropanol and NAD(P)+ (conversion 5)
wherein the at least one DNA molecule is heterologous to said microbial host cell;
(b) contacting the host cell of (i) with a fermentable carbon substrate in a fermentation medium under conditions whereby isopropanol is produced; and
(c) recovering said isopropanol.
[0024] In yet another embodiment, there is provided isopropanol produced by a method comprising:
(a) providing a recombinant microbial host cell comprising each of the DNA molecules encoding a polypeptide that catalyzes the conversion:
(i) Acetyl-CoA to Acetoacetyl-CoA and CoA (conversion 2)
(ii) Acetoacetyl-CoA +• H2O → Acetoacetate + CoA (conversion 3.2)
(iii) Acetoacetate to Acetone and CO2 (conversion 4)
(iv) Acetone and NAD(P)H and H+ to Isopropanol and NAD(P)+ (conversion 5) wherein the at least one DNA molecule is heterologous to said microbial host cell;
(b) contacting the host cell of (i) with a fermentable carbon substrate in a fermentation medium under conditions whereby isopropanol is produced; and
(c) recovering said isopropanol.
[0025] In yet another embodiment, there is provided a method of making a bio-based material precursor, the method comprising: a) providing a feedstock comprising a suitable carbon source obtained from starch, cellulose, hemicelluϊose, or pectin; and b) contacting the feedstock of a) with a biocatalyst operable to produce the bio-based material precursor, wherein the bio-based material precursor is produced at a yield of at least about 50 per cent of theoretical yield; and c) recovering the bio-based material precursor.
[0026] In yet another embodiment, there is provided a method of making a bio-based material precursor, the method comprising: a) providing a feedstock comprising a suitable carbon source obtained from starch, cellulose> hemicellulose, or pectin; and b) contacting the feedstock of a) with a biocatalyst operable to produce the bio-based material precursor, wherein the bio-based material precursor is produced at a volumetric productivity of at least about 0.4 g/L/h.; and c) recovering the bio-based material precursor.
[0027] In yet another embodiment, there is provided a method of making a bio-based material precursor, the method comprising: a) providing a feedstock comprising a suitable carbon source obtained from starch, cellulose, hemicellulose, or pectin; and b) contacting the feedstock of a) with a biocatalyst operable to produce the bio-based material precursor, wherein
the bio-based material precursor is produced at a titer of at least about 14 g/L.; and c) recovering the bio-based material precursor.
[0028] In yet another embodiment, there is provided a method of making a bio-based material precursor, the method comprising: a) providing a feedstock comprising a suitable carbon source obtained from starch, cellulose, hemicellulose, or pectin; and b) contacting the feedstock of a) with a biocatalyst operable to produce the bio-based material precursor, wherein the bio-based material precursor is produced at: i) a yield of at least about 50 per cent of theoretical; ii) a volumetric productivity of at least about 0.4 g/L/h; and iii) a titer of at least about 14 g/L; and c) recovering the bio-based material precursor. [0029] In yet another embodiment, there is provided a method of producing propylene comprising: a) contacting a biocatalyst with a fermentable carbon source under conditions whereby propanol is produced; b) recovering the propanol; and c) dehydrating the recovered propanol in the presence of an acid catalyst, thereby producing propylene and water. The method optionally includes (d) separating the propylene from the water obtained in step (c); and (e) recovering the propylene. [0030] Other embodiments are also disclosed.
BRIEF DESCRIPTION OF THE DRAWINGS
[0031] FIGURE 1 illustrates the metabolic pathways involved in the conversion of glucose to acids and solvents in Clostridium acetobutylicum (A). Other strains of the genus Clostridium produce isopropanol by reduction of acetone via an alcohol dehydrogenase (B).
[0032] FIGURES 2A and 2B illustrate a pathway in E. coli from glucose to isopropanol according to embodiments of the present disclosure. The pathway is shown under aerobic conditions (FIGURE 2A) and anaerobic conditions (FIGURE 2B).
[0033] FIGURE 3 depicts plasmid pACT, also referred to herein as pGV 1031, containing the thl, ctfA, ctfB, and adc genes from Clostridium acetobutylicum which are expressed from the native thiolase promoter.
[0034] FIGURE 4 depicts plasmid pGV 1093 containing the C. beijerinckii adhl open reading frame inserted between the EcoRl and BamΗl sites in the pUC19 plasmid vector.
[0035] FIGURE 5 depicts plasmid pGVl 259 containing the C. beijerinckii adhl gene which is expressed from the Puaco-i promoter.
- J l -
[0036] FIGURE 6 depicts plasmid pGV 1699 containing the C. acetobutylicum thl, ctfA, ctβ, and adc genes expressed from the native thl promoter as well as the C beijerinckii adhl gene expressed form the PuacO-i promoter.
DETAILED DESCRIPTION
Definitions
[0037] As used herein, the term "microorganism" includes prokaryotic and eukaryotic microbial species from the domains Archaea, Bacteria and Eukaryote, the latter including yeast and filamentous fungi, protozoa, algae, or higher Protista. The terms "cell," "microbial cells," and "microbes" are used interchangeably with the term microorganism.
[0038] "Gram-negative bacteria" include cocci, nonenteric rods and enteric rods. The genera of Gram-negative bacteria include, for example, Neisseria, Spirillum, Pasleurella, Brucella, Yersinia, Francisella, Haemophilus, Bordetella, Escherichia, Salmonella, Shigella, Klebsiella, Proteus, Pseudomonas, Bacteroides, Acelobacter, Aerobacter, Agrobacterium, Azotobacter, Myxococcus, Spirilla, Serratia, Vibrio, Rhizobium, Chlamydia, Rickettsia, Treponema and Fusobacterium.
[0039] "Gram positive bacteria" include cocci, nonsporulating rods and sporulating rods. The genera of gram positive bacteria include, for example, Actinomyces, Bacillus, Clostridium, Corynebacterium, Erysipelothrix, Lactobacillus, Listeria, Mycobacterium, Nocardia, Staphylococcus, Streptococcus and Streptomyces.
[0040] The terra "carbon source" generally refers to a substrate or compound suitable to be used as a source of carbon for prokaryotic or simple eukaryotic cell growth. Carbon sources may be in various forms, including, but not limited to polymers, carbohydrates, acids, alcohols, aldehydes, ketones, amino acids, peptides, etc. These include, for example, various monosaccharides such as glucose, oligosaccharides, polysaccharides, celMosic material, saturated or unsaturated fatty acids, succinate, lactate, acetate, ethanol, etc., or mixtures thereof. The carbon source may additionally be a product of photosynthesis, including, but not limited to glucose. The term "carbon source" may be used interchangeably with the term "energy source," since in chemoorgano trophic metabolism the carbon source is used both as an electron donor during catabolism as well as a source of carbon during cell growth.
[0041] Carbon sources which serve as suitable starting materials for the production of isopropanol include, but are not limited to, biomass hydrolysates, glucose, starch, cellulose, hemicellulose, xylose, lignin, lignin compounds, dextrose, fructose, galactose, com, liquefied corn meal, corn steep liquor (a byproduct of corn wet milling process that contains nutrients leached out of corn during soaking), molasses, lignocellulose, and maltose. Photosynthetic organisms can additionally produce a carbon source as a product of photosynthesis. In an embodiment, carbon sources may be selected from biomass hydrolysates and glucose. Glucose, dextrose and starch can be from an endogenous or exogenous source. [0042] It should be noted that other carbon sources which may be more accessible, inexpensive, or both, can be substituted for glucose with relatively minor modifications to the host microorganisms. For example, in certain embodiments, use of other renewable and economically feasible substrates may be preferred. These may include agricultural waste, starch- based packaging materials, corn fiber hydrolysate, soy molasses, fruit processing industry waste, and whey permeate, etc.
[0043] As used herein, the term "y^dd" refers to the amount of product per amount of carbon source in g/g. The yield may be exemplified for glucose as the carbon source. It is understood unless otherwise noted that yield is expressed as a percentage of the theoretical yield. In reference to a microorganism or metabolic pathway, "theoretical yield" is defined as the maximum amount of product that can be generated per total amount of substrate as dictated by the stoichiometry of the metabolic pathway used to make the product. For example, the theoretical yield for one typical conversion of glucose to isopropanol is 0.33 g/g. As such, a yield of isopropanol from glucose of 29.7 g/g would be expressed as 90% of theoretical or 90% theoretical yield. It is understood that while in the present disclosure the yield is exemplified for glucose as a carbon source, the invention can be applied to other carbon sources and the yield may vary depending on the carbon source used. One skilled in the art can calculate yields on various carbon sources.
[0044] The microorganisms herein disclosed are, in some cases, engineered using genetic engineering techniques, to provide microorganisms which utilize heterologously expressed enzymes to produce isopropanol at high yield.
[0045] The term "enzyme" as used herein refers to any substance that catalyzes or promotes one or more chemical or biochemical reactions, which usually includes enzymes totally or
partially composed of a polypeptide, but can include enzymes composed of a different molecule including polynucleotides.
[0046] The term "polynucleotide" is used herein interchangeably with the term "nucleic acid" and refers to an organic polymer composed of two or more monomers including nucleotides, or nucleosides, including but not limited to single stranded or double stranded, sense or antisense deoxyribonucleic acid (DNA) of any length and, where appropriate, single stranded or double stranded, sense or antisense ribonucleic acid (RNA) of any length, including siRNA. The term "nucleotide" refers to any of several compounds that consist of a ribose or deoxyribose sugar joined to a purine or a pyrimidine base and to a phosphate group, and that are the basic structural units of nucleic acids. The term "nucleoside" refers to a compound (as guanosine or adenosine) that consists of a purine or pyrimidine base combined with deoxyribose or ribose and is found especially in nucleic acids. Accordingly, the term polynucleotide includes nucleic acids of any length, DNA, RNA, analogs and fragments thereof, A polynucleotide of three or more nucleotides is also called "nucleotidic oligomer" or "oligonucleotide". [0047] The term "protein" or "polypeptide" as used herein indicates an organic polymer composed of two or more amino acidic monomers and/or analogs thereof. As used herein, the term "amino acid" or "amino acidic monomer" refers to any natural and/or synthetic amino acids including glycine and both D or L optical isomers. Accordingly, the term polypeptide includes amino acidic polymer of any length including Ml length proteins, and peptides as well as analogs and fragments thereof.
[0048] As used herein, the term "pathway" refers to a biological process including one or more enzymatically controlled chemical reactions by which a substrate is converted into a product. Accordingly, a pathway for the conversion of a carbon source to isopropanol is a biological process including one or more enzymatically controlled reactions by which the carbon source is converted into isopropanol. A "heterologous pathway" refers to a pathway wherein at least one of the one or more chemical reactions is catalyzed by at least one heterologous enzyme. On the other hand, a "native pathway" refers to a pathway wherein the one or more chemical reactions are catalyzed by a native enzyme.
[0049] The term "heterologous" or "exogenous" as used herein with reference to enzymes and polynucleotides, indicates enzymes or polynecleotides that are expressed in an organism other than the organism from which they originated or are found in nature, independently on the
level of expression that can be lower, equal to, or higher than the level of expression of the molecule in the native microorganism.
[0050] On the other hand, the term "native" or "endogenous" as used herein with reference to enzymes and polynucleotides, indicates enzymes and polynucleotides that are expressed in the organism in which they originated or are found in nature, independently of the level of expression that can be lower equal or higher than the level of expression of the molecule in the native microorganism.
[0051] The terms "host" or "host cells" are used interchangeably herein and refer to microorganisms, native or wild-type, eukaryotic or prokaryotic that can be engineered for the conversion of a carbon source to isopropanol. The terms "host" and "host cells" refers not only to the particular subject cell but to the progeny or potential progeny of such a cell. Because certain modifications may occur in succeeding generations due to either mutation or environmental influences, such progeny may not, in fact, be identical to the parent cell, but are still included within the scope of the term as used herein. A "parental microorganism" or a "parent cell" functions as a reference cell for successive genetic modification events. Each modification event may be accomplished by introducing a nucleic acid molecule in to the reference cell. The introduction facilitates the expression or over-expression of a target enzyme. Il is understood that the term "facilitates" encompasses the activation of endogenous polynucleotides encoding a target enzyme through genetic modification of e.g., a promoter sequence in a parental microorganism. It is further understood that the term "facilitates" encompasses the introduction of heterologous polynucleotides encoding a target enzyme in to a parental microorganism.
[0052] The terms "activate" or "activation" as used herein with reference to a biologically active molecule, such as an enzyme, indicates any modification in the genome and/or proteome of a microorganism that increases the biological activity of the biologically active molecule in the microorganism. Exemplary activations include but are not limited to modifications that result in the conversion of the molecule from a biologically inactive form to a biologically active form and from a biologically active form to a biologically more active form, and modifications that result in the expression of the biologically active molecule in a microorganism wherein the biologically active molecule was previously not expressed or expressed at lower concentrations. For example, activation of a biologically active molecule can be performed by expressing a native or heterologous polynucleotide encoding for the biologically active molecule in the
microorganism, by expressing a native or heterologous polynucleotide encoding for an enzyme involved in the pathway for the synthesis of the biological active molecule in the microorganism, or by expressing a native or heterologous molecule that enhances the expression of the biologically active molecule in the microorganism. The term "metabolically engineered" or "metabolic engineering" involves rational pathway design and assembly of biosynthetic genes, genes associated with operons, and control elements of such polynucleotides, for the production of a desired metabolite. "Metabolically engineered" can further include optimization of metabolic flux by regulation and optimization of transcription, translation, protein stability and protein functionality using genetic engineering and appropriate culture condition including the reduction of, disruption, or knocking out of, a competing metabolic pathway that competes with an intermediate leading to a desired pathway.
[0053] In particular, the recombinant microorganisms herein disclosed are engineered to activate, and, in particular, express heterologous enzymes that can be used in the production of isopropanol. In particular, in certain embodiments, the recombinant microorganisms are engineered to activate heterologous enzymes that catalyze the conversion of acetyl-CoA to isopropanol. The term "recombinant microorganism" and "recombinant host cell" are used interchangeably herein and refer to microorganisms that have been genetically modified to express or over-express endogenous polynucleotides, or to express heterologous polynucleotides, such as those included in a vector, or which have a reduction in expression of an endogenous gene. The polynucleotide generally encodes a target enzyme involved in a metabolic pathway for producing a desired metabolite. It is understood that the terms "recombinant microorganism" and "recombinant host cell" refer not only to the particular recombinant microorganism but to the progeny or potential progeny of such a microorganism. Because certain modifications may occur in succeeding generations due to either mutation or environmental influences, such progeny may not, in fact, be identical to the parent cell, but are still included within the scope of the term as used herein.
[0054] As used herein, "deleting genes" means that a gene is deleted or otherwise mutated to inactivate the gene. Deletions can be of coding sequences or regulatory sequences provided they do not tend to revert and provided they inactivate the gene product (or gene products as the case may be). Operons can be inactivated as well.
[0055] As used herein, "sequence identity" refers to the occurrence of exactly the same nucleotide or amino acid in the same position in aligned sequences. "Sequence similarity" takes
approximate matches into account, and is meaningful only when such substitutions are scored according to some measure of "difference" or "sameness" with conservative or highly probable substitutions assigned more favorable scores than non-conservative or unlikely ones.
[0056] In certain embodiments, any enzyme that catalyzes a conversion described in herein may be used.
[0057] In certain embodiments, any homologous enzymes that are at least about 70%, 80%,
90%, 95%, 99% identical, or sharing at least about 60%, 70%, 80%, 90%, 95% sequence identity to any of the enzymes of the isopropanol pathway may be used in place of the enzymes described. These enzymes sharing the requisite sequence identity or similarity may be wild-type enzymes from a different organism, or may be artificial, i.e., recombinant, enzymes.
[0058] In certain embodiments, any genes encoding for enzymes with the same activity as any of the enzymes of the isopropanol pathway may be used in place of the enzymes. These enzymes may be wild-type enzymes from a different organism, or may be artificial, recombinant or engineered enzymes.
[0059] Additionally, due to the inherent degeneracy of the genetic code, other nucleic acid sequences which encode substantially the same or a functionally equivalent amino acid sequence can also be used express the polynucleotide encoding such enzymes. As will be understood by those of skill in the art, it can be advantageous to modify a coding sequence to enhance its expression in a particular host. The codons that are utilized most often in a species are called
"optimal codons", and those not utilized very often are classified as "rare or low-usage codons".
Codons can be substituted to reflect the preferred codon usage of the host, a process sometimes called "codon optimization" or "controlling for species codon bias." Methodology for optimizing a nucleotide sequence for expression in a plant is provided, for example, in U.S. Pat. No.
6,015,891.
[0060] Expression of the genes may be accomplished by conventional molecular biology techniques. For example, the heterologous or native genes can be under the control of an inducible promoter or a constitutive promoter. The heterologous genes may either be integrated into a chromosome of the host microorganism, or exist as an extra-chromosomal genetic elements that can be stably passed on ("inherited") to daughter cells. Such extra-chromosomal genetic elements (such as plasmids, BAC, YAC, etc.) may additionally contain selection markers that ensure the presence of such genetic elements in daughter cells.
[0061] Methods of over-expressing, expressing at various levels, and repressing expression of genes in microorganisms are well known in the art, and any such method is contemplated for use in the construction of the microorganisms of the present invention. For example, integrational mutagenesis is a genetic engineering technique that can be used to selectively inactivate undesired genes from a host chromosome. Pursuant to this technique, a fragment of a target gene is cloned into a non-replicative vector with a selection marker to produce a non- replicative integrational plasmid. The partial gene in the non-replicative plasmid can be recombined with the internal homologous region of the original target gene in the parental chromosome, which results in insertional inactivation of the target gene. [0062] Any method can be used to introduce an exogenous nucleic acid molecule into microorganisms and many such methods are well known to those skilled in the art. For example, transformation, electroporation, conjugation, and fusion of protoplasts are common methods for introducing nucleic acid into microorganisms.
[0063] The exogenous nucleic acid molecule contained within a microorganism described herein can be maintained within that cell in any form. For example, exogenous nucleic acid molecules can be integrated into the genome of the cell or maintained in an episomai state that can stably be passed on ("inherited") to daughter cells. Such extra-chromosomal genetic elements (such as plasmids, etc.) may additionally contain selection markers that ensure the presence of such genetic elements in daughter cells. Moreover, the microorganisms can be stably or transiently transformed. In addition, the microorganisms described herein can contain a single copy, or multiple copies of a particular exogenous nucleic acid molecule as described above.
[0064] Methods for expressing polypeptide from an exogenous nucleic acid molecule are well known to those skilled in the art. Such methods include, without limitation, constructing a nucleic acid such that a regulatory element promotes the expression of a nucleic acid sequence that encodes the desired polypeptide. Typically, regulatory elements are DNA sequences that regulate the expression of other DNA sequences at the level of transcription. Thus, regulatory elements include, without limitation, promoters, enhancers, and the like. For example, the exogenous genes can be under the control of an inducible promoter or a constitutive promoter. [0065] Moreover, methods for expressing a polypeptide from an exogenous nucleic acid molecule in microorganisms are well known to those skilled in the art. In another embodiment, heterologous control elements can be used to activate or repress expression of endogenous genes.
Additionally, when expression is to be repressed or eliminated, the gene for the relevant enzyme, protein or RNA can be eliminated by known deletion techniques. [0066] As described herein, microorganisms within the scope of the disclosure can be identified by techniques specific to the particular enzyme being expressed, over-expressed or repressed. Methods of identifying the strains with the desired phenolype are well known to those skilled in the art. Such methods include, without limitation, PCR and nucleic acid hybridization techniques such as northern and Southern blot analysis, altered growth capabilities on a particular substrate or in the presence of a particular substrate, a chemical compound, a selection agent and the like. In some cases, immunohistochemistry and biochemical techniques can be used to determine if a cell contains a particular nucleic acid by detecting the expression of the encoded polypeptide. For example, an antibody having specificity for an encoded enzyme can be used to determine whether or not a particular cell contains that encoded enzyme. Further, biochemical techniques can be used to determine if a cell contains a particular nucleic acid molecule encoding an enzymatic polypeptide by detecting a product produced as a result of the expression of the enzymatic polypeptide. For example, transforming a cell with a vector encoding an alcohol dehydrogenase (ADH) and detecting isopropanol in the cytosol, cell extracts or culture medium supernatant resulting from the ADH catalyzed conversion of acetone to isopropanol indicates that the vector is both present and the gene product is active. Methods for detecting specific enzymatic activities or the presence of particular products are well known to those skilled in the art.
[0067] Metabolization of a carbon source is said to be "balanced" when the NAD(P)H produced during the oxidation reactions of the carbon source equals the NAD(P)H utilized to convert the carbon source to metabolization end products. Under these conditions, all the NAD(P)H is recycled. Without recycling, the NAD(P)H/NAD(P)+ ratio becomes imbalanced and will cause the organism to ultimately die unless alternate metabolic pathways are available to maintain a balanced NAD(P)H/NAD(P)+ ratio.
[0068] The term "biocatalyst" means a living system or cell of any type that speeds up chemical reactions by lowering the activation energy of the reaction and is neither consumed nor altered in the process. Biocatalysts may include, but are not limited to, microorganisms such as yeasts, fungi, bacteria, and archaea, including recombinant microorganisms and metabolically engineered microorganisms.
[0069] The term "feedstock" is defined as a raw material or mixture of raw materials supplied to a biocatalyst or fermentation process from which other products can be made. For example, a carbon source, such as biomass or the carbon compounds derived from biomass are a feedstock for a biocatalyst that produces a bio-based material precursor in a fermentation process. However, a feedstock may contain nutrients other than a carbon source. The term feedstock is used interchangeably with the term "renewable feedstock", as the feedstocks used in the present invention are generated from biomass or traditional carbohydrates, which are renewable substances.
[0070] The term "petrochemical-based precursor" refers to a compound in which some or all carbon contained within the compound is derived from petroleum, natural gas or coal. [0071] The term "bio-based material precursor" or "renewable material precursor" refers to a compound in which all carbon contained within the compound is derived from biomass that is biochemically converted, at least in part, in to a bio-based material precursor by a biocatalyst. A bio -based material precursor is further defined as an alcohol that contains three carbon atoms and which contains less than 0.5 oxygen atoms per carbon atom. A bio-based material precursor may be configured for conversion, either chemically or biochemically, into a bio-based material. [0072] The term "bio-based material" or "renewable material" refers to a substance in which all carbon contained within the substance is derived from bio-based material precursors, which are connected to each other by chemical or biochemical reactions. A bio-based material is comprised of at least two bio-based material precursors.
[0073] The term "volumetric productivity" is defined as the amount of product per volume of media in a fermenter per unit of time. In other words, the rate is the amount of product per unit of time, e.g., g/hr, inasmuch as the volume of the fermenter may be fixed at a chosen volume.
[0074] The term "specific productivity" is defined as the rate of formation of the product.
To describe productivity as an inherent parameter of the microorganism or biocatalyst and not of the fermentation process, productivity is herein further defined as the specific productivity in g product per g of cell dry weight (cdw) per hour (g product g cdw'! h"1). [0075] The term "titer" is defined as the strength of a solution or the concentration of a substance in solution. For example, the titer of a bio-based material precursor in a fermentation broth is described as g of bio-based material precursor in solution per liter of fermentation broth. The term "titer" is used interchangeably throughout with the term "titre".
[0076] The term "tolerance" is defined as the ability of the biocatalyst to maintain its specific productivity at a given concentration of an inhibitor. The term "tolerant" describes a biocatalyst that maintains its specific productivity at a given concentration of an inhibitor. For example if in the presence of 2% of an inhibitor a biocatalyst maintains the specific productivity that it had at 0 to 2%, the biocatalyst is tolerant to 2% of the inhibitor or has a tolerance to 2% of the inhibitor.
[0077] The term "rate of inhibition" is defined as the rate of decrease of the specific productivity of a biocatalyst relative to the increased concentration of an inhibitor, at inhibitor levels above the inhibitory concentration.
[0078] The term "resistance" is defined as the property of a biocatalyst to have a low rate of inhibition in the presence of increasing concentrations of an inhibitor in the fermentation broth. The term "more resistant" describes a biocatalyst that has a lower rate of inhibition towards an inhibitor than another biocatalyst with a higher rate of inhibition towards the same inhibitor. For example the two biocatalysts A and B, both with a tolerance of 2% to an inhibitor bio-based material precursor and a specific productivity of 1 g product g CDVT1 h"1, exhibit at 3% bio-based material precursor a specific productivity of 0.5 g product g CDW1 h"1 and 0.75 g product g CDW"1 If'for A and B, respectively. The biocatalyst B is more resistant than A. [0079] The term "byproduct" means an undesired product related to the production of bio-based material precursor. Byproducts are generally disposed as waste, adding cost to a process.
[0080] The term "co-product" means a secondary or incidental product related to the production of bio-based material precursor. Co-products have potential commercial value that increases the overall value of bio-based material precursor production, and may be the deciding factor as to the viability of a particular bio-based material precursor production process. [0081] The term "distillers dried grains", abbreviated herein as DDG, refers to the solids remaining after a fermentation, usually consisting of unconsumed feedstock solids, remaining nutrients, protein, fiber, and oil, as well as biocatalyst cell debris. The term may also include soluble residual material from the fermentation and is then referred to as "distillers dried grains and solubles" (DDGS).
[0082] The term "homofermentation" means a fermentation that produced predominantly or greater than 90% one metabolite or product other than carbon dioxide.
[0083] Biomass processed via thermo-chemical and enzymatic hydrolysis processes provide a variety of substrates for fermentation. Since raw materials account for the majority of the production cost for biologically produced commodity chemicals and bio-based material precursors, for example by fermentation, it is important to utilize most, if not all carbon- containing compounds from renewable substrates. Further, the carbon source must be converted with high yield into the desired product, as undesired byproducts increase the overall cost of the process.
[0084] In some cases, especially for commodity chemicals, the substrate cost can represent up to 70% of the value of the product (Danner, H. 1999 Chemical Society Reviews 28:395-405). Corn, for example, is typically processed into starch and further processed to dextrose. However, when corn is processed to starch there are a variety of impurities present. Some of the impurities are corn gluten, gluten meal and germ. Others are a variety of starch, dextrin, and soluble dextrins or other and/or all oligomers and dextrose. Here, dextrose (glucose) is currently the only feedstock for further fermentation.
[0085] Economic studies indicate that the predominant factor accounting for the production cost for commodity chemicals and fuels from fermentation processes is attributed to the feedstock cost. An important measure of the process economics is therefore the product yield. Complete substrate utilization is one of the prerequisites to render bio-based material precursor processes economically competitive. Therefore, not only must the microorganism convert all carbon sources within a feedstock to the bio-based material precursor, it must also perform this conversion to near completion.
[0086] The ABE process reaches a 80% theoretical yield of butanol, corresponding to
0.33 g butanol/g glucose (Jones, D. T. and Woods, D. R. Acetone-Butanol Fermentation revisited. Microbiological Review 1986, 50:484-524). As an example for a commodity chemical produced by fermentation, the ethanol fermentation process of sugar and starch generally reaches 90-95% of the theoretical yield, equivalent to 0.45-0.48 g/g sugar in the raw material. [0087] For a biocatalyst to produce a bio-based material precursor most economically, high concentrations of a single product is desired. Extra products reduce primary product yield increasing capital and operating costs, particularly if those extra, undesired products have little or no value. Extra products also require additional capital and operating costs to separate these products from the product or bio-based material precursor of interest.
[0088] In an economical industrial fermentation process, a biocatalyst produces a high level, or titer, of the desired product. A high product titer reduces the cost of downstream processing and product separation and can reduce the operating costs associated with purification of the product. In a fermentation process to produce a bio-based material precursor, the higher the bio-based material precursor concentration, the less cost of recovering that bio-based material precursor from the fermentation broth during product recovery. High product titers also reduce the waste streams coming out of the fermentation and out of the downstream processing, which reduces the overall process cost. In order for a biocatalyst to produce high levels of bio-based material precursor during fermentation, the biocatalyst must be tolerant and resistant to high levels of the bio-based material precursor.
[0089] The biocatalyst of this invention produces high levels of bio-based material precursor during a fermentation process and is resistant to high levels of the bio-based material precursor. The biocatalyst of this invention functions normally or with minimal impairment in the presence of high levels of bio-based material precursor.
[0090] The performance characteristics of the biocatalyst described herein include a high productivity of the conversion of a feedstock to a bio-based material precursor. Productivity has an impact on capital costs for a bio-based material precursor plant and depends on the amount of biocatalyst used during the fermentation and the specific activity of the biocatalyst. High volumetric productivity of the biocatalyst shortens the process time and, therefore, for a given plant size, increases the output of the plant over the plant lifetime. High volumetric productivity increases the return on the capital investment and decreases the cost of the bio-based material precursor. High cell density fermentation increases the volumetric productivity and reduces investment costs. However, it also increases the cost for producing the cell mass, which is a function of the price for added nutrients and decreases the product yield since feedstock is converted to biomass. Therefore, a high specific productivity, which measures the efficiency of the biocatalyst, translates to a lower amount of cell mass required in the fermentation step. For example, ethanol production plants operate at volumetric productivities ranging from 1-3 g ethanol I"1 h'1 with the specific ethanol productivity, e.g., for Saccharomyces cerevisiae being 2 g ethanol g cell dry weight (CDW)"1 h'! (Appl. Microbiol. Biotcchnol. 2007 74:937-953), and 2.1 g CDW"1 h"1 for an engineered Escherichia coli (US Patent 5,424,202). Specific productivity of the biocatalyst depends on the capacity of the terminal pathway converting an intermediate of
metabolism of the biocatalyst into a bio-based material precursor. Another limiting factor for the specific productivity is the glycolytic flux of the biocatalyst.
[0091] The conversion of a carbon source into isopropanol using helerologously expressed fermentative pathways in E. coli has recently been reported. Hanai, T, et al expressed several genes from Clostridium and Thermoanaerobacter spec, in E. coli to produce isopropanol from glucose. A titer of 4.9 g/L was reached at a yield of 43.5% of theoretical and at a productivity of 0.16 g/L/h (Hanai, T. et al. 2007 Applied and Environmental Microbiology 73:7814-7818). Jojima, T. et al. produced isopropanol from glucose in recombinant E. coli following a similar approach. Isopropanol tiler in fed batch fermentation reached 13.6 g/L at a productivity of 0.38 g/L/h and at a yield of 51% of the theoretical yield (Jojima, T. et al. 2008 Applied Microbiology and Biotechnology. 77: 1219-1224).
[0092] 1-propanol was recently produced in recombinant E. coll Atsumi et al. expressed enzymes from Lactococcus lactis (Kivd) and from Saccharomyces cerevisiae (Adh2) to produce 1-propanol from glucose. The titer reached was 0.03 g/L at a productivity of 0.0008 g/L/h. The yield was not reported (Atsumi et al. 2008 Nature 451 :86-89). Shen and Liao (Shen CR and JC Liao. Metabolic Engineering. 2008 10:312-320) have recently described the production of 1- propanol in recombinant E. coli cells. A titer of 1 g/L, a productivity of 0.014 g/L/h, and a yield of 0.045 g/g were achieved. The theoretical yield was not reported. [0093] A method is provided herein which uses a biocatalyst that can economically, and biochemically convert, such as through a fermentation, a feedstock, including carbohydrates and sugars derived from renewable biomass, into a bio-based material precursor, such as 1-propanol or 2-propanol (isopropanol). The bio-based material precursor can then be used in further chemical or biochemical processing to generate a bio-based material, such as propylene or polypropylene. The polymerization of propylene to polypropylene is known in the art. The bio- based material precursor such as 1-propanol and/or 2-propanol generated by the biocatalyst in a fermentation process must be free of unwanted by products so as to be useful to generate a bio- based material, such as propylene or polypropylene, with properties as required by the American Society for Testing and Materials (ASTM).
[0094] Propylene is an important petrochemical feedstock for producing materials such as polypropylene and chemicals such as cumene, butanols, isopropanol, acrylonitrile, and propylene oxide. Propylene is a petroleum product derived from processing oil, natural gas, and coal. Traditionally, propylene was obtained directly by distillation of oil or condensation of liquids
from natural gas. As world-wide demand has exceeded these sources, additional propylene is produced by cracking larger hydrocarbons and converting natural gas and coal gas using chemical catalysts. Because of its relatively high value and high demand, most propylene intentionally produced at refineries is sold into the chemical market. In a few cases, propylene generated at refinery may be oligomerized with other small olefins produced in a cracking unit to produce hydrocarbons that are blended with fuels such as gasoline. Propylene is produced in three major grades as described in Standard Guide ASTM D5273, the industry guideline for specifying grades of propylene concentrates. The three grades are Polymer Grade - the highest purity at >99% propylene, Chemical Grade - 92-99% propylene suitable for producing petrochemicals, and Refinery Grade - 60-90% propylene suitable for producing polygas and other fuel-related materials.
[0095] Propylene can also be produced by the chemical dehydration of propanol, for example 1- or 2-propanol, using one of many different types of acid catalysts including, but not limited to, acidic alumina and zeolites, acidic organic-sulfonic acid resins, mineral acids such as phosphoric and sulfuric acids, and Lewis acids such as boron trifluoride and aluminum compounds(March, Jerry. Advanced Organic Chemistry. New York: John Wiley and Sons, 1992). Propatiols used to produce propylene by dehydration can be generated chemically by condensing syngas produced by the gasification of coal, natural gas, or biomass. [0096] An additional route to producing renewable propanols from biomass includes fermentation technologies such as the Isopropanol-Butanol-Ethanol (IBE) process described previously (George HA et al. Appl Environ Microbiol. 1983 Mar;45(3):l 160-1163. Chen JS and SF Hiu. BiotechnoL Lett. 1986 8(5):371-376. Durre P. Appl. Microbiol. BiotechnoL 1998 49:639-648) and the homofermentation of carbohydrates to 1- or 2-propanol described herein and in the literature (Hanai T, et al. Appl. Environ. Microbiol. 2007 73(24):7814-7818. Jojima . T, et al. Appl. Microbiol. BiotechnoL 2007 DOI 10.1007/s00253-007-1246-8. Shen CR and JC Liao. Metabolic Engineering. 2008 10:312-320). The homofermentation route is especially attractive because it produces a pure stream of 1- or 2-propanol that upon dehydration produces Polymer Grade polypropylene suitable for any industrial use. Other technologies for producing propanols generate alcohol or solvent mixtures, from which the propanol must be purified from before dehydration to produce the higher grades of propylene. Further, product mixtures reduce the overall yield of the desired product, in this case propanol, and increase the cost of the fermentation process. Renewable propylene of any grade has chemical properties virtually
indistinguishable from propylene produced from non-renewable sources such as oil, natural gas, and coal (however, renewable propylene can be distinguished from non-renewable propylene using ASTM 6866-05). All materials and chemicals produced from non-renewable propylene can be made with renewable propylene using processes and techniques described in the art. The homofermentation of feedstock to 1- or 2-propanol described herein, however, is required to enable the production of renewable versions of these materials and chemicals at costs that are competitive with the non-renewable routes.
[0097] The chemical dehydration of propanols to propylene produces an equivalent of water.
The process for producing propylene from 1 - or 2-proρanol is stable to water and includes a mechanism for removing this water as it is generated. With little or no modification, a typical propanol dehydration process can accommodate propanols containing additional water.
Propanols produced by the fermentation of carbohydrates are removed from the aqueous environment of the fermenter using various techniques, generating propanols that contain varying amounts (e.g. 0-70% w/w) of water. These "wet" propanols (e.g., propanols comprising about 1% to about 30% water) are dehydrated using the same process as dry propanols (e.g., propanols comprising less than about 1% water) except that additional water is removed from the process after dehydration occurs. The quality of the propylene produced from wet propanol is unchanged relative to propylene produced from dry propanol.
[0098] In an embodiment, the recombinant microorganism is capable of converting a carbon source to isopropanol.
[0099] In certain embodiments, the recombinant microorganism of the present disclosure is capable of converting a carbon source to acetyl-Co A and of converting acetyl-CoA to isopropanol.
[00100] Host organisms can be engineered to express a metabolic pathway for the conversion of acetyl-CoA to isopropanol wherein at least one of the pathway enzymes is heterologous to the host (FIGURES 2A and 2B).
[00101] In certain embodiments, the recombinant microorganism of the present disclosure is capable of catalyzing the following chemical conversions (Pathway 1):
Acetyl-CoA → Acetate + CoA (conversion 1)
2 Acetyl-CoA → Acetoacetyl-CoA + CoA (conversion 2)
Acetoacetyl-CoA + Acetate -→ Acetoacetate + Acetyl-CoA (conversion 3.1)
Acetoacetate → Acetone + CO2 (conversion 4)
Acetone + NAD(P)H + H+ → Isopropanol + NAD(P)+ (conversion 5)
Where the net reaction is as follows:
2 Acetyl-CoA + NAD(P)H + H+ → Isopropanol + NAD(P)+ + CO2 + 2 CoA and where the theoretical is 1 mole of isopropanol per mole of glucose or 0.33 gram isopropanol per gram of glucose,
[00102] In certain embodiments, the recombinant microorganism of the present disclosure expresses genes encoding the following enzymes that catalyze conversions 1, 2, 3.1 , 4 and 5 of
Pathway 1 : phosphate acetyltrasferase and acetate kinase (catalyzes conversion 1) acetyl-CoA-acetyltransferase (thiolase) (catalyzes conversion 2) acetoacetyl-Co A:acetate/butyrate coenzyme- A transferase (catalyzes conversion 3.1) acetoacetate decarboxylase (catalyzes conversion 4) secondary alcohol dehydrogenase (catalyzes conversion 5)
[00103] In certain embodiments, the recombinant microorganism of the present disclosure is capable of catalysing the following chemical conversions (Pathway 2):
2 Acetyl-CoA → Acetoacetyl-CoA + CoA (conversion 2)
Acetoacetyl-CoA + H2O → Acetoacetate + CoA (conversion 3.2)
Acetoacetate → Acetone + CO2 (conversion 4)
Acetone + NAD(P)H + H+ → Isopropanol + NAD(P)+ (conversion 5)
Where the net reaction is as follows:
2 Acetyl-CoA + NAD(P)H + H+ + H2O → Isopropanol + NAD(P)+ + CO2 + 2 CoA and where the theoretical is 1 mole of isopropanol per mole of glucose or 0.33 g isopropanol per gram of glucose.
[00104] In certain embodiments, the recombinant microorganism of the present disclosure expresses genes encoding the following enzymes that catalyze above reactions 2, 3.2, 4, and 5 of
Pathway 2: acetyl-CoA-acetyltransferase (thiolase) (catalyzes conversion 2) acetoacetyl-CoA hydrolase (catalyzes conversion 3.2)
acetoacetate decarboxylase (catalyzes conversion 4) secondary alcohol dehydrogenase (catalyzes conversion 5)
[00105] In certain embodiments, at least one of the genes expressed within the recombinant microorganism is heterologous to the microorganism. Such heterologous genes may be identified within and obtained from a heterologous microorganism (such as Clostridium acetobulylicum or Clostridium beijerinckii), and can be introduced into an appropriate host using conventional molecular biology techniques. The at least one of heterologous genes enable the recombinant microorganism to produce isopropanol or a metabolic intermediate thereof, at least in an amount greater than that produced by the wild-type counterpart microorganism. [00106] Useful microorganisms that can be used as recombinant hosts may be either eukaryotic or prokaryotic microorganisms. While Escherichia is one of the hosts that may be used according to the present disclosure, other hosts may be used, including yeast strains such as Saccharomyces strains.
[00107] In certain embodiments, other suitable recombinant hosts include, but are not limited to, Pichia, Hansenula, Yarrow ia, Aspergillus, Kluyveromyces, Pachysolen, Rhodotorula, Zygosaccharomyces, Galactomyces, Schizosaccharomyces, Torulaspora, Debaryomyces, Williopsis, Dekkera, Kloeckera, Metschnikowia and Candida.
[00108] In certain embodiments the recombinant hosts include, but are not limited to, Arthrobacter, Bacillus, Brevibacterium, Clostridium, Corynebacterium, Gluconobacter, Nocardia, Pseudomonas, Rhodococcus, Salmonella, Streptomyces, and Xanthomonas . [00109] In certain embodiments, such hosts include E, coli W3110, E. coli B5 Pseudomonas oleovorans, Pseudomonas fluorescens, Pseudomonas putida, and Saccharomyces cerevisiae. [00110] In one embodiment, the engineered microorganism is an E. coli, [00111] In another embodiment, the engineered microorganism is yeast, for example Saccharomyces cerevisiae. Yeasts have pathways in both the cytosol and the mitochondria that generate acetyl-CoA. Because the conversion in yeast of acetyl-CoA to isopropanol takes place in the cytosol, it is desirable for recombinant yeast of the present invention to have increased cytosolic concentrations of acetyl-CoA relative to wild-type levels. Additionally, mitochondrial concentrations of acetyl-Co A can be reduced.
[00112] In certain embodiments conversion 1 is catalyzed by enzymes classified as E.C.2,3.1.8 and E.C.2.7.2.1 that convert acetyl-CoA to acetate via the intermediate acetylphosphate, e.g., the enzymes phosphate acetyltrasferase (pta) and acetate kinase (ackAB)
from either E. coli or Clostridium species. Conversion 2 is catalyzed by an enzyme classified as E.C. 2.3.1,19, i.e., an cetyl-CoA acetyltransferase (thiolase). Conversion 3.1 is catalyzed by an enzyme classified as E.C. 2.8.3.9, i.e., an acetoacetyl-CoA:acetate/butyrate coenzyme-A transferase (CoAT). Conversion 3.2 is catalyzed by an enzyme classified as EC 3.1.2.11, i.e., an acetoacetyl-CoA hydrolase. Conversion 4 is catalyzed by an enzyme classified as E.C. 4.1.1.4, i.e., an acetoacetate decarboxylase. Conversion 5 is catalyzed by an alcohol dehydrogenase, such as an alcohol dehydrogenase from the C. beijerinckii, the Burkholderia sp., or Thermoanaerobacter brockii,
[00113] In one embodiment, a recombinant microorganism provided herein includes activation of enzymes that convert acetyl-CoA to acetate via the intermediate acetylphosphate. In one embodiment, activation results from the expression of the endogenous enzymes. In another embodiment, activation results from the expression of heterologous enzymes. Suitable enzymes, include, but are not limited to, phosphate acetyltrasferase, which catalyzes the conversion of acetyl-CoA to acetylphosphate, and acetate kinase, which catalyzes the conversion of acetylphosphate to acetate. In one embodiment, these enzymes are encoded by pta and ackAB from E, coli or a Clostridium species.
[00114] In one embodiment, a recombinant microorganism provided herein is engineered to activate an acetyl-CoA acetyltransferase (thiolase) as compared to a parental microorganism. Thiolase (E.C. 2.3.1.19) catalyzes the condensation of an acetyl group onto an acetyl-CoA molecule. This enzyme has been overexpressed, amongst other enzymes, in E. coli under its native promoter for the production of acetone (Bermejo et at,, Appl Environ. Mirobiol 64: 1079-1085, 1998).
[00115] In one embodiment, the increased thioiase expression results from the activation of an endogenous thiolase. In another embodiment, the increased thiolase expression results from the expression of a heterologous thiolase gene. In a further embodiment, the heterologous thiolase gene is from a Clostridium species. In yet a further embodiment, the thiolase is the C. acetobutylicum enzyme encoded by the gene thl (GenBank accession U08465, protein ID AAA82724.1), and whose amino acid sequence is given in SEQ ID NO; 4. [00116] Other homologous thiolases include, but are not limited to, those from:, C. pasteurianum (e.g., protein ID ABAl 8857.1), C. beijerinckii sp. (e.g., protein ID EAP59904.1 or EAP59331.1), Clostridium perfringens sp. (e.g., protein ID ABG86544.1, ABG83108.1), Clostridium difficile sp. (e.g., protein ID CAJ67900.1 or ZPJJ1231975.1),
Thermoanaerobaclerium thermosaccharolyticum (e.g. , protein ID CAB07500.1), Thermoanaerobacter tengcongensis {e.g., AAM23825.1), Carboxydothermus hydro ge no/or mans (e.g., protein ID ABB 13995.1), Desulfotomaculum reducens MI-I (e.g., protein ID EAR45123.1), Candida tropicalis (e.g., protein ID BAA02716.1 or BAA02715.1), Saccharomyces cerevisiae (e.g., protein ID AAA62378.1 or CAA30788.1), Bacillus sp., Megasphaera elsdenii, or Butryivibrio fibrisolvens, etc. In addition, an E. coli thiolase could also be active in a hetorologously expressed isopropanol pathway. E. coli synthesizes two distinct 3-ketoacyI-CoA thiolases. One is a product of the fadA gene, the second is the product of the atoB gene.
[00117] In one embodiment, a recombinant microorganism provided herein is engineered to activate an acetoacetyl-CoA:acetate/butyrate coenzyme-A transferase (CoAT) as compared to a parental microorganism. CoAT (E.C. 2.8.3.9) transfers the coenzyme A from acetoacetyl-CoA to acetate resulting in the products acetoacetate and acetyl- CoA.
[00118] In one embodiment, the increased CoAT expression results from the activation of an endogenous CoAT. In another embodiment, the increased CoAT expression results from the expression of a heterologous CoAT gene. In a further embodiment, the heterologous CoAT gene is from a Clostridium species. In yet a further embodiment, the CoAT is the C. acetobutylicum enzyme encoded by the two genes ctfA (GenBank accession NC_001988, protein ID NPJ49326.1) and ctβ (GenBank accession NC_001988, protein ID NPJ 49327.1), and whose amino acid sequences are given in SEQ ID N0:5 and SEQ ID NO:6, respectively. [00119] In one embodiment, a recombinant microorganism provided herein is engineered to activate an acetoacetyl-CoA hydrolase as compared to a parental microorganism. Acetoacetyl- CoA hydrolase (EC 3.1.2.11) catalyzes the hydrolysis of acetoacetyl-CoA to form acetoacetate and CoA.
[00120] In one embodiment, the increased acetoacetyl-CoA hydrolase expression results from activation of an endogenous acetoacetyl-CoA hydrolase. In another embodiment, the increased acetoacetyl-CoA hydrolase expression results from the expression of a heterologous acetoacetyl- CoA hydrolase gene.
[00121] Suitable acetoacetyl-CoA hydrolases have been identified in mammalian cells (see e.g., Drummond, 1960; Baird, 1970; Baird, 1969; Zammit, 1979; Rous, 1976; Aragon, 1983; Patel, 1978; Patel, 1978). Alternatively, the substrate specificity of an acetyl-CoA hydrolase (E.C. 3.1.2,1) can be altered by protein engineering techniques such as 'directed evolution' so
lhat it can convert acetoacetyl-CoA as a substrate. For example, the acetyl-CoA hydrolase Achlp from Saccharomyces cerevisae (Genbank accession NPJ)09538.1) can be used for this purpose.
[00122] In one embodiment, a recombinant microorganism provided herein is engineered to activate an acetoacetate decarboxylase as compared to a parental microorganism. Acetoacetate decarboxylase (E.C. 4.1.1.4) converts acetoacetate into acetone and carbon dioxide. [00123] In one embodiment, the increased acetoacetate decarboxylase expression results from activation of an endogenous acetoacetate decarboxylase. In another embodiment, the increased acetoacetate decarboxylase expression results from the expression of a heterologous acetoacetate decarboxylase gene. In a further embodiment, the heterologous acetoacetate decarboxylase gene is from a Clostridium species. In yet a further embodiment, the acetoacetate decarboxylase is the C. acetobutylicum enzyme encoded by the adc gene (GenBank accession NC_001988, protein ID NP_149328.1), and whose amino acid sequence is given in SEQ ID NO: 7. [00124] In one embodiment, a recombinant microorganism provided herein is engineered to activate an alcohol dehydrogenase (ADH) as compared to a parental microorganism. ADH reduces acetone to isopropanol with the oxidation OfNAD(P)H to NAD(P)+. [00125] In one embodiment, the increased ADH expression results from activation of an endogenous ADH. In another embodiment, the increased ADH expression results from the expression of a heterologous ADH gene. In a further embodiment, the heterologous ADH gene is from a Clostridium species. In yet a further embodiment, the ADH is the NADPH-dependant C. beijerinckii enzyme encoded by the adhl gene (GenBank accession AFl 57307, protein ID AAA23199.2), and whose amino acid sequence is given in SEQ ID NO: 8. Other suitable alcohol dehydrogenases, include, but are not limited to, the Burkholderia sp. AIU 652 enzyme, which is NADH-dependent or the Thermoanaerobacter brockii alcohol dehydrogenase (Genbank protein ID CAA46053.1) encoded by tbad gene (Genbank accession number X64841). [00126] In certain embodiments, any enzyme that catalyzes the above described conversions may be used.
[00127] In certain embodiments, any homologous enzymes that are at least about 70%, 80%, 90%, 95%, 99% identical with respect to their amino acid sequence, or sharing at least about 60%, 70%, 80%, 90%, 95% sequence homology with respect to their amino acid sequence to any of the polypeptides described herein, can be used in place of these wild-type polypeptides. One skilled in the art can easily identify corresponding, homologous genes in other microorganisms
by convention molecular biology techniques (such as sequence homology search, cloning based on homologous sequences, etc.).
[00128] Nucleic acid sequences that encode enzymes useful for generating metabolic intermediates of the isopropanol pathway disclosed herein (e.g., thiolase, phosphate acetyl trasferase, acetate kinase, acetoacetyl~CoA:acetate/butyrate coenzyrne-A transferase, acetoacetate decarboxylase, acetoacetyl-CoA hydrolase, alcohol dehydrogenase) including homologs, variants, fragments, related fusion proteins, or functional equivalents thereof, are used in recombinant nucleic acid molecules that direct the expression of such polypeptides in appropriate host cells, such as bacterial or yeast cells. It is understood that the addition of sequences which do not alter the encoded activity of a nucleic acid molecule, such as the addition of a non-functional or non-coding sequence, is a conservative variation of the basic nucleic acid.
[00129] In one embodiment, all five genes encoding for enzymes that catalyze conversions of Pathway 1, namely conversions 1, 2, 3.1, 4, and 5 are expressed from a single piasmid. In this embodiment, several combinations are possible, including, but not limited to; all genes expressed on a high-copy, medium-copy, or low-copy piasmid; all genes expressed from a single promoter; all genes expressed each with their own promoter; and synthetic operons of one, two, three, and/or four genes expressed from several promoters. Methods for optimizing the expression level ratios of the genes to achieve high productivity are known to those skilled in the art and can be applied to the expression system for expression of these genes.
[00130] Further, in one embodiment, all five genes adhl, (hi, ct/A, ct/B, and adc, are expressed from a single piasmid. In this embodiment, several combinations are possible, including, but not limited to; all genes expressed on a high-copy, medium-copy, or low-copy piasmid; all genes expressed from a single promoter; all genes expressed each with their own promoter; and synthetic operons of one, two, three, and/or four genes expressed from several promoters. [00131] In one embodiment, all four genes encoding for enzymes that catalyze conversions of Pathway 2, namely conversions 2, 3.2, 4, and 5 are expressed from a single piasmid. In this embodiment, several combinations are possible, including but not limited to; all genes expressed on a high-copy, medium-copy, or low-copy piasmid; all genes expressed from a single promoter; all genes expressed each with their own promoter; and synthetic operons of one, two, three, and/or four genes expressed from several promoters. Methods for optimizing the expression
level ratios of the genes to achieve high productivity are known to those skilled in the art and can be applied to the expression system for expression of these genes.
[00132] Many heterogeneously-expressed enzymes may not be initially optimized for use as a metabolic enzyme inside a host microorganism. However, these enzymes can usually be improved using protein engineering techniques, including directed evolution. In other words, even if the activity of an isopropanol-producing strain is low initially, it is possible to improve upon this pathway. For example, in directed evolution, genetic diversity is created by mutagenesis and/or recombination of one or more parental gene sequences. These altered genes are cloned back into a plasmid for expression in a suitable host organism (bacteria or yeast). Clones expressing improved enzymes are identified in a high-throughput screen, or in some cases, by selection, and the gene(s) encoding those improved enzymes are isolated and the process is applied iteratively until an enzyme with the desired activity is obtained. For example, using engineered E. coli strains, which contain the most effective variant of a desired isopropanol-producing pathway, directed evolution of the enzyme can be performed to obtain improved enzymes resulting in an improved isopropanol production pathway. Similar processes can also be used to identify and isolate strains with a higher isopropanol yield per glucose metabolized.
[00133] The production of isopropanol from a carbohydrate source by the metabolic pathways 1 and 2 is not balanced with respect to NAD(P)H produced and NAD(P)H consumed. For example, under anaerobic conditions in E. coli, the conversion of glucose to acetyl-CoA generates 2 moles of NAD(P)H, while the conversion of acetyl-CoA to isopropanol only requires 1 mole OfNAD(P)H (see FIGURE 1). Similarly under aerobic conditions in E. coli, the conversion of glucose to acetyl-CoA generates 4 moles of NAD(P)H while the conversion of acetyl-CoA to isopropanol requires I mole of NAD(P)H . Unless alternate metabolic pathways recycle NAD(P)H, the NAD(P)H/NAD(P)+ ratio will become imbalanced and will cause the organism to ultimately die.
[00134] In another embodiment, NADH that is not oxidized during the conversion of acetyl- CoA to isopropanol is otherwise oxidized so that metabolism is balanced with respect to NAD+ reduction and NADH oxidation.
[00135] In one embodiment, excess NADH is oxidized by native enzymes or metabolic pathways.
[00136] In another embodiment, excess NADH is oxidized by heterologously expressed enzymes or metabolic pathways.
[00137] In another embodiment, excess NAD(P)H produced during the conversion of a carbon source to isopropanol can be removed by coupling the oxidation OfNAD(P)H to the reduction of a metabolic intermediate.
[00138] In yet another embodiment, such a metabolic intermediate is pyruvate or acetyl-CoA.
[00139] One solution is for the engineered isopropanol pathway to run under aerobic or microaerobic conditions, in which case excess reducing equivalents would be consumed by the native respiratory pathway(s) of the microorganisms. The overall net reactions for the production process from glucose to isopropanol under such conditions is as follows:
1 Glucose + 1.5 O2 → l Isopropanol + 3 CO2
[00140] It is preferable to divert as much carbon flux as possible to acetyl-CoA as substrate for the engineered isopropanol pathway. Competing pathways, such as the tricarboxylic acid (TCA) cycle under aerobic conditions, that consume acetyl-CoA should preferably be eliminated or impaired. The TCA cycle can be disrupted at the succinate dehydrogenase/fumarate reductase step or at the alpha-keto glutarate dehydrogenase step to prevent consumption of acetyl-CoA through this pathway and the consequent loss of carbon as CO2. However, disruption of the TCA cycle must occur in such a way that all required anapleurotic pathways are maintained. It has been shown that flux through the TCA cycle can be decreased using either a succinate dehydrogenase/malate dehydrogenase double knockout (Fischer, E. and Sauer, U., Metabolic flux profiling of Escherichia colt mutants in central carbon metabolism using GC-MS, Eur. J. Biochem. 270:880-891 (2003)) or an alpha-ketoglutarate dehydrogenase mutant (Causey T.B., Zhou S.5 Shanmugam K.T., Ingram L.O., Engineering the metabolism of Escherichia coli W3110 for the conversion of sugar to redox-neutral and oxidized products: homoacetate production, Proc. Natl. Acad. Sci. USA. 100(3):825-32 (2003)).
[00141] Another solution that allows the engineered isopropanol pathway to operate anaerobically is to couple the isopropanol pathway with expression of another biocatalyst, such as a cytochrome P450 or a reductase, thereby consuming the remaining reducing equivalents to generate a redox-balanced pathway. One non-limiting example of this embodiment is to use an engineered P450 to convert propane to propanol while consuming reducing equivalents.
[00142] Alternatively, excess NAD(P)H produced during the conversion of a carbon source to isopropanol can be removed by a heterologously overexpressed hydrogenase, which couples the oxidation of NADH to the formation of hydrogen.
[00143] In certain embodiments of the current disclosure where the alcohol dehydrogenase is
NADPH-dependent, endogenous processes that produce NADPH are upregulated. Examples of such processes include, but are not limited to, upregulating the pentose phosphate pathway and the activity of transhydrogenase enzymes.
[00144] In certain embodiments of the current disclosure where the alcohol dehydrogenase is
NADPH-dependent, protein engineering techniques may be used to convert said NADPH- dependent alcohol dehydrogenase (s) to an N ADH-dependent alcohol dehydrogenase(s).
[00145] In certain embodiments the second biochemical process comprises of culturing a recombinant microorganism of the invention in a suitable culture medium under suitable culture conditions.
[00146] Suitable culture conditions depend on the temperature optimum, pli optimum, and nutrient requirements of the host microorganism and are known by those skilled in the art. These culture conditions may be controlled by methods known by those skilled in the art.
[00147] For example, E. coli cells are typically grown at temperatures of about 25°C to about
400C and a pH of about pH 4.0 to pH 8.0. Growth media used to produce isopropanol according to the present invention include common media such as Luria Bertani (LB) broth, EZ-Rich medium, and commercially relevant minimal media that utilize cheap sources of nitrogen, sulfur, phosphorus, mineral salts, trace elements and a carbon source as defined.
[00148] In certain embodiments the fermentation is performed using a batch reactor. In other embodiments, the fermentation can be done by fed-batch or continuous reactors. Fermentations may be performed under aerobic or anaerobic conditions, where anaerobic or microaerobic conditions are preferred during the isopropanol production phase.
[00149] The amount of isopropanol produced in the fermentation medium can be determined using a number of methods known in the art, for example, high performance liquid chromatography or gas chromatography
[00150] In some embodiments, a method of producing isopropanol is provided which comprises culturing any of the recombinant microorganisms of the present disclosure for a time under aerobic conditions or micro-aerobic conditions, to produce a cell mass, in particular in the range of from about 1 to about 100 g dry cells liter, or preferably in the range of from about 1 to
about 1O g dry cells liter"1, then altering the culture conditions for a time and under conditions to produce isopropanol, in particular for a time and under conditions wherein isopropanol is detectable in the culture, and recovering isopropanol. In certain embodiments, the culture conditions are altered from aerobic or micro-aerobic conditions to anaerobic conditions. In certain embodiments, the culture conditions are altered from aerobic conditions to micro-aerobic conditions.
[00151] Methods for recovering the isopropanol and propanol produced are well known to those skilled in the art. For example, isopropanol may be isolated from the culture medium by methods, such as pervaporation, liquid-liquid extraction, or gas stripping. Alternately, novel technologies, such as use of azeotropic distillation or separation, as disclosed in US12342992 and PCTUS0888187, may be used to recover propanols from fermentation broth.
[00152] In certain embodiments, the engineered microorganism produces isopropanol at a yield of greater than 40% of theoretical, a volumetric productivity of greater than 0.2 g/l/h and a final titer of greater than 5 g/1 isopropanol.
[00153] In certain embodiments, the engineered microorganism produces isopropanol at a yield of greater than 50% of theoretical, a volumetric productivity of greater than 0.4 g/l/h and a final titer of greater than 14 g/1 isopropanol.
[00154] In certain embodiments, a recombinant microorganism herein described that expresses a pathway for the production of isopropanol, is further engineered to inactivate any competing pathways that consume metabolic intermediates of the isopropanol producing pathway. In other words the recombinant microorganism is further engineered to direct the carbon flux from the carbon source to isopropanol. In particular, direction of carbon-flux to isopropanol can be performed by inactivating metabolic pathways that compete with the isopropanol production pathway.
[00155] In certain embodiments, inactivation of a competing pathway is performed by inactivating an enzyme involved in the conversion of a substrate to a product within the competing pathway. The enzyme that is inactivated may preferably catalyze the conversion of a metabolic intermediate for the production of isopropanol or may catalyze the conversion of a metabolic intermediate of the competing pathway.
[00156] Accordingly, in certain embodiments the inactivation is performed by deleting from the microorganism's genome a gene coding for an enzyme involved in pathway that competes
wlth the isopropanol production to make available the carbon to the one or more enzymes of the isopropanol producing pathway.
[00157] In certain embodiments, deletion of the genes encoding for these enzymes improves the isopropanol yield because more carbon is made available to one or more enzymes of the isopropanol producing pathway.
[00158] It will be appreciated by those skilled in the art that various omissions, additions and modifications may be made to the invention described above without departing from the scope of the invention, and all such modifications and changes are intended to fall within the scope of the invention, as defined by the appended claims.
Example 1
Materials and Methods [00159] Constructs [00160] pGV1031: E. coli cells transformed with plasmid pACT, also referred to herein as plasmid pGV1031 were used to convert glucose to acetone. The plasmid contains the thl, ctfA, ct/B, and adc genes under the control of the native thiolase promoter. Plasmid pACT has been described previously (Bermejo LL, Welker NE, Papoutsakis ET, Expression of Clostridium acetobutylicum ATCC 824 genes in Escherichia coli for acetone production and acetate detoxification, Appl Environ Microbiol, 64(3): 1079-85 (1998 Mar), thl encodes the thiolase enzyme that catalyzes the condensation reaction of two acetyl CoA molecules to generate acetoacetyl-CoA. ctfA and ctfB encode subunits of acetoacetyl-CoA:acetate/butyrate CoA tranferase (CoAT) that converts the acetoacetyl-CoA and acetic/butyric acid into acetoacetate and the corresponding acyl-CoA. adc encodes the acetoacetate decarboxylase that catalyzes the conversion of acetoacetate to acetone and carbon dioxide. Plasmid pGV1031 is shown in FIGURE 3 and its sequence is given in SEQ ID NO:1.
[00161] pGV1093: E. coli cells transformed with plasmid pGV 1093 were used to convert acetone to isopropanoi. This plasmid contains the gene for the primary/secondary alcohol dehydrogenase (adhl) from the Clostridium beijerinckii strain NRRL B593. Plasmid pGV1093 was derived from the previously described pGL89 plasmid (Peretz M, Bogin O, TeI-Or S, Cohen A, Li G, Chen JS, Burstein Y. Molecular Cloning, Nucleotide Sequencing, and Expression of Genes Encoding Alcohol Dehydrogenases From the Thermophile Thermoanaerobacter brockii and the Mesophile Clostridium beijerinckii, Anaerobe, 3(4):259-70) (Aug 1997). pGV1093 was
constructed by subcloning an approximately 1.6 kb EcoRI/BamHI fragment containing adhl from pGL89 into pUC19 digested with EcoRI/BamHI. pGV1093 is shown in FIGURE 4 and its sequence is given in SEQ ID NO:2.
[00162] pGV1259: To convert glucose to isopropanol directly, five genes are co-expressed from two separate plasmids. These are: a primary/secondary alcohol dehydrogenase from Clostridium beijerinckii, herein referred to as adhl; thl, a gene encoding thiolase from Clostridium acetobutylicum; ctfA and ctβ, the genes encoding acetoacetyl-CoA:acetate/butyrate coenzyme-A transferase subunits from C. acetobutylicum; and adc, the gene encoding acetoacetate decarboxylase from C. acetobutylicum. pGV1093, the plasmid expressing adhl is not preferred for co-transformation into E. coli with pACT for two reasons: 1) both plasmids have a CoIEl origin of replication, and 2) both plasmids contain an ampicillin resistance marker for plasmid maintenance. To solve these problems and in order to co-express adhl and the genes on pGV 1031, adhl is subcloned from pGV 1093 into a more suitable expression vector, pZA32 (Lutz and Bujard, Nucleic Acids Res., 25(6): 1203-1210, 1997). pZA32 has a pl5A origin of replication, a chloramphenicol resistance marker for plasmid maintenance, and Puaoo-i promoter for adhl expression. The adhl gene is PCR amplified from pGV1093 using primers 487 (5'- AATTGGCGCCGAATTCATGAAAGGTTTTGC-S') and 488 (5'~
AATTCCCGGGGGATCCTAATATAACTACTG-3') containing EcoRl and BamEl restriction sites in the forward and reverse primers, respectively. The amplified PCR product and pZA32 are digested with the restriction enzymes EcoRl and BamUΪ, gel purified, and then ligated together. The resulting plasmid, pGV1259, expresses adhl from the Puaco-t promoter. The plasmid map of pGV1259 is depicted in FIGURE 5, the sequence is given in SEQ ID NO:3. [00163] pGV1699: As an alternative to pGV1259 plasmid pGV1699 is designed which expresses all five genes of pathway 1 on a single plasmid. The nucleotide sequence encoding for PLιac0-ι and adhl is PCR amplified from ρGV1259 using primers 1246 (5'- AATTGTCGACCGAGAAATGTGAGCGGAT AAC-3') and 1247 (5'- AATTGCATGCGTCTTTCGACTGAGCCTTTCG-3') containing Sail and Sphl, respectively. The amplified PCR product and pGV1031 are restriction digested using enzymes Sail and Sphl, gel purified, and then ligated together using the Rapid Ligation Kit (Roche, Indianapolis, IN). The resulting plasmid expresses the C. acetobutylicum thl, ctβ./ B, adc genes from the native thl promoter and the C. beijerinckii adhlΫwm the Ptiaco-i promoter. The plasmid map of pGV1699 is depicted in FIGURE 6 and its sequence is given in SEQ ID NO:9.
Example 2
In vivo Acetone Production in E. coli Using C, acetobulylicum Genes [00164] Transformation and Cell Growth. Electrocompetent E. coli W3110 (GenBank: AP009048), E. coli B (GenBank: AAWW00000000) and E. coli ER2275 (Bermejo et al, AppL Environ, Microbiol., 64(3): 1079-1085, 1998) cells were freshly transformed with pGV1031 and plated onto LB-ampicillin 100 μg/mL plates for 12 hrs at 370C. Single colonies from the LB- ampicillin plates were used to inoculate 5 rnL cultures of SD-7 medium (LuIi and Strohl, Appl Environ. Microbiol, 56(4), 1004-1011, 1990) containing 100 μg/mL ampicillin and allowed to grow for 12 hrs at 370C at 250rpm. The above precultures were used to inoculate 125 mL of SD- 8 medium (LuIi and Strohl, _4p/?/. Environ, Microbiol, 64(3), 1004-1011, 1990) containing 100 μg/mL ampicillin in 2 L Erlenmeyer flasks at 1% (vol/vol) of inoculum. Cultures were grown at 37 0C and 250 rpm. 3 mL samples were taken from the cultures every 3 hrs for 30 hrs with the first sample taken at the time of inoculation, Samples were used to monitor acetone and acetate production by gas chromatography (GC) and liquid chromatography (LC). [00165] Product analysis. Samples were prepared for GC analysis by centrifuging the 3 mL aliquots at 5000 x g for 10 min, followed by filtration through a 0.2 μm filter. A volume of 900 μL of the sample was transferred to a 1.5 mL gas chromatography vial and 90 μL of 10 mM 1- butanol was added as an internal standard. Samples were run on a Series II Plus gas chromatograph with a flame ionization detector (FID), fitted with a HP-7673 autosampler system using purchased standards and 5-ρoint calibration curves with internal standards. All samples were injected at a volume of 1.0 μL. Direct analysis of the acetone product was performed on a Supelco SPB-I capillary column (60 m length, 0.53 mm ID5 5 μm film thickness) connected to the FID detector. The temperature program for separating the products was 2250C injector, 225°C detector, 500C oven for 3 minutes, then 8°C/minute gradient to 800C, 13°C/minute gradient to 17O0C, 50°C/minute gradient to 22O0C then 22O0C for 3 minutes. [00166] The samples were also analyzed by LC to monitor acetate production. A 900 μL volume of the filtered samples was transferred to 1.5ml vial. The samples were run on an Aminex HPX-87H column using a 0.008N sulfuric acid mobile phase at a flow rate of 0.05 mL/min. The total run time was 30 min.
[00167] Results. The results shown in Table 1 demonstrate that acetone was produced in all three strains of E. coli tested carrying plasmid pGV1031. These experiments also demonstrate that acetone starts to accumulate 8-10 hrs after inoculation.
Table 1: Acetone production in E. coli strains transformed with pGV1031
Example 3
Heterologous Expression of the C. beijerinckii adhl Gene in E. coli to Convert Acetone to isopropanol
[00168] Transformation and Ceil Growth. E. coli DH5α Zl electrocompetent cells were freshly transformed with pGV1093. As a control, E. coli DH5α Zl electrocompetent cells were freshly transformed with pUC19, which does not contain an alcohol dehydrogenase. The transformed cells were plated onto LB-Ampicillin 100 μg/mL plates and incubated for 12 hrs at 37°C. To grow the strains, 4 niL precultures of both E. coli DH5α Zl pGV1093 and E. coli DH5α Zl pUC19 in LB-Ampicillin 100 μg/ml were inoculated with single colonies of freshly transformed cells from the LB-Ampicillin plates, These cultures were grown overnight (approximately 18h) at 370C with shaking at 250 rpm. Precultures were used to inoculate 15 mL LB-Ampicillin 100 μg/mL cultures in 250 mL Erlenmeyer flasks at a rate of 1% (vol/vol) of the preculture used as inoculum. Cultures were grown at 37°C with shaking at 250 rpm for 5 hrs, then induced with 1 mM IPTG (isopropyl-β-D-thiogalactopyranoside). To initiate the biotransformation, 96 μL of acetone was added to each of the cultures. The cultures were then further incubated at 30 0C at 250 rpm. To determine protein expression levels and to measure isopropanol and acetone concentrations, 1 mL samples were removed from each of the cultures prior to acetone addition, directly after the acetone addition, and 3 hrs after acetone addition. [00169] Product analysis. Samples were prepared for GC analysis of isopropanol and acetone content by centrifuging the 1 mL aliquots at 5000 x g for 10 min, followed by filtration through a 0.2 μm filter. A 900 μL volume of the sample was transferred to a 1.5 mL gas chromatography vial and 90 μL of 10 mM 1-butanol was added as an internal standard. Samples were run on a Series II Plus gas chromatograph with a flame ionization detector (FID), fitted with a HP-7673 autosampler system using purchased standards and 5 -point calibration curves
with internal standards. All samples were injected at a volume of 1.0 μL. Direct analysis of the acetone substrate and the isopropanol product was performed on a Supelco SPB-I capillary column (60 m length, 0,53 mm ID5 5 μm film thickness) connected to the FID detector. The temperature program for separating the alcohol products was 225°C injector, 225°C detector, 5O0C oven for 3 minutes, then 15°C/minute gradient to 1 15°C, 25°C/minute gradient to 2250C, then 2500C for 3 minutes.
[00170] Results. The results shown in Table 2 demonstrate that isopropanol was produced in E. coli containing pGV1093 but not pUC19.
Table 2: Isopropanol production in E. coli strains transformed with p GV 1093
Example 4
In vivo isopropanol Production in E. coli using C, acetobutylicum Genes and the C. beijerinckii adhl Gene expressed from two plasmids
[00171] E. coli W3110 Zl (Lutz and Bujard, Nucleic Acids Res,, 25(6): 1203-1210, 1997) electrocompetent cells are freshly co-transformed with pGV 1259 and pGV 1031. The transformed cells are plated onto LB-ampicillin 100 μg/mL, -chloramphenicol 25 μg/mL plates and incubated for 12 hrs at 37°C.
[00172] Single colonies from the transformed plates are used to inoculate 5 mL of SD-7 medium (LuIi and Strohl, Appl Environ. Microbiol, 56(4), 1004-101 1, 1990) containing ampicillin 100 μg/mL and chloramphenicol 25 μg/mL. These cultures are incubated for 12 hrs at 370C at 250 rpm. The above precultures are used to inoculate 125 mL of SD-8 medium (LuIi
and Strohl, Appl. Environ, Microbiol, 56(4), 1004-101 1, 1990) containing ampicillin 100 μg/mL and chloramphenicol 25 μg/mL in 2 L Erlenmeyer flasks at 1% (vol/vol) of inoculum. [00173] Cultures are grown at 370C and growth is monitored by OD 600 nm every hour. The culture is induced with 1 mM isopropyl β-D-thiogalactoside (IPTG) during the late-exponential phase. To monitor isopropanol production, culture samples (3 mL) are taken from the cultures every 3 hrs for 30 hrs with the first sample taken at the time of inoculation. Samples are processed and analyzed by GC and LC for acetone and isopropanol production as described in Example 2and Example 3.
[00174] The engineered microorganism is expected to produce isopropanol at a yield of greater than 40% of theoretical, a volumetric productivity of greater than 0.2 g/I/h and a final titer of greater than 5 g/1 isopropanol.
[00175] Using this system, the thl, clfA/B and adc genes are expressed constitutively from the native thiolase promoter whereas the adhl gene is expressed from the inducible PuacO-t promoter, to allow for initial acetone accumulation followed by production of isopropanol. This system allows the time of induction of the adhl gene to vary and then the corresponding isopropanol production to be monitored.
Example 5
In vivo isopropanol Production in E. coli using C. acetobutylicum Genes and the C. beijerinckii adhl Gene expressed from a single plasmid
[00176] E. coli W3110 Zl (Lutz and Bujard, Nucleic Acids Res., 25(6): 1203-1210, 1997) electrocompetent cells are freshly co-transformed with pGV1699, carrying genes thl, ctfA/B, adc expressed from the native C. acetobutylicum thl promoter and C. beijerinckii adhl, from a Py^o-i promoter . The transformed cells are plated onto LB-ampicillin 100 μg/mL plates and incubated for l2 hrs at 37°C.
[00177] Single colonies from the transformed plates are used to inoculate 5 mL of SD-7 medium (LuIi and Strohl, Appl Environ. Microbiol, 56(4), 1004-101 15 1990) containing ampicillin 100 μg/mL. These cultures are incubated for 12 hrs at 370C at 250 rpm. The above precultures are used to inoculate 125 mL of SD-8 medium (LuIi and Strohl, Appl Environ. Microbiol, 56(4), 1004-1011, 1990) containing ampicillin 100 μg/mL and chloramphenicol 25 μg/mL in 2 L Erlenmeyer flasks at 1% (vol/vol) of inoculum.
[00178] Cultures are grown at 370C and growth is monitored by OD 600 nm every hour. The culture is induced with 1 mM isopropyl β-D-thiogalactoside (IPTG) during the late-exponential phase. To monitor isopropanol production, culture samples (3 mL) are taken from the cultures every 3 hrs for 30 hrs with the first sample taken at the time of inoculation. Samples are processed and analyzed by GC and LC for acetone and isopropanol production as described in Example 2 and Example 3.
[00179] The engineered microorganism is expected to produce isopropanol at a yield of greater than 50% of theoretical, a volumetric productivity of greater than 0.4 g/l/h and a final titer of greater than 14 g/1 isopropanol.
Example 6: Wet 2-propanoI dehydration
[00180] 23 g of a commercial gamma-alumina catalyst was loaded into a fixed-bed tubular reactor. Wet 2-propanol containing 20% water was fed through a preheater and onto the catalyst bed. The internal reactor temperature was maintained at 35O0C. The weight hourly space velocity (WHSV) of the 2-propanol was ~ό/hr. Propylene and water were recovered; the water contained <1 % of unreacted 2-propanol. Conversion of alcohol to olefin was >99%. The products were separated in a gas-liquid separator and the propylene recovered. GC-MS of the gas phase effluent indicated it was >99% propylene and of sufficient purity to meet the suggested specifications for polymer grade propylene in ASTM D5273.
Example 7: Dry 2-propanol dehydration
[00181] 23 g of a commercial gamma-alumina catalyst was loaded into a fixed-bed tubular reactor. Dry (less than 0.5% water) 2-propanol was fed through a preheater and onto the catalyst bed. The internal reactor temperature was maintained at 3500C. The weight hourly space velocity (WHSV) of the 2-propanol was ~6/hr. Propylene and water were recovered; the water contained <1% of unreacted 2-propanol. Conversion of alcohol to olefin was >99%. The products were separated in a gas-liquid separator and the propylene recovered. GC-MS of the gas phase effluent indicated it was >99% propylene and of sufficient purity to meet the suggested specifications for chemical grade propylene in ASTM D5273.
Example 8: Wet l-propanol dehydration
[00182] 23 g of a commercial gamma-alumina catalyst was loaded into a fixed-bed tubular reactor. Wet 1-proρanol containing 20% water was fed through a preheater and onto the catalyst
bed. The internal reactor temperature was maintained at 350°C. The weight hourly space velocity (WHSV) of the 1-propanol was ~6/hr. Propylene and water were recovered; the water contained <1% of unreacted 1-propanol. Conversion of alcohol to olefin was >99%. The products were separated in a gas-liquid separator and the propylene recovered. GC-MS of the gas phase effluent indicated it was >99% propylene and of sufficient purity to meet the suggested specifications for chemical grade propylene in ASTM D5273.
Example 9: Dry 1-propanol dehydration
[00183] 23 g of a commercial gamma-alumina catalyst was loaded into a fixed-bed tubular reactor. Dry (less than 0.5% water) 1-propanol was fed through a preheater and onto the catalyst bed. The internal reactor temperature was maintained at 35O0C. The weight hourly space velocity (WHSV) of the 1-ρroρanol was ~6/hr. Propylene and water were recovered; the water contained <1% of unreacted 1-propanol. Conversion of alcohol to olefin was >99%. The products were separated in a gas-liquid separator and the propylene recovered. GC-MS of the gas phase effluent indicated it was >99% propylene and of sufficient purity to meet the suggested specifications for chemical grade propylene in ASTM D5273.
[00184] In various embodiment, the present application provides a recombinant microbial host cell comprising each of the DNA molecules encoding a polypeptide or group of polypeptides that catalyze the conversion: (i) Acetyl-CoA to Acetate and CoA (conversion 1); (ii) Acetyl-CoA to Acetoacetyl-CoA and CoA (conversion 2); (iii) Acetoacetyl-CoA and Acetate to Acetoacetate and Acetyl-CoA (conversion 3.1); (iv) Aceloacetate to Acetone and CO2 (conversion 4); (v) Acetone and NAD(P)H and H+ to Isopropanol and NAD(P)+ (conversion 5), wherein the at least one DNA molecule is heterologous to said microbial host cell and wherein said microbial host cell produces isopropanol at a yield of greater than 25%, 40%, 50%, or 75% of theoretical. The group of polypeptides that catalyzes conversion 1 may include phosphate acetyltransferase and acetate kinase. The phosphate acetyltransferase may be encoded by the E. coli gene pta and the acetate kinase may be encoded by the E. coli gene ackAB. The polypeptide that catalyzes conversion 2 may be acetyl-CoA-acety ransferase having an amino acid sequence of SEQ ID NO:4. The polypeptide that catalyzes conversion 3.1 may be acetoacetyl-CoA:acetate/butyrate coenzyme-A transferase. The acetoacetyl- CoA:acetate/butyrate coenzyme-A transferase may be encoded by the C. acetobutyrlicum genes ctfA and ctfB having a corresponding amino acid sequence of SEQ ID NO: 5 and 6. The
polypeptide that catalyzes conversion 4 may be acetoacetate decarboxylase having an amino acid sequence of SEQ ID NO:7. The polypeptide that catalyzes conversion 5 may be a secondary alcohol dehydrogenase that may or may not be heterologous to said microorganism. The secondary alcohol dehydrogenase may be from Clostridium beijerinckii, from Burkholderia spp., or from Thermo anaerobacter brockii. The Clostridium beijerinckii may be strain NRRL B593 or strain NESTE 225. The alcohol dehydrogenase includes the amino acid sequence of SEQ ID NO:8. The microorganism may include a deletion or inactivation of competing acetyl-CoA consuming genes. The microorganism may be an E. coli strain that includes a deletion or inactivation of a gene or genes selected from the group consisting of poxB, adhE, ldhA, frdABCD, succinate dehydrogenase, malate dehydrogenase, alpha-ketoglutarate dehydrogenase and combinations thereof. The microorganism may be an E. coli strain that includes a deletion or inactivation of a gene or genes selected from the group consisting of poxB, ldhA, frdABCD and combinations thereof. The cell may be selected from the group consisting of: a bacterium, a cyanobacterium, a filamentous fungus and a yeast. The microorganism may be an E. coli., Saccharomyces cerevisiae, a member of the genus Salmonella, a member of the genus Bacillus, or a member of the genus Clostridium. The microorganism may be a member of a genus selected from the group consisting of Pichia, Hansenula, Yarrowia, Aspergillus, Kluyveromyces, Pachysolen, Rhodotorula, Zygosaccharomyces, Galactomyces, Schizosaccharomyces, Torulaspora, Debaryomyces, Williopsis, Dekkera, Kloeckera, Metschnikowia or Candida. The microorganism may be a member of a genus selected from the group consisting of Arthrobacter, Bacillus, Brevibacterium, Clostridium, Corynebacterium, Gluconobacter, Nocardia, Pseudomonas, Rhodococcus, Streptomyces, or Xanthomonas. In some embodiments, all of the polypeptides are heterologous to said microorganism.
[00185] In other embodiments, a recombinant microbial host cell is provide that each of the DNA molecules encoding a polypeptide that catalyzes the conversion: (i) Acetyl-CoA to Acetoacetyl-CoA and CoA (conversion 2); (U) Acetoacetyl-CoA + H2O → Acetoacetate + CoA (conversion 3.2); (iii) Acetoacetate to Acetone and CO2 (conversion 4); (iv) Acetone and NAD(P)H and H+ to Isopropanol and NAD(P)+ (conversion 5); wherein the at least one DNA molecule is heterologous to said microbial host cell and wherein said microbial host cell produces isopropanol. The host cell may produce isopropanol at a yield of greater than 25%, 40%, 50%, or 75% of theoretical. The polypeptide that catalyzes conversion 2 may be acetyl- CoA-acetyltransferase having an amino acid sequence of SEQ ID NO:4. The polypeptide that
catalyzes conversion 3,2 may be acetoacetyl-CoA hydrolase. The polypeptide that catalyzes conversion 4 may be acetoacetate decarboxylase having an amino acid sequence of SEQ ID NO:7, The polypeptide that catalyzes conversion 5 may be a secondary alcohol dehydrogenase heterologous or not heterologous to said microorganism. The secondary alcohol dehydrogenase may be derived from Clostridium beijerinckii, from Burkholderia spp., or from Thermoanaerobacter brockii. The Clostridium beijerinckii may be strain NRRL B593 or strain NESTE 225. The secondary alcohol dehydrogenase may include an amino acid sequence of SEQ ID NO:8. The host cell may include a deletion or inactivation of competing acetyl-CoA consuming genes. The host cell may be an E. coli strain which comprises deletion or inactivation of a gene or genes selected from the group consisting of poxB, adhE, ldhA, frdABCDj succinate dehydrogenase, malate dehydrogenase, alpha-ketoglutarate dehydrogenase and combinations thereof. The host cell may be an E, coli strain which comprises deletion or inactivation of a gene or genes selected from the group consisting of poxB, idhA, frdABCD and combinations thereof. The host cell may be selected from the group consisting of: a bacterium, a cyanobacterium, a filamentous fungus and a yeast. The host cell may be E. coli., Saccharomyces cerevisiae, a member of the genus Salmonella, a member of the genus Bacillus, or a member of the genus Clostridium. The host cell may be a member of a genus selected from the group consisting of Pichia, Hansenula, Yarrowia> Aspergillus, Kluyveromyces, Pachysolen, Rhodotorula, Zygosaccharomyces, Galactomyces, S chizo saccharomyces, Torulaspora, Debaryomyces, Williopsis, Dekkera, Kloeckera, Metschnikowia or Candida. The host cell may be a member of a genus selected from the group consisting of Arthrobacter, Bacillus, Brevibacterium, Clostridium, Corynebacterium, Gluconobacter, Nocardia, Pseudomonas, Rhodococcus, Streptomyces, or Xanthomonas. In addition, all of said enzymes may be heterologous to said microbial host cell.
[00186] In another embodiment, a method for the production of isopropanol is provided, the method includes (a) providing a recombinant microbial host cell comprising each of the DNA molecules encoding a polypeptide or group of polypeptides that catalyze the conversion: (i) Acetyl-CoA to Acetate and CoA (conversion 1); (ii) Acetyl-CoA to Acetoacetyl-CoA and CoA (conversion 2); (iii) Acetoacetyl-CoA and Acetate to Acetoacetate and Acetyl-CoA (conversion 3.1); (iv) Acetoacetate to Acetone and CO2 (conversion 4); (v) Acetone and NAD(P)H and H+ to Isopropanol and NAD(P)+ (conversion 5), wherein the at least one DNA molecule is heterologous to said microbial host cell; (b) contacting the host cell of (i) with
a fermentable carbon substrate in a fermentation medium under conditions whereby isopropanol is produced; and (c) recovering said isopropanoi. The fermentable carbon substrate may be selected from the group consisting of monosaccharides, oligosaccharides, and polysaccharides. The carbon substrate may be selected from the group consisting of glucose, sucrose, and fructose. The conditions may be anaerobic, microaerobic or aerobic. The host cell may be contacted with the carbon substrate in a minimal medium. The group of polypeptides that catalyzes conversion 1 may be phosphate acetyltrasferase and acetate kinase. The phosphate acetyltransferase may be encoded by the E. coli gene pta and the acetate kinase may be encoded by the E. coli gene ackAB. The polypeptide that catalyzes conversion 2 may be acetyl-CoA- acetyltransferase having an amino acid sequence of SEQ ID NO:4. The polypeptide that catalyzes conversion 3.1 may be acetoacetyl-CoA:acetate/butyrate coenzyme- A transferase. The acetoacetyl-CoA:acetate/butyrate coenzyme- A transferase may be encoded by the C. acetobutyrlicum genes ctfA and ctfB which have corresponding amino acid sequence of SEQ ID NO:5 and 6. The polypeptide that catalyzes conversion 4 may be acetoacetate decarboxylase having an amino acid sequence of SEQ ID NO:7, The polypeptide that catalyzes conversion 5 may be a secondary alcohol dehydrogenase having an amino acid sequence of SEQ ID NO:8. The host cell may be selected from the group consisting of: a bacterium, a cyanobacterium, a filamentous fungus and a yeast. The host cell may be E. coli., Saccharomyces cerevisiae, a member of the genus Salmonella, a member of the genus Bacillus, or a member of the genus Clostridium. The host cell may be a member of a genus selected from the group consisting of Pichia, Hansenula, Yarrowia, Aspergillus, Kluyveromyces, Pachysolen, Rhodotorula, Zygosaccharomyces, Galactomyces, Schizosaccharomyces, Tomϊaspora, Debaryomyces, Williopsis, Dekkera, Kloeckera, Metschnikowia or Candida. The host cell may be a member of a genus selected from the group consisting of Arthrobacter, Bacillus, Brevibacterium, Clostridium, Corynebacterium, Gluconobacter, Nocardia, Pseudomonas, Rhodococcus, Streptomyces, or Xanthomonas.
[00187] In other embodiments, an isopropanol containing fermentation medium is provided. The medium is produced by a method comprising: (a) providing recombinant microbial host cell comprising each of the DNA molecules encoding a polypeptide or group of polypeptides that catalyze the conversion: (i) Acetyl-CoA to Acetate and CoA (conversion 1 ); (ii) Acetyl-CoA to Acetoacetyl-CoA and CoA (conversion 2); (iii) Acetoacetyl-CoA and Acetate to Acetoacetate and Acetyl-CoA (conversion 3.1); (iv) Acetoacetate to Acetone and CO2
(conversion 4); (v) Acetone and NAD(P)H and H+ to Isopropanol and NAD(P)+ (conversion 5), wherein the at least one DNA molecule is heterologous to said microbial host cell; (b) contacting the host cell of (i) with a fermentable carbon substrate in a fermentation medium under conditions whereby isopropanol is produced; and (c) recovering said isopropanol. [00188] Additional embodiments include isopropanol produced by a method comprising: (a) providing recombinant microbial host cell comprising each of the DNA molecules encoding a polypeptide or group of polypeptides that catalyze the conversion: (i) Acetyl-CoA to Acetate and CoA (conversion 1); (ϋ) Acetyl-CoA to Acetoacetyl-CoA and CoA (conversion 2); (iii) Acetoacetyl-CoA and Acetate to Acetoacetate and Acetyl-CoA (conversion 3.1); (iv) Acetoacetate to Acetone and CO2 (conversion 4); (v) Acetone and NAD(P)H and H+ to Isopropanol and NAD(P)+ (conversion 5), wherein the at least one DNA molecule is heterologous to said microbial host cell; (b) contacting the host cell of (i) with a fermentable carbon substrate in a fermentation medium under conditions whereby isopropanol is produced; and (c) recovering said isopropanol.
[00189] Other embodiments include a method for the production of isopropanol comprising: (a) providing a recombinant microbial host cell comprising each of the DNA molecules encoding a polypeptide that catalyzes the conversion: (i) Acetyl-CoA to Acetoacetyl- CoA and CoA (conversion 2); (ii) Acetoacetyl-CoA + H2O → Acetoacetate + CoA (conversion 3.2); (iii) Acetoacetate to Acetone and CO2 (conversion 4); (iv) Acetone and NAD(P)H and H+ to Isopropanol and NAD(P)+ (conversion 5), wherein the at least one DNA molecule is heterologous to said microbial host cell; (b) contacting the host cell of (i) with a fermentable carbon substrate in a fermentation medium under conditions whereby isopropanol is produced; and (c) recovering said isopropanol. The fermentable carbon substrate may be selected from the group consisting of monosaccharides, oligosaccharides, and polysaccharides. The carbon substrate may be selected from the group consisting of glucose, sucrose, and fructose. The conditions may be anaerobic, microaerobic, or aerobic. The host cell may be contacted with the carbon substrate in a minimal medium. The polypeptide that catalyzes conversion 2 may be acetyl-CoA-acetyltransferase having an amino acid sequence of SEQ ID NO:4. The polypeptide that catalyzes conversion 3.2 may be acetoacetyl-CoA hydrolase. The polypeptide that catalyzes conversion 4 may be acetoacetate decarboxylase having an amino acid sequence of SEQ ID NO:7. The polypeptide that catalyzes conversion 5 may be a secondary alcohol dehydrogenase having an amino acid sequence of SEQ ID NO:8. The host cell is selected from the group
consϊsting of: a bacterium, a cyanobacterium, a filamentous fungus and a yeast. The host cell may be E. coli, Saccharomyces cerevisiae, a member of the genus Salmonella, a member of the genus Bacillus, or a member of the genus Clostridium. The host cell may be a member of a genus selected from the group consisting of Pichia, Hansenula, Yarrowia, Aspergillus, Kluyveromyces, Pachysolen, Rhodotorula, Zygosaccharomyces, Galactomyces, Schizosaccharomyces, Torulaspora, Debaryomyces, Williopsis, Dekkera, Kloeckera, Metschnikowia or Candida. The host cell may be a member of a genus selected from the group consisting of Arthrobacter, Bacillus, Brevibacterium, Clostridium, Corynebacterium, Gluconobacter, Nocardia, Pseudomonas, Rhodococcus, Streptomyces, or Xanthomonas. [00190] In other embodiments, an isopropanol containing fermentation medium is provided. The medium is produced by a method comprising: (a) providing a recombinant microbial host cell comprising each of the DNA molecules encoding a polypeptide that catalyzes the conversion: (i) Acetyl-CoA to Acetoacetyl-CoA and CoA (conversion 2); (ii) Acetoacetyl- CoA + H2O → Acetoacetate + CoA (conversion 3.2); (iii) Acetoacetate to Acetone and CO2 (conversion 4); (iv) Acetone and NAD(P)H and H+ to Isopropanol and NAD(P)+ (conversion 5), wherein the at least one DNA molecule is heterologous to said microbial host cell; (b) contacting the host cell of (i) with a fermentable carbon substrate in a fermentation medium under conditions whereby isopropanol is produced; and (c) recovering said isopropanol. [00191 ] In other embodiments, also provided is isopropanol produced by a method comprising: (a) providing a recombinant microbial host cell comprising each of the DNA molecules encoding a polypeptide that catalyzes the conversion: (i) Acetyl-CoA to Acetoacetyl- CoA and CoA (conversion 2); (ii) Acetoacetyl-CoA + H2O → Acetoacetate + CoA (conversion 3.2); (iii) Acetoacetate to Acetone and CO2 (conversion 4); (iv) Acetone and NAD(P)H and H+ to Isopropanol and NAD(P)+ (conversion 5), wherein the at least one DNA molecule is heterologous to said microbial host cell; (b) contacting the host cell of (i) with a fermentable carbon substrate in a fermentation medium under conditions whereby isopropanol is produced; and (c) recovering said isopropanol. [00192] SEQUENCE LISTING
SEO ID NO:1
TCGCGCGTTTCGGTGATGACGGTGAAAACCTCTGACACATGCAGCTCCCGGAGACGGTCACAGCTTGTCTGTAAGCG
GATGCCGGGAGCAGACAAGCCCGTCAGGGCGCGTCAGCGGGTGTTGGCGGGTGTCGGGGCTGGCTTAACTATGCGGC ATCAGAGCAGATTGTACTGAGAGTGCACCATATGCGGTGTGAAATACCGCACAGATGCGTAAGGAGAAAATACCGCA TCAGGCGCCATTCGCCATTCAGGCTGCGCAACTGTTGGGAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACGCCAG CTGGCGAAAGGGGGΆTGTGCTGCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTCACGACGTTGTAAAAC
TTGAAAATTTAAGGTCATTCTTTAAAGATGGGATGACAATTATGATTGGAGGTTTTTTAAACTGTGGCACTCCAACC
GCAAAAAACTTTTTAATAATGAACTTGAAGTAGAGCTCTCTCCCCAAGGAACTCTAGTGGAAAGAATACGTGCAGGC GGATCTGGCTTAGGTGGTGTACTAACTAAAACAGGTTTAGGAACTTTGATTGAAAAAGGAΆAGAAAAAAATATCTAT
GAAGCTGAAAATTTAGTTAGCTGTGAAAAACTAGAAAAGGAAAAAGCAATGACCCCCGGAGTTCTTATAAATTATAT
CGTGGTGGTCACGTAGATGTTACTGTTTTAGGGGCTCTCCAGGTAGATGAAAAGGGTAATATAGCCAATTGGATTGT
ATTGTAACAGAACTTGGAGTAATTGAGGTTATTAATGATGGTTTACTTCTCACTGAAATTAATAAAAACACAACCAT
TCTTGATATCAGGAAGGTGACTTTTATGTTAAAGGATGAAGTAATTAΆACAAATTAGCACGCCATTAACTTCGCCTG CATTTCCTAGAGGACCCTATAAATTTCATAATCGTGAGTATTTTAACATTGTATATCGTACAGATATGGATGCTCTT
TGGACTTGGTTGTTATACAGAAAGCGGACAGGCTATTCCCGTAAGCTGTAATGGAGTTAAGGGAGATTATCTTCATA TGATGTATTTAGATAATGAGCCTGCAATTGCAGTAGGAAGGGAATTAAGTGCATATCCTAAAAAGCTCGGGTATCCA
GTACAAACATAAAGCCTTAGATGCTAATGAAGCAAAGGATCAAATTTGTCGCCCTAATTATATGTTGAAAATAATAC CCAATTATGATGGAAGCCCTAGGATATGTGAGCTTATAAATGCGAAAATCACAGATGTTACCGTACATGAAGCTTGG ACAGGACCAACTCGACTGCAGTTATTTGATCACGCTATGGCGCCACTTAATGATTTGCCAGTAAAAGAGATTGTTTC
CTGTTTCCTGTGTGAAATTGTTATCCGCTCACAATTCCACACAACATACGAGCCGGAAGCATAAAGTGTAAAGCCTG
GCCAGCTGCATTAATGAATCGGCCAACGCGCGGGGAGAGGCGGTTTGCGTATTGGGCGCTCTTCCGCTTCCTCGCTC ACTGACTCGCTGCGCTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATACGGTTATCCAC AGAATCAGGGGATAACGCAGGAAAGAACATGTGAGCAAAAGGCCAGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGT
CCGACAGGACTATAAAGATACCAGGCGTTTCCCCCTGGAAGCTCCCTCGTGCGCTCTCCTGTTCCGACCCTGCCGCT
CGGTGTAGGTCGTTCGCTCCAAGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCCCGACCGCTGCGCCTTATCCGGT
TCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAGTAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGC CATTGCTACAGGCATCGTGGTGTCACGCTCGTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGATCAAGGC
GCCGCAGTGTTATCACTCATGGTTATGGCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTC TGTGACTGGTGAGTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGCTCTTGCCCGGCGTCAA
TCAAGGATCTTACCGCTGTTGAGATCCAGTTCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCATCTTTTAC TTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGCAAAAAAGGGAATAAGGGCGACACGGAAAT
TTTGAATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAGTGCCACCTGACGTCTAAGA AACCATTATTATCATGACATTAACCTATAAAAATAGGCGTATCACGAGGCCCTTTCGTC
SEO ID NO:2 TCGCGCGTTTCGGTGATGACGGTGAAAACCTCTGACACATGCAGCTCCCGGAGACGGTCACAGCTTGTCTGTAAGCG
GATGCCGGGAGCAGACAAGCCCGTCAGGGCGCGTCAGCGGGTGTTGGCGGGTGTCGGGGCTGGCTTAACTATGCGGC ATCAGAGCAGATTGTACTGAGAGTGCACCATATGCGGTGTGAAATACCGCACAGATGCGTAAGGAGAΆAATACCGCA TCAGGCGCCATTCGCCATTCAGGCTGCGCAACTGTTGGGAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACGCCAG CTGGCGΆAAGGGGGATGTGCTGCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTCACGACGTTGTAAAAC
GAGAATATATTGTTTGTTAGCTCCTTTTTACTAACTATCTTGTACATGTATAATCCTCCATGATCTATTATGTTATA ATATAACTACTGCTTTAATTAAGTCTTTTGGCTTATCTTTCATTAATAACAGTGCTTCTTCTATGTGATCAAATCCA TGATATACATGTGTAACTAATTTACTTAGATCAACACGATTATATACTACCATATCTCTTAACATTTCTGCTCTCAA ACGTCCCCCAGGACAAAGACCTCCTTTTATAGTCTTGTGAGCCATTCCACATCCCCATTCTACACGTGGTATTAGTA AAGCATCTCCACTTCCATGATAATTTATATTAGAAATTATTCCTCCTGGTTTAACCATAGATACTGCTTGGGATAAT GTTTCAGAACCACCGCCTGCCATAATTACGCGGTCAACGCCTTTTCCATTCGTTAATTTCATAACTTGATCAACTAT ATGACCATTTTTATAATTTAGAATATCTGTTGCTCCATAAAATTTTGCAGCCTCAACACAAATCGGCCTGCTCCCCA CTCCAATTATTCTACCTGCTCCACGTAATTTAGCACCTGCTATTCCCATTAAGCCAACAGCTCCAATGCCAATTACC ACAACACTTGΆACCCATTTGAATATCTGCAAGTTCTGCTCCATGAAATCCAGTAGTCATCATATCTGTTATCATAAC AGCATTTTCTAATGGCATGTCTTTAGGTAGAATCGCAAGATTCATATCCGCATCATTTACATGAAAATATTCACCAA AAACTCCATCCTTGAAATTTGAAAATTTCCATCCTGCGAGCATACCGTTTGAGTGCTGTTGAAAACCAGCTTGAACT TCCAΆAGATCTCCAATCTGGAGTTGTACAAGGAACTATAACTCTGTCACCAGGTTTAAAATCCTTCACTTCACTTCC TACTTCAACAACTTCACCTACAGCTTCATGCCCTAAAATCATATTCTTCCTATCTCCAAGAGCTCCCTCAAAAACAG TATGTATATCTGATGTACACGGAGATACTGCTAATGGGCGTACAATAGCATCATATGAACCCGCAACTGGCCTTTCT TTTTCGATCCATCCTAACTTATTAATACCTAGCATTGCAAAACCTTTCATAAAATATGTTCCTCCTTAAAAATATTC
ACTATGCCAAAATATAATATTTTAAACATATTATGAAGTTATATTATAACTATCTGCCTGTTCATCGCTATTTCGCT TGAGATATAATATAAGCTTTTATGAATAATAATATTATTATTCATATTGAACCAGAAATGCTGTTGAAAAAAACAAC ATTTACATTTCCAATAACTGTCGTATTTTCCGCCAGTGTTGTATTTTCATACATGTTTTAAATTATTGATTGTTAAA AAATATCCATAAAATCATCTGACTTTTATATTATATTTTTTTATCTTTATATATAGTGTACTTCTGTTTATTCCTAA TGGATCCTCTAGAGTCGACCTGCAGGCATGCAAGCTTGGCGTAATCATGGTCATAGCTGTTTCCTGTGTGAAATTGT TATCCGCTCACAATTCCACACAACATACGAGCCGGAAGCATAAAGTGTAAAGCCTGGGGTGCCTAATGAGTGAGCTA ACTCACATTAATTGCGTTGCGCTCACTGCCCGCTTTCCAGTCGGGAAACCTGTCGTGCCAGCTGCATTAATGAATCG GCCAACGCGCGGGGAGAGGCGGTTTGCGTATTGGGCGCTCTTCCGCTTCCTCGCTCACTGACTCGCTGCGCTCGGTC GTTCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATACGGTTATCCACAGAATCAGGGGATAACGCAGG AAAGAACATGTGAGCAAAAGGCCAGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTCCATAGGC
AAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCTGΆCAGTTACCAATGCTTAATCAGTGAG
AACCTATAAAAATAGGCGTATCACGAGGCCCTTTCGTC
TCAGAGAACCTTCGAAAAACCGCCCTGCAAGGCGGTTTTTTCGTTTTCAGAGCAAGAGATTACGCGCAGACCAAAAC GATCTCAAGAAGATCATCTTATTAATCAGATAAAATATTTCTAGATTTCAGTGCAATTTATCTCTTCAAATGTAGCA
TTCATCAGGCGGGCAAGAATGTGAATAAAGGCCGGATAAAACTTGTGCTTATTTTTCTTTACGGTCTTTAAAAAGGC
GCCATTGGGATATATCAACGGTQGTATATCCAGTGATTTTTTTCTCCATTTTAGCTTCCTTAGCTCCTGAAAATCTC GATAACTCAAAAAATACGCCCGGTAGTGATCTTATTTCATTATGGTGAAAGTTGGAACCTCTTACGTGCCGATCAAC
GGAAGTTCAAGCTGGTTTTCAACAGCACTCAAACGGTATGCTCGCAGGATGGAAATTTTCAAATTTCAAGGATGGAG
TTTTTGGTGAATATTTTCATGTAAATGATGCGGATATGAATCTTGCGATTCTACCTAAAGACATGCCATTAGAAAAT GCTGTTATGATAACAGATATGATGACTACTGGATTTCATGGAGCAGAACTTGCAGATATTCAAATGGGTTCAAGTGT TGTGGTAATTGGCATTGGAGCTGTTGGCTTAATGGGAATAGCAGGTGCTAAATTACGTGGAGCAGGTAGAATAATTG GAGTGGGGAGCAGGCCGATTTGTGTTGAGGCTGCAAAATTTTATGGAGCAACAGATATTCTAAATTATAAAAATGGT
AACATTATCCCAAGCAGTATCTATGGTTAAACCAGGAGGAATAATTTCTAATATAAATTATCATGGAAGTGGAGATG
TCATGGATTTGATCACATAGAAGAAGCACTGTTATTAATGAAAGATAAGCCAAAAGACTTAATTAAAGCAGTAGTTA GCCTTTCGTTTTATCTGTTGTTTGTCGGTGAACGCTCTCCTGAGTAGGACAAATCCGCCGCCCTAGAC
SEO ID NO:4
MKEWIASAVRTAIGSYGKSLItDVPAVDLGATAIKEAVKKAGIKPEDVHEVILGNVLQAGLGQNPARQASFKAGLPV E I PAMT INKVCG S GLRTVS LAAQ I I KAGDADVI I AGGMENMSRAPy LAHNARWGYRMGN AKFVDBMI TDGLWDAFND YHMGITAΞNIAERWNISREEQDEFALASQKKAEΞAIKSGQFKDEIVPWIKGRKGETWDTDΞHPRFGSTIΞGLAKL KPAFKKDGTVTAGNASGLNDCAAVLVIMSAEKAKΞLG VKPLAKIVSYGSAGVDPAIMGYGPFYATKAAIEKAGWTVD ΞLDLIESNEAFAAQSLAVAKDLKFDMNKWVNGGAIALGHPIGASGARILVTLVHAMQKRDAKKGLATLCIGGGQGT AILLΞKC
SEQ ID NO:5
MNSKIIRFENLRSFFKDGMTIMIGGFLNCGTPTKLIDFLVNLNIKNLTIISNDTCYPNTGIGKLISHNQVKKLIASY IGSNPDTGKKLFNNELEVELSPQGTLVERIRAGGSGLGGVLTKTGLGTLIEKGKKKISINGTEYLLELPLTADVALI KGSIVDEAGNTFYKGTTKNFNPYMAMAAKTVIVEAENLVSCEKLEKEKAMTPGVLINYIVKKPA
SEO ID NO:6
MINDKNLAKEIIAKRVARELKNGQLVNLGVGLPTMVADYIPKNFKITFQSENGIVGMGASPKINEADKDWNAGGDY TTVLPDGTFFDSSVSFSLIRGGHVDVTVLGALQVDΞKGNIANWIVPGKMLSGMGGAMDLVNGAKKVIIAMRHTNKGQ PKILKKCTLPLTAKSQANLIVTELGVIΞVINDGLLLTEINKNTTIDEIRSLTAADLLISNELRPMAV
SEO ID NO:7
MLKDEVIKQISTPLTSPAFPRGPYKFHNREYF]SIIVYRTDMDALRKWPEPLEIDEPLVRFEIMAMHDTSGLGCYTES GQAIPVSFNGVKGDYLHMMYLDNEPAIAVGRELSAYPKKLGYPKLFVDSDTLVGTLDYGKLRVATATMGYKHKALDA NBAKDQICRPNYMLKIIPNYDGSPRICELINAKITDVTVHΞAWTGPTRLQLFDHAMAPLNDLPVKEIVSSSHILADI ILPRAΞVIYDYLK
SEQ ID NO:8
MKGFAMLGINKLGWIΞKERPVAGSYDAIVRPLAVSPCTSDIHTVFΞGALGDRKNMILGHEAVGEWEVGSEVKDFKP
GDRVivpcTTPDWRSLEVQΆGFQQHSNGMLAGWKFSNFKDGVFGEYFHVNDADMNLAILPKDMPLENAVMITDMMTT
GFHGAELAD I QMGS S VWI GI GAVGLMG I AG AKLRGAGR 11 G VGSRP I CVE AAKF YGATD I LN YKNGH I VDQ VMKLT NGKGVDRVIMAGGGSETLS QAVSMVKPGGI ISNINYHGSGDALLIPRVEWGCGMAHKTIKGGLCPGGRLRAEMLRDM WYNRVDLSKLVTHVYHGFDHIΞEALLLMKDKPKDLIKAWIL
SEO IDNO:9
TCGCGCGTTTCGGTGATGACGGTGAAAACCTCTGACACATGCAGCTCCCGGAGACGGTCACAGCTTGTCTGTAAGCG GATGCCGGGAGCAGACAAGCCCGTCAGGGCGCGTCAGCGGGTGTTGGCGGGTGTCGGGGCTGGCTTAACTATGCGGC ATCAGAGCAGATTGTACTGAGAGTGCACCATATGCGGTGTGAAATACCGCACAGATGCGTAAGGAGAAAATACCGCA TCAGGCGCCATTCGCCATTCAGGCTGCGCAACTGTTGGGAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACGCCAG CTGGCGAAAGGGGGATGTGCTGCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTCACGACGTTGTAAAAC GACGGCCAGTGAATTCGAGCTCGGTACCATATGCATAAGTTTAATTTTTTTGTTAAAAAATATTAAACTTTGTGTTT TTTTTAACAAAATATATTGATAAAAATAATAATAGTGGGTATAATTAAGTTGTTAGAGAAAACGTATAAATTAGGGA TAAACTATGGAACTTATGAAATAGATTGAAATGGTTTATCTGTTACCCCGTATCAAAATTTAGGAGGTTAGTTAGAA TGAAAGAAGTTGTAATAGCTAGTGCAGTAAGAACAGCGATTGGATCTTATGGAAAGTCTCTTAAGGATGTACCAGCA GTAGATTTAGGAGCTACAGCTATAAAGGAAGCAGTTAAAAAAGCAGGAATAAAACCAGAGGATGTTAATGAAGTCAT
TTTAGGAAATGTTCTTCΆAGCAGGTTTAGGACAGAATCCAGCAAGACAGGCATCTTTTAAAGCAGGATTACCAGTTG
GCAGGAGATGCTGACGTAATAATAGCAGGTGGTATGGAAAATATGTCTAGAGCTCCTTACTTAGCGAATAACGCTAG ATGGGGATATAGAATGGGAAACGCTAAATTTGTTGATGAAATGATCACTGACGGATTGTGGGATGCATTTAATGATT ACCACATGGGAATAACAGCAGAAAACATAGCTGAGAGATGGAACATTTCAAGAGAAGAACAAGATGAGTTTGCTCTT GCATCACAAAAAAAAGCTGAAGAAGCTATAAAATCAGGTCAATTTAAAGATGAAATAGTTCCTGTAGTAATTAAAGG CAGAAAGGGAGAAACTGTAGTTGATACAGATGAGCACCCTAGATTTGGATCAACTATAGAAGGACTTGCAAAATTAA
ATCATGAGTGCAGAAAAAGCTAAAGAGCTTGGAGTAAAACCACTTGCTAAGATAGTTTCTTATGGTTCAGCAGGAGT TGACCCAGCAATAATGGGATATGGACCTTTCTATGCAACAAAAGCAGCTATTGAAAAAGCAGGTTGGACAGTTGATG AATTAGATTTAATAGAATCAAATGAAGCTTTTGCAGCTCAAAGTTTAGCAGTAGCAAAAGATTTAAAATTTGATATG
TCTTGTACACGCAATGCAAAAAAGAGATGCAAAAAAAGGCTTAGCAACTTTATGTATAGGTGGCGGACAAGGAACAG CAATATTGCTAGAAAAGTGCTAGAAAGGATCCAGAATTTAAAAGGAGGGATTAAAATGAACTCTAAAATAATTAGAT TTGAAAATTTAAGGTCATTCTTTAAAGATGGGATGACAATTATGATTGGAGGTTTTTTAAACTGTGGCACTCCAACC
AGGTATTGGTAAGTTAATATCAAATAATCAAGTAAAAAAGCTTATTGCTTCATATATAGGCAGCAACCCAGATACTG
AAATGGAACGGAATATTTGTTAGAGCTACCTCTTACAGCCGATGTAGCATTAATTAAAGGTAGTATTGTAGATGAGG CCGGAAACACCTTCTATAAAGGTACTACTAAAAACTTTAATCCCTATATGGCAATGGCAGCTAAAACCGTAATAGTT
AGTAAAGGAGCCTGCATAAAATGATTAATGATAAAAACCTAGCGAAAGAAATAATAGCCAAAAGAGTTGCAAGAGAA TTAAAAAATGGTCAACTTGTAAACTTAGGTGTAGGTCTTCCTACCATGGTTGCAGATTATATACCAAAAAATTTCAA AATTACTTTCCAATCAGAAAACGGAATAGTTGGAATGGGCGCTAGTCCTAAAATAAATGAGGCAGATAAAGATGTAG TAAATGCAGGAGGAGACTATACAACAGTACTTCCTGACGGCACATTTTTCGATAGCTCAGTTTCGTTTTCACTAATC CGTGGTGGTCACGTAGATGTTACTGTTTTAGGGGCTCTCCAGGTAGATGAAAAGGGTAATATAGCCAATTGGATTGT TCCTGGAAAAATGCTCTCTGGTATGGGTGGAGCTATGGATTTAGTAAATGGAGCTAAGAAAGTAATAATTGCAATGA GACATACAAATAAAGGTCAACCTAAAATTTTAAAAAAATGTACACTTCCCCTCACGGCAAAGTCTCAAGCAAATCTA ATTGTAACAGAACTTGGAGTAATTGAGGTTATTAATGATGGTTTACTTCTCACTGAAATTAATAAAAACACAACCAT TGATGAAATAAGGTCTTTAACTGCTGCAGATTTACTCATATCCAATGAACTTAGACCCATGGCTGTTTAGAAAGAAT TCTTGATATCAGGAAGGTGACTTTTATGTTAAAGGATGAAGTAATTAAACAAATTAGCACGCCATTAACTTCGCCTG CATTTCCTAGAGGACCCTATAAATTTCATAATCGTGAGTATTTTAACATTGTATATCGTACAGATATGGATGCTCTT
CGTAAΆGTTGTGCCAGAGCCTTTAGAAATTGATGAGCCCTTAGTCAGGTTTGAAATTATGGCAATGCATGATACGAG
TGGACTTGGTTGTTATACAGAAAGCGGACAGGCTATTCCCGTAAGCTGTAATGGAGTTAAGGGAGATTATCTTCATA TGATGTATTTAGATAATGAGCCTGCAATTGCAGTAGGAAGGGAATTAAGTGCATATCCTAAAAAGCTCGGGTATCCA AAGCTTTTTGTGGATTCAGATACTTTAGTAGGAACTTTAGACTATGGAAAACTTAGAGTTGCGACAGCTACAATGGG GTACAAACATAAAGCCTTAGATGCTAATGAAGCAAAGGATCAAATTTGTCGCCCTAATTATATGTTGAAAATAATAC CCAATTATGATGGAAGCCCTAGGATATGTGAGCTTATAAATGCGAAAATCACAGATGTTACCGTACATGAAGCTTGG ACAGGACCAACTCGACTGCAGTTATTTGATCACGCTATGGCGCCACTTAATGATTTGCCAGTAAAAGAGATTGTTTC TAGCTCTCACATTCTTGCAGATATAATATTGCCTAGAGCTGAAGTTATATATGATTATCTTAAGTAATAAAAATAAG AGTTACCTTAAATGGTAACTCTTATTTTTTTAATGTCGACCGAGAAATGTGAGCGGATAACAATTGACATTGTGAGC GGATAACAAGATACTGAGCACATCAGCAGGACGCACTGACCGGGAATTCATGAAAGGTTTTGCAATGCTAGGTATTA ATAAGTTAGGATGGATCGAAAAAGAAAGGCCAGTTGCGGGTTCATATGATGCTATTGTACGCCCATTAGCAGTATCT CCGTGTACATCAGATATACATACTGTTTTTGAGGGAGCTCTTGGAGATAGGAAGAATATGATTTTAGGGCATGAAGC TGTAGGTGAAGTTGTTGAAGTAGGAAGTGAAGTGAAGGATTTTAAACCTGGTGACAGAGTTATAGTTCCTTGTACAA CTCCAGATTGGAGATCTTTGGAAGTTCAAGCTGGTTTTCAACAGCACTCAAACGGTATGCTCGCAGGATGGAAATTT TCAAATTTCAAGGATGGAGTTTTTGGTGAATATTTTCATGTAAATGATGCGGATATGAATCTTGCGATTCTACCTAA AGACATGCCATTAGAAAATGCTGTTATGATAACAGATATGATGACTACTGGATTTCATGGAGCAGAACTTGCAGATA TTCAAATGGGTTCAAGTGTTGTGGTAATTGGCATTGGAGCTGTTGGCTTAATGGGAATAGCAGGTGCTAAATTACGT GGAGCAGGTAGAATAATTGGAGTGGGGAGCAGGCCGATTTGTGTTGAGGCTGCAAAATTTTATGGAGCAACAGATAT TCTAAATTATAAAAATGGTCATATAGTTGATCAAGTTATGAAATTAACGAATGGAAAAGGCGTTGACCGCGTAATTA TGGCAGGCGGTGGTTCTGAAACATTATCCCAAGCAGTATCTATGGTTAAACCAGGAGGAATAATTTCTAATATAAAT TATCATGGAAGTGGAGATGCTTTACTAATACCACGTGTAGAATGGGGATGTGGAATGGCTCACAAGACTATAAAAGG AGGTCTTTGTCCTGGGGGACGTTTGAGAGCAGAAATGTTAAGAGATATGGTAGTATATAATCGTGTTGATCTAAGTA
GTGTGCACGAACCCCCCGTTCAGCCCGACCGCTGCGCCTTATCCGGTAACTATCGTCTTGAGTCCAACCCGGTAAGA
CACGACTTATCGCCACTGGCAGCAGCCACTGGTAACAGGATTAGCAGAGCGAGGTATGTAGGCGGTGCTACAGAGTT
TCGGAAAAAGAGTTGGTAGCTCTTGATCCGGCAAACAAACCACCGCTGGTAGCGGTGGTTTTTTTGTTTGCAAGCAG CAGATTACGCGCAGAAAAAAAGGATCTCAΆGAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGA
GTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCTGACAGTTACCAATGCTTAATCAGTGAGGCACCTATC TCAGCGATCTGTCTATTTCGTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGGCTT ACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCTCCAGATTTATCAGCAATAAACCAGC
AAGCGGTTAGCTCCTTCGGTCCTCCGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATGGCA GCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGACTGGTGAGTACTCAACCAAGTCATT CTGAGAATAGTGTATGCGGCGACCGAGTTGCTCTTGCCCGGCGTCAATACGGGATAATACCGCGCCACATAGCAGAA CTTTAAAAGTGCTCATCATTGGAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGCTGTTGAGATCCAGT
ATTATTGAAGCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTGAATGTATTTAGAAAAATAAACAAATA
GGGGTTCCGCGCACATTTCCCCGAAAAGTC
AAATAGGCGTATCACGAGGCCCTTTCGTC
Claims
1. A method of making a bio-based material precursor, the method comprising: a) providing a feedstock comprising a suitable carbon source obtained from starch, cellulose, hemicellulosef or pectin; and b) contacting the feedstock of a) with a biocatalyst operable to produce the bio-based material precursor, wherein the bio-based material precursor is produced at a yield of at least about 50 per cent of theoretical yield; and c) recovering the bio-based material precursor.
2. The method of claim 1, wherein the bio-based material precursor comprises 1-proρanol or 2-propanol.
3. The method of claim 1, wherein the precursor-derived bio-based material comprises propylene or polypropylene.
4. The method of claim 1 , wherein the biocatalyst is a yeast.
5. The method of claim 1 , wherein the carbon source comprises at least one of a six-carbon sugar, a six-carbon sugar oligomer, or a five-carbon sugar.
6. The method of claim 1 , wherein the bio-based material precursor is produced at a yield of at least about 60 per cent of theoretical.
7. The method of claim 1, wherein the bio-based material precursor is produced at a yield of at least about 70 per cent of theoretical,
8. The method of claim 1 , wherein the bio-based material precursor is produced at a yield of at least about 80 per cent of theoretical.
9. The method of claim 1 , wherein the bio-based material precursor is produced at a yield of at least about 90 per cent of theoretical.
10. A method of making a bio-based material precursor, the method comprising: a) providing a feedstock comprising a suitable carbon source obtained from starchy cellulose, hemicellulose, or pectin; and b) contacting the feedstock of a) with a biocatalyst operable to produce the bio-based material precursor, wherein the bio-based material precursor is produced at a volumetric productivity of at least about 0.4 g/L/h.; and c) recovering the bio-based material precursor.
11. The method of claim 10, wherein the bio-based material precursor comprises 1-propanol or 2-ρroρanol.
12. The method of claim 10, wherein the precursor-derived bio-based material comprises propylene or polypropylene.
13. The method of claim 10, wherein the biocatalyst is a yeast.
14. The method of claim 10, wherein the carbon source comprises at least one of a six-carbon sugar, a six-carbon sugar oligomer, or a five-carbon sugar.
15. The method of claim 11 , wherein the bio-based material precursor is produced at a volumetric productivity of at least about 1 g/L/h.
16. The method of claim 12, wherein the bio-based material precursor is produced at a volumetric productivity of at least about 2 g/L/h.
17. A method of making a bio-based material precursor, the method comprising: a) providing a feedstock comprising a suitable carbon source obtained from starch, cellulose, hemicellulose, or pectin; and
b) contacting the feedstock of a) with a biocatalyst operable to produce the bio-based material precursor, wherein the bio-based material precursor is produced at a titer of at least about 14 g/L/h; and c) recovering the bio-based material precursor.
18. The method of claim 17, wherein the bio-based material precursor comprises 1-propanol or 2-propanol.
19. The method of claim 17, wherein the precursor-derived bio-based material comprises propylene or polypropylene.
20. The method of claim 17, wherein the biocatalyst is a yeast.
21. The method of claim 17, wherein the carbon source comprises at least one of a six-carbon sugar, a six-carbon sugar oligomer, or a five-carbon sugar.
22. The method of claim 17, wherein the bio-based material precursor is produced at a titer of at least about 20 g/L.
23. The method of claim 17, wherein the bio-based material precursor is produced at a titer of at least about 30 g/L.
24. A method of making a bio-based material precursor, the method comprising: a) providing a feedstock comprising a suitable carbon source obtained from starch, cellulose, hemicellulose, or pectin; and b) contacting the feedstock of a) with a biocatalyst operable to produce the bio-based material precursor, wherein the bio-based material precursor is produced at: i) a yield of at least about 50 per cent of theoretical; ii) a volumetric productivity of at least about 0.4 g/L/h; and iii) a titer of at least about 14 g/L; and c) recovering the bio-based material precursor.
25. A method of producing propylene comprising: a) contacting a biocatalyst with a fermentable carbon source under conditions whereby propanol is produced; b) recovering the propanol; and c) dehydrating the recovered propanol in the presence of an acid catalyst, thereby producing propylene and water.
26. The method of claim 25, wherein the biocatalyst is a recombinant microorganism.
27. The method of claim 25, wherein the propanol is 1-propanol.
28. The method of claim 25, wherein the propanol is isopropanol.
29. The method of claim 25, wherein said contacting of step (a) is a homofermentation.
30. The method of claim 25, further comprising:
(d) separating the propylene from the water obtained in step (c); and
(e) recovering the propylene.
31. The method of claim 30, wherein the purity of the propylene recovered in step (e) is in the range of about 60% to about 90%.
32. The method of claim 30, wherein the purity of the propylene recovered in step (e) is in the range of about 92% to about 99%.
33. The method of claim 30, wherein the purity of the propylene recovered in step (e) is greater than about 99%.
34. The method of claim 25, wherein said propanol dehydrated in step (c) is aqueous propanol comprising about 1% to about 30% water.
35. The method of claim 25, wherein said propanol dehydrated in step (c) dry propanol comprising less than about 1 % water.
36. The method of claim 26, wherein the recombinant microbial host cell comprises each of the DNA molecules encoding a polypeptide or group of polypeptides that catalyze the conversion:
(i) Acetyl-Co A to Acetate and CoA (conversion 1 )
(ϋ) Acetyl-CoA to Acetoacetyl-CoA and CoA (conversion 2)
(iii) Acetoacetyl-CoA and Acetate to Acetoacetate and Acetyl-CoA (conversion
3.1)
(iv) Acetoacetate to Acetone and CO2 (conversion 4)
(v) Acetone and NAD(P)H and H+ to Isopropanol and NAD(P)+ (conversion 5) wherein the at least one DNA molecule is heterologous to said microbial host cell and wherein said microbial host cell produces isopropanol.
37. The method of claim 36, wherein said contacting of step (a) is a homo fermentation.
38. The method of claim 36, further comprising:
(d) separating the propylene from the water obtained in step (c); and
(e) recovering the propylene.
39. The method of claim 38, wherein the purity of the propylene recovered in step (e) is in the range of about 60% to about 90%.
40. The method of claim 38, wherein the purity of the propylene recovered in step (e) is in the range of about 92% to about 99%.
41. The method of claim 38, wherein the purity of the propylene recovered in step (e) is greater than about 99%.
42. The method of claim 25, wherein said propanol dehydrated in step (c) is aqueous isopropanol comprising about X% to about Y% water.
43. The method of claim 25, wherein said propanol dehydrated in step (c) dry iso-propanol comprising less than about Z% water.
Applications Claiming Priority (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US2918308P | 2008-02-15 | 2008-02-15 | |
US2920008P | 2008-02-15 | 2008-02-15 | |
US61/029,200 | 2008-02-15 | ||
US61/029,183 | 2008-02-15 | ||
US3365908P | 2008-03-04 | 2008-03-04 | |
US61/033,659 | 2008-03-04 | ||
US5588608P | 2008-05-23 | 2008-05-23 | |
US61/055,886 | 2008-05-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2009103026A1 true WO2009103026A1 (en) | 2009-08-20 |
Family
ID=40810599
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2009/034152 WO2009103026A1 (en) | 2008-02-15 | 2009-02-13 | Engineered microorganisms for producing isopropanol |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2009103026A1 (en) |
Cited By (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7858350B2 (en) | 2008-09-10 | 2010-12-28 | Genomatica, Inc. | Microorganisms for the production of 1,4-butanediol |
WO2011029166A1 (en) | 2009-09-09 | 2011-03-17 | Braskem S.A. | Microorganisms and process for producing n-propanol |
US7947483B2 (en) | 2007-08-10 | 2011-05-24 | Genomatica, Inc. | Methods and organisms for the growth-coupled production of 1,4-butanediol |
US7977084B2 (en) | 2008-03-05 | 2011-07-12 | Genomatica, Inc. | Primary alcohol producing organisms |
WO2011111638A1 (en) | 2010-03-09 | 2011-09-15 | 三井化学株式会社 | Highly productive isopropyl alcohol-producing bacterium |
US8026386B2 (en) | 2007-08-10 | 2011-09-27 | Genomatica, Inc. | Methods for the synthesis of olefins and derivatives |
US8067214B2 (en) | 2007-03-16 | 2011-11-29 | Genomatica, Inc. | Compositions and methods for the biosynthesis of 1,4-butanediol and its precursors |
WO2012020833A1 (en) | 2010-08-12 | 2012-02-16 | 三井化学株式会社 | Isopropyl alcohol-producing bacterium having improved productivity by gntr destruction |
US8129154B2 (en) | 2008-06-17 | 2012-03-06 | Genomatica, Inc. | Microorganisms and methods for the biosynthesis of fumarate, malate, and acrylate |
US8129169B2 (en) | 2009-06-04 | 2012-03-06 | Genomatica, Inc. | Microorganisms for the production of 1,4-butanediol and related methods |
WO2012058566A1 (en) | 2010-10-29 | 2012-05-03 | Novozymes A/S | Polypeptides having succinyl-coa:aceto acetate transferase activity and polynucleotides encoding same |
WO2012058603A1 (en) | 2010-10-29 | 2012-05-03 | Novozymes A/S | Recombinant n-propanol and isopropanol production |
WO2012080421A1 (en) * | 2010-12-17 | 2012-06-21 | Total Petrochemicals Research Feluy | Process for producing propylene from syngas via fermentative propanol production and dehydration |
EP2467490A1 (en) * | 2009-08-21 | 2012-06-27 | Mascoma Corporation | Production of propanols, alcohols, and polyols in consolidated bioprocessing organisms |
WO2012168668A1 (en) * | 2011-06-10 | 2012-12-13 | Arkema France | Process for synthesizing bifunctional hydrocarbon-based compounds from biomass |
EP2563926A1 (en) * | 2010-04-30 | 2013-03-06 | Genomatica, Inc. | Microorganisms and methods for the biosynthesis of propylene |
FR2981089A1 (en) * | 2011-10-11 | 2013-04-12 | IFP Energies Nouvelles | PRODUCTION OF ISOPROPANOL BY IMPROVED RECOMBINANT STRAINS |
WO2013178699A1 (en) | 2012-05-31 | 2013-12-05 | Novozymes A/S | Isopropanol production by bacterial hosts |
US8691553B2 (en) | 2008-01-22 | 2014-04-08 | Genomatica, Inc. | Methods and organisms for utilizing synthesis gas or other gaseous carbon sources and methanol |
WO2014068010A1 (en) | 2012-10-31 | 2014-05-08 | Novozymes A/S | Isopropanol production by bacterial hosts |
WO2014076232A2 (en) | 2012-11-19 | 2014-05-22 | Novozymes A/S | Isopropanol production by recombinant hosts using an hmg-coa intermediate |
US8865439B2 (en) | 2008-05-01 | 2014-10-21 | Genomatica, Inc. | Microorganisms for the production of methacrylic acid |
US8993285B2 (en) | 2009-04-30 | 2015-03-31 | Genomatica, Inc. | Organisms for the production of isopropanol, n-butanol, and isobutanol |
US9017983B2 (en) | 2009-04-30 | 2015-04-28 | Genomatica, Inc. | Organisms for the production of 1,3-butanediol |
US9222113B2 (en) | 2009-11-25 | 2015-12-29 | Genomatica, Inc. | Microorganisms and methods for the coproduction 1,4-butanediol and gamma-butyrolactone |
US9562241B2 (en) | 2009-08-05 | 2017-02-07 | Genomatica, Inc. | Semi-synthetic terephthalic acid via microorganisms that produce muconic acid |
US9650651B2 (en) * | 2013-03-14 | 2017-05-16 | Rathin Datta | Method for production of n-propanol and other C3-containing products from syngas by symbiotic co-cultures of anaerobic microorganisms |
US9677045B2 (en) | 2012-06-04 | 2017-06-13 | Genomatica, Inc. | Microorganisms and methods for production of 4-hydroxybutyrate, 1,4-butanediol and related compounds |
US9938542B2 (en) | 2015-02-27 | 2018-04-10 | White Dog Labs, Inc. | Mixotrophic fermentation method for making acetone, isopropanol, butyric acid and other bioproducts, and mixtures thereof |
US10167477B2 (en) | 2009-10-23 | 2019-01-01 | Genomatica, Inc. | Microorganisms and methods for the production of aniline |
CN109996865A (en) * | 2016-07-12 | 2019-07-09 | 布拉斯肯有限公司 | It is dehydrated to form alkene by the enzymatic of alkanol |
US10385344B2 (en) | 2010-01-29 | 2019-08-20 | Genomatica, Inc. | Microorganisms and methods for the biosynthesis of (2-hydroxy-3methyl-4-oxobutoxy) phosphonate |
US10793882B2 (en) | 2010-07-26 | 2020-10-06 | Genomatica, Inc. | Microorganisms and methods for the biosynthesis of aromatics, 2,4-pentadienoate and 1,3-butadiene |
US10829789B2 (en) | 2016-12-21 | 2020-11-10 | Creatus Biosciences Inc. | Methods and organism with increased xylose uptake |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007095398A2 (en) * | 2006-02-14 | 2007-08-23 | Verenium Corporation | Xylanases, nucleic acids encoding them and methods for making and using them |
US20070243592A1 (en) * | 2006-04-13 | 2007-10-18 | David Peter R | Compositions and methods for producing fermentation products and residuals |
WO2008131286A1 (en) * | 2007-04-18 | 2008-10-30 | Gevo, Inc. | Engineered microorganisms for producing isopropanol |
-
2009
- 2009-02-13 WO PCT/US2009/034152 patent/WO2009103026A1/en active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007095398A2 (en) * | 2006-02-14 | 2007-08-23 | Verenium Corporation | Xylanases, nucleic acids encoding them and methods for making and using them |
US20070243592A1 (en) * | 2006-04-13 | 2007-10-18 | David Peter R | Compositions and methods for producing fermentation products and residuals |
WO2008131286A1 (en) * | 2007-04-18 | 2008-10-30 | Gevo, Inc. | Engineered microorganisms for producing isopropanol |
Non-Patent Citations (4)
Title |
---|
ATSUMI SHOTA ET AL: "Non-fermentative pathways for synthesis of branched-chain higher alcohols as biofuels", NATURE, NATURE PUBLISHING GROUP, LONDON, UK, vol. 451, no. 7174, 1 January 2008 (2008-01-01), pages 86 - 90, XP002491157, ISSN: 0028-0836 * |
DIMITAR KARAKASHEV ET AL: "Anaerobic biotechnological approaches for production of liquid energy carriers from biomass", BIOTECHNOLOGY LETTERS, KLUWER ACADEMIC PUBLISHERS, DO, vol. 29, no. 7, 5 April 2007 (2007-04-05), pages 1005 - 1012, XP019498089, ISSN: 1573-6776 * |
HANAI T ET AL: "Engineered synthetic pathway for isopropanol production in Escherichia coli", APPLIED AND ENVIRONMENTAL MICROBIOLOGY, vol. 73, no. 24, December 2007 (2007-12-01), pages 7814 - 7818, XP009120156, ISSN: 0099-2240 * |
TORU JOJIMA ET AL: "Production of isopropanol by metabolically engineered Escherichia coli", APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, SPRINGER, BERLIN, DE, vol. 77, no. 6, 7 November 2007 (2007-11-07), pages 1219 - 1224, XP019586231, ISSN: 1432-0614 * |
Cited By (76)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8889399B2 (en) | 2007-03-16 | 2014-11-18 | Genomatica, Inc. | Compositions and methods for the biosynthesis of 1,4-butanediol and its precursors |
US9487803B2 (en) | 2007-03-16 | 2016-11-08 | Genomatica, Inc. | Compositions and methods for the biosynthesis of 1,4-butanediol and its precursors |
US8969054B2 (en) | 2007-03-16 | 2015-03-03 | Genomatica, Inc. | Compositions and methods for the biosynthesis of 1,4-butanediol and its precursors |
US11371046B2 (en) | 2007-03-16 | 2022-06-28 | Genomatica, Inc. | Compositions and methods for the biosynthesis of 1,4-butanediol and its precursors |
US8067214B2 (en) | 2007-03-16 | 2011-11-29 | Genomatica, Inc. | Compositions and methods for the biosynthesis of 1,4-butanediol and its precursors |
US7947483B2 (en) | 2007-08-10 | 2011-05-24 | Genomatica, Inc. | Methods and organisms for the growth-coupled production of 1,4-butanediol |
US8026386B2 (en) | 2007-08-10 | 2011-09-27 | Genomatica, Inc. | Methods for the synthesis of olefins and derivatives |
US8691553B2 (en) | 2008-01-22 | 2014-04-08 | Genomatica, Inc. | Methods and organisms for utilizing synthesis gas or other gaseous carbon sources and methanol |
US9051552B2 (en) | 2008-01-22 | 2015-06-09 | Genomatica, Inc. | Methods and organisms for utilizing synthesis gas or other gaseous carbon sources and methanol |
US10550411B2 (en) | 2008-01-22 | 2020-02-04 | Genomatica, Inc. | Methods and organisms for utilizing synthesis gas or other gaseous carbon sources and methanol |
US9885064B2 (en) | 2008-01-22 | 2018-02-06 | Genomatica, Inc. | Methods and organisms for utilizing synthesis gas or other gaseous carbon sources and methanol |
US9260729B2 (en) | 2008-03-05 | 2016-02-16 | Genomatica, Inc. | Primary alcohol producing organisms |
US10208320B2 (en) | 2008-03-05 | 2019-02-19 | Genomatica, Inc. | Primary alcohol producing organisms |
US7977084B2 (en) | 2008-03-05 | 2011-07-12 | Genomatica, Inc. | Primary alcohol producing organisms |
US11613767B2 (en) | 2008-03-05 | 2023-03-28 | Genomatica, Inc. | Primary alcohol producing organisms |
US8865439B2 (en) | 2008-05-01 | 2014-10-21 | Genomatica, Inc. | Microorganisms for the production of methacrylic acid |
US9951355B2 (en) | 2008-05-01 | 2018-04-24 | Genomatica, Inc. | Microorganisms for the production of methacrylic acid |
US8900837B2 (en) | 2008-05-01 | 2014-12-02 | Genomatica, Inc. | Microorganisms for the production of 2-hydroxyisobutyric acid |
US8129154B2 (en) | 2008-06-17 | 2012-03-06 | Genomatica, Inc. | Microorganisms and methods for the biosynthesis of fumarate, malate, and acrylate |
US8178327B2 (en) | 2008-09-10 | 2012-05-15 | Genomatica, Inc. | Microorganisms for the production of 1,4-butanediol |
US9175297B2 (en) | 2008-09-10 | 2015-11-03 | Genomatica, Inc. | Microorganisms for the production of 1,4-Butanediol |
US7858350B2 (en) | 2008-09-10 | 2010-12-28 | Genomatica, Inc. | Microorganisms for the production of 1,4-butanediol |
US8993285B2 (en) | 2009-04-30 | 2015-03-31 | Genomatica, Inc. | Organisms for the production of isopropanol, n-butanol, and isobutanol |
US9017983B2 (en) | 2009-04-30 | 2015-04-28 | Genomatica, Inc. | Organisms for the production of 1,3-butanediol |
US10273508B2 (en) | 2009-06-04 | 2019-04-30 | Genomatica, Inc. | Microorganisms for the production of 1,4-butanediol and related methods |
US11401534B2 (en) | 2009-06-04 | 2022-08-02 | Genomatica, Inc. | Microorganisms for the production of 1,4- butanediol and related methods |
US9434964B2 (en) | 2009-06-04 | 2016-09-06 | Genomatica, Inc. | Microorganisms for the production of 1,4-butanediol and related methods |
US8129169B2 (en) | 2009-06-04 | 2012-03-06 | Genomatica, Inc. | Microorganisms for the production of 1,4-butanediol and related methods |
US10041093B2 (en) | 2009-08-05 | 2018-08-07 | Genomatica, Inc. | Semi-synthetic terephthalic acid via microorganisms that produce muconic acid |
US10415063B2 (en) | 2009-08-05 | 2019-09-17 | Genomatica, Inc. | Semi-synthetic terephthalic acid via microorganisms that produce muconic acid |
US9562241B2 (en) | 2009-08-05 | 2017-02-07 | Genomatica, Inc. | Semi-synthetic terephthalic acid via microorganisms that produce muconic acid |
US11634735B2 (en) | 2009-08-21 | 2023-04-25 | Lallemand Hungary Liquidity Management Llc | Production of propanols, alcohols, and polyols in consolidated bioprocessing organisms |
US9957530B2 (en) | 2009-08-21 | 2018-05-01 | Lallemand Hungary Liquidity Management Llc | Production of propanols, alcohols, and polyols in consolidated bioprocessing organisms |
EP2467490A1 (en) * | 2009-08-21 | 2012-06-27 | Mascoma Corporation | Production of propanols, alcohols, and polyols in consolidated bioprocessing organisms |
WO2011029166A1 (en) | 2009-09-09 | 2011-03-17 | Braskem S.A. | Microorganisms and process for producing n-propanol |
US10612029B2 (en) | 2009-10-23 | 2020-04-07 | Genomatica, Inc. | Microorganisms and methods for the production of aniline |
US10167477B2 (en) | 2009-10-23 | 2019-01-01 | Genomatica, Inc. | Microorganisms and methods for the production of aniline |
US9988656B2 (en) | 2009-11-25 | 2018-06-05 | Genomatica, Inc. | Microorganisms and methods for the coproduction 1,4-butanediol and gamma-butyrolactone |
US10662451B2 (en) | 2009-11-25 | 2020-05-26 | Genomatica, Inc. | Microorganisms and methods for the coproduction 1,4-butanediol and gamma-butyrolactone |
US9222113B2 (en) | 2009-11-25 | 2015-12-29 | Genomatica, Inc. | Microorganisms and methods for the coproduction 1,4-butanediol and gamma-butyrolactone |
US10385344B2 (en) | 2010-01-29 | 2019-08-20 | Genomatica, Inc. | Microorganisms and methods for the biosynthesis of (2-hydroxy-3methyl-4-oxobutoxy) phosphonate |
US8932845B2 (en) | 2010-03-09 | 2015-01-13 | Mitsui Chemicals, Inc. | Highly productive isopropyl alcohol-producing bacterium |
WO2011111638A1 (en) | 2010-03-09 | 2011-09-15 | 三井化学株式会社 | Highly productive isopropyl alcohol-producing bacterium |
EP2563926A4 (en) * | 2010-04-30 | 2013-11-20 | Genomatica Inc | Microorganisms and methods for the biosynthesis of propylene |
EP2563926A1 (en) * | 2010-04-30 | 2013-03-06 | Genomatica, Inc. | Microorganisms and methods for the biosynthesis of propylene |
US9023636B2 (en) | 2010-04-30 | 2015-05-05 | Genomatica, Inc. | Microorganisms and methods for the biosynthesis of propylene |
US10793882B2 (en) | 2010-07-26 | 2020-10-06 | Genomatica, Inc. | Microorganisms and methods for the biosynthesis of aromatics, 2,4-pentadienoate and 1,3-butadiene |
WO2012020833A1 (en) | 2010-08-12 | 2012-02-16 | 三井化学株式会社 | Isopropyl alcohol-producing bacterium having improved productivity by gntr destruction |
US9267156B2 (en) | 2010-08-12 | 2016-02-23 | Mitsui Chemicals, Inc. | Isopropyl alcohol-producing bacterium having improved productivity by GntR destruction |
CN103068968B (en) * | 2010-08-12 | 2014-07-23 | 三井化学株式会社 | Isopropyl alcohol-producing bacterium having improved productivity by gntr destruction |
JP5674789B2 (en) * | 2010-08-12 | 2015-02-25 | 三井化学株式会社 | Isopropyl alcohol-producing bacterium with improved productivity by destroying gntR |
CN103068968A (en) * | 2010-08-12 | 2013-04-24 | 三井化学株式会社 | Isopropyl alcohol-producing bacterium having improved productivity by gntr destruction |
JP2013544083A (en) * | 2010-10-29 | 2013-12-12 | ノボザイムス アクティーゼルスカブ | Recombinant n-propanol and isopropanol production |
US8728804B2 (en) | 2010-10-29 | 2014-05-20 | Novozymes A/S | Polypeptides having succinyl-CoA: acetoacetate transferase activity and polynucleotides encoding same |
WO2012058603A1 (en) | 2010-10-29 | 2012-05-03 | Novozymes A/S | Recombinant n-propanol and isopropanol production |
WO2012058566A1 (en) | 2010-10-29 | 2012-05-03 | Novozymes A/S | Polypeptides having succinyl-coa:aceto acetate transferase activity and polynucleotides encoding same |
WO2012080421A1 (en) * | 2010-12-17 | 2012-06-21 | Total Petrochemicals Research Feluy | Process for producing propylene from syngas via fermentative propanol production and dehydration |
US10030255B2 (en) | 2011-06-10 | 2018-07-24 | Arkema France | Process for synthesizing bifunctional hydrocarbon-based compounds from biomass |
WO2012168668A1 (en) * | 2011-06-10 | 2012-12-13 | Arkema France | Process for synthesizing bifunctional hydrocarbon-based compounds from biomass |
WO2013054022A1 (en) * | 2011-10-11 | 2013-04-18 | IFP Energies Nouvelles | Production of isopropanol by improved recombinant strains |
US9399781B2 (en) | 2011-10-11 | 2016-07-26 | IFP Energies Nouvelles | Production of isopropanol by improved recombinant strains |
FR2981089A1 (en) * | 2011-10-11 | 2013-04-12 | IFP Energies Nouvelles | PRODUCTION OF ISOPROPANOL BY IMPROVED RECOMBINANT STRAINS |
CN103930391A (en) * | 2011-10-11 | 2014-07-16 | Ifp新能源公司 | Production of isopropanol by improved recombinant strains |
WO2013178699A1 (en) | 2012-05-31 | 2013-12-05 | Novozymes A/S | Isopropanol production by bacterial hosts |
US11932845B2 (en) | 2012-06-04 | 2024-03-19 | Genomatica, Inc. | Microorganisms and methods for production of 4-hydroxybutyrate, 1,4-butanediol and related compounds |
US9677045B2 (en) | 2012-06-04 | 2017-06-13 | Genomatica, Inc. | Microorganisms and methods for production of 4-hydroxybutyrate, 1,4-butanediol and related compounds |
US11085015B2 (en) | 2012-06-04 | 2021-08-10 | Genomatica, Inc. | Microorganisms and methods for production of 4-hydroxybutyrate, 1,4-butanediol and related compounds |
WO2014068010A1 (en) | 2012-10-31 | 2014-05-08 | Novozymes A/S | Isopropanol production by bacterial hosts |
WO2014076232A2 (en) | 2012-11-19 | 2014-05-22 | Novozymes A/S | Isopropanol production by recombinant hosts using an hmg-coa intermediate |
US9650651B2 (en) * | 2013-03-14 | 2017-05-16 | Rathin Datta | Method for production of n-propanol and other C3-containing products from syngas by symbiotic co-cultures of anaerobic microorganisms |
US9938542B2 (en) | 2015-02-27 | 2018-04-10 | White Dog Labs, Inc. | Mixotrophic fermentation method for making acetone, isopropanol, butyric acid and other bioproducts, and mixtures thereof |
EP3484998A4 (en) * | 2016-07-12 | 2020-02-26 | Braskem S.A. | Formation of alkenes through enzymatic dehydration of alkanols |
US11286490B2 (en) | 2016-07-12 | 2022-03-29 | Braskem S.A. | Formation of alkenes through enzymatic dehydration of alkanols |
CN109996865A (en) * | 2016-07-12 | 2019-07-09 | 布拉斯肯有限公司 | It is dehydrated to form alkene by the enzymatic of alkanol |
US20190323016A1 (en) * | 2016-07-12 | 2019-10-24 | Braskem S.A. | Formation of alkenes through enzymatic dehydration of alkanols |
US10829789B2 (en) | 2016-12-21 | 2020-11-10 | Creatus Biosciences Inc. | Methods and organism with increased xylose uptake |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20090246842A1 (en) | Engineered microorganisms for producing propanol | |
WO2009103026A1 (en) | Engineered microorganisms for producing isopropanol | |
US11634735B2 (en) | Production of propanols, alcohols, and polyols in consolidated bioprocessing organisms | |
US20080293125A1 (en) | Engineered microorganisms for producing isopropanol | |
AU2010292910B2 (en) | Microorganisms and process for producing n-propanol | |
CA2882276E (en) | Recombinant microorganisms expressing a stereospecific diol dehydratase enzyme | |
US20180057843A1 (en) | Methods for biosynthesis of isobutene | |
AU2012221176B2 (en) | Recombinant microorganisms and uses therefor | |
WO2009049274A2 (en) | Microorganism engineered to produce isopropanol | |
WO2012045022A2 (en) | Metabolic engineering of clostridium tyrobutyricum for butanol production | |
JP6407141B2 (en) | Enzymes with altered metabolite activity | |
US20150152445A1 (en) | Microorganisms and methods for the production of ketones | |
Erz | 2, 3-Butanediol production using acetogenic bacteria |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 09710386 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 09710386 Country of ref document: EP Kind code of ref document: A1 |